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Abstract
Upon an instantaneous increase in work rate (WR), pulmonary O2 uptake (V̇O2p) increases in
an exponential-like manner towards a new steady-state. To support this increase in V̇O2p there
is an increase in blood flow (BF; O2 delivery) to the muscle. Previous research has shown that
the rate of this increase in V̇O2p (which defines V̇O2p kinetics) becomes progressively slower
with increasing baseline WR (WRbl). Given the paucity of research on blood flow dynamics
and underlying muscle metabolic rate, this thesis examined the effect of metabolic rate on the
dynamics and relationships amongst V̇O2p, BF, and muscle deoxygenation (deoxy[Hb + Mb]).
Using mass spectrometry and volume turbinometry, Doppler ultrasound, and near-infrared
spectroscopy (NIRS), the response of V̇O2p, BF, and deoxy[Hb + Mb] were measured,
respectively, in response to step transitions in alternate-leg, knee-extension exercise from: i) a
common WRbl (3 W) to increasing ΔWR (21, 30, 42, 51, 63 W); and ii) increasing WRbl (3,
12, 24, 33, 45 W) with a common ΔWR (21 W). As the BF signal is distorted by fluctuations
in arterial pressure (from the heart rate (HR) cycle) and intramuscular pressure (from the
contraction-relaxation (CR) cycle), it was necessary to first determine an acceptable technique
for integrating the BF signal. From integrating BF by the CR or HR cycle over 1, 2, or 5 cycles
using either ‘binning’ or ‘rolling’ averages, it was found that averaging the signal over a single
CR cycle (CR1) was preferred due to its low variability. In analyzing the kinetic response to
the various exercise transitions, it was found that: i) BF kinetics were similar across different
ΔWR’s, but became progressively slower with increasing WRbl before significantly speeding
at the highest WRbl; ii) V̇O2p kinetics became progressively slower with both increasing ΔWR
and WRbl; iii) the increase in BF relative to the increase in metabolic demand (ΔBF/ΔV̇O2p)
became progressively smaller with both increasing ΔWR and increasing WRbl; iv) deoxy[Hb
+ Mb] kinetics became progressively faster with increasing ΔWR, but became progressively
slower with increasing WRbl. These findings suggest that with an increasing ΔWR, the muscle
has an attenuated increase in bulk BF and a larger reliance on O2 extraction to meet the O2
requirements of the muscle, but with an increasing WRbl the muscle relies less on O2 extraction
and more on BF redistribution within the muscle microvasculature.
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Summary for Lay Audience
Whenever you instantaneously increase your activity level (work rate (WR)), your body must
also instantly increase energy production to continue working at the higher WR. However,
your body’s aerobic (oxidative) system, which requires O2 to make energy, does not
immediately meet all of these energy needs, but instead gradually increases towards the higher
energy requirements until its contribution to energy production is maximized. The rate of
increase in aerobic energy production becomes progressively slower as the starting, baseline,
intensity (WRbl) becomes higher. Given that increases in muscle BF and O2 delivery are
required to support the higher muscle O2 requirements, this thesis investigated the role that
blood flow (BF) and O2 delivery to exercising muscle plays in the response of the aerobic
system by measuring the rate of adjustment of O2 uptake (V̇O2) and BF. A mass spectrometer
and volume turbine were used to measure V̇O2, Doppler ultrasound was used to measure BF,
and near-infrared spectroscopy was used to infer muscle O2 extraction from the blood. Subjects
performed an instantaneous increase in WR on a knee-extension ergometer from: i) a WRbl of
3 W to 24, 33, 45, 54, or 66 W; or ii) a WR increase (ΔWR) of 21 W from a WRbl of 3, 12, 24,
33, or 45 W. Due to fluctuations in the BF signal caused by the heart pumping, as well as the
muscle contracting and relaxing, it was necessary to determine an appropriate technique to
analyze BF. By averaging BF over either a single, or 2 or 5 ‘binned’ or ‘rolling’ averages of a
heart contraction cycle (HR), or a muscle contraction cycle (CR), it was determined that a
single CR cycle was the best method for analyzing BF. When looking at how quickly V̇O2 and
BF increased to the new WR for each trial, it was found that: i) BF increases at a similar speed
with different ΔWR’s, but the increase becomes slower as WRbl increases, except for the
highest WRbl in which BF increased much faster; ii) V̇O2 increases at a slower speed with
larger ΔWRs and higher WRbls; iii) the increase in BF relative to the increase in V̇O2 becomes
less as ΔWR and WRbl become greater; iv) O2 extraction by the muscle increased faster when
ΔWR was greater, but increased slower at higher WRbls. These findings suggest that to meet
the requirements for O2 and energy, the muscle relies less on bulk BF and more on O2
extraction at larger ΔWRs, but at higher WRbls it relies less on O2 extraction and more on BF
in the microvasculature to meet its V̇O2 needs.
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CHAPTER I: Introduction
Energy Production
The capacity for the human body to perform work is accomplished by the force generated
from muscular contractions, which requires the constant breakdown of energy (in the form
of adenosine triphosphate (ATP)) by the muscle. However, the muscle has very limited
stores of ATP, and therefore, the body requires the constant regeneration of ATP in order to
continue working. This regeneration of ATP is accomplished by the breakdown of
carbohydrate and fat (and to a minor extent, protein) from the food we eat through the use
of our body’s three energy systems. The two anaerobic systems, phosphocreatine (PCr) and
glycolysis, rely on substrate-level phosphorylation to resynthesize ATP from adenosine
diphosphate (ADP). The third energy system, oxidative phosphorylation, is the preferred
system for generating ATP as it produces the largest amount of ATP, and does so very
efficiently (breaking down the macronutrient fully, and producing no unwanted by-products
(e.g., lactic acid)). The oxidative phosphorylation system is aerobic in nature and relies on
oxygen (O2) as the final electron acceptor at the end of the electron transport chain (ETC),
after having used the energy from the electrons to pump protons across the inner
mitochondrial membrane to create an electrochemical gradient. As the protons re-enter the
mitochondrial matrix through proton channels their kinetic energy is ‘coupled’ with ATP
synthase which resynthesizes ATP from ADP and inorganic phosphate (Pi). The electrons
used in the ETC are donated by reducing equivalents, nicotinamide adenine dinucleotide
(NADH) (or flavin adenine dinucleotide, FADH2), which are generated from the metabolic
pathways of glycolysis, β-oxidation, and the tricarboxylic acid cycle. Therefore, the overall
process of oxidative phosphorylation can be summarized as:
5 ADP + 5 Pi + 2 NADH + 2 H+ + O2 → 5 ATP + 2 NAD+ + 2 H2O
Based on this equation, a lack in any of the above substrates would serve to limit the rate of
oxidative phosphorylation.
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As the name implies, oxidative phosphorylation is dependent upon O2, and therefore the
body requires an efficient method of transporting O2 from the atmosphere to the level of the
mitochondria within the muscle cell. In this regard, the pulmonary system, cardiovascular
system, and metabolic system all work together to distribute O2 to where it is needed within
the body.
Oxygen Transport
When O2 enters the lungs during inhalation, it proceeds down its pressure gradient by
crossing several very thin membranes (~0.5 µm thick in total) from the alveoli into the blood.
Once in the blood, O2 binds to haemoglobin (Hb) in the erythrocyte with a very small amount
of O2 (~0.3 mL/dL blood) dissolved in the plasma. The blood, now carrying O2 (and other
nutrients), is transported throughout the body via the vascular system to satisfy the O2 and
nutrient requirements of the tissues. Blood flow (BF) to an area is determined by several
factors that are represented in Poiseuille’s law:
BF = πPr4 · (8ηl)-1
where P is the pressure gradient between the two ends of the vasculature, r is the radius of
the vessel, η is the viscosity of the fluid (blood), and l is the length of the vessel. In the closed
system of the body, the length of the vessels do not change, and while blood viscosity can
change by a small amount (Hitosugi et al., 2004) and mean arterial pressure (MAP –
equivocal to ‘pressure’ in Poiseuille’s law) can change greatly, these changes are
comparative between the different areas of the body when measured at the same level of the
arteriolar tree (Fronek & Zweifach, 1975). Therefore, with the factors of viscosity, length,
and pressure being unchanged between the different parts of the body, vessel radius becomes
the principal factor determining BF to an area in the body, with its role amplified due to its
exponential effect (to the power of four). Through changes in vessel radius there is a decrease
in BF with vasoconstriction, while vasodilation causes an increase in BF to the area supplied
by the effected artery/arteriole. This O2-rich blood perfuses all of the capillaries supplied by
its terminal arteriole, creating an O2 pressure gradient between the microvasculature in the
capillary bed and the muscle cells adjacent to those capillaries. This pressure gradient causes
O2 to dissociate from Hb and diffuse into the myocyte. Inside the cell, O2 will continue down
2

its pressure gradient towards the mitochondria, specifically towards complex IV of the ETC
in the inner mitochondrial membrane, via either ‘free’ diffusion through the cytoplasm or
via “facilitated” diffusion bound to myoglobin (Mb).
During oxidative phosphorylation, the metabolic processes of the muscle also produce
carbon dioxide (CO2) which diffuses from the mitochondria into the blood where it is
transported back to the lungs in one of three ways: dissolved as CO2 in the plasma (~5-10%);
bound to the erythrocyte as carbamino haemoglobin (~20%); or by being converted to
bicarbonate (~70-75%) through a reversible reaction with water (H2O) by carbonic
anhydrase.
Exercise Blood Flow
With the increased metabolic demands of exercise (increases that can be more than 20x
resting requirements) there is an increased need for O2 within the active muscle tissue, which
is met by a proportional increase in BF (Andersen & Saltin 1985). Blood flow to an area is
determined by the vasoconstriction and vasodilation of the arteries/arterioles supplying that
area, which is accomplished by the contraction and relaxation, respectively, of smooth
muscle cells (SMC) surrounding the vessels. However, due to the large mass of recruited
muscle and the vast ability of its vasculature to vasodilate during exercise, there is the
potential for BF requirements of the active muscle to far exceed the heart’s ability to produce
the necessary cardiac output (Q̇T) to maintain MAP, a phenomenon referred to as the
“sleeping giant hypothesis” (Rowell, 1997). As MAP is the product of both Q̇T and total
peripheral resistance (TPR – from the friction of blood against the vessel walls; MAP = Q̇T
· TPR), the body must closely regulate the diameter of the vasculature in order to maintain
MAP since MAP is regulated less by Q̇T and more by TPR when HR is elevated (Ogoh et
al., 2003). Many factors contribute to vessel tone and BF distribution through their control
on the contractile state of the SMC. In particular, there is an increase in output from the
sympathetic nervous system (SNS) during exercise that is in proportion to the exercise
intensity, causing an increase in Q̇T (via increased heart rate (HR) and cardiocyte contractility
causing a larger stroke volume) and increased TPR (via SMC contraction (vasoconstriction)
throughout the body), which acts to increase perfusion pressure (i.e., MAP) in the body.
3

While vasoconstriction caused by the SNS assists in maintaining adequate MAP during
exercise, it is necessary to redirect BF from less active regions within the body towards more
active regions within the muscle to help meet the increased metabolic demands required of
the exercise (an increase in BF to an area that can be as much as ~100x resting (Laughlin et
al., 1996)). To assist with this increase in BF, it has been suggested that there is a blunting
of the vasoconstriction signal from the SNS to the vasculature in the contracting muscle, a
process known as ‘sympatholysis’ (Remensnyder et al., 1962). The cause of this
sympatholysis may be attributed to the release of various metabolites from the skeletal
muscle during exercise and their effect of either inhibiting the release of neurotransmitters
from the SNS or by inhibiting the postjunctional receptors on the vasculature (Verhaeghe &
Shepherd, 1976, Verhaeghe et al., 1977). However, at very high exercise intensities, when
muscle BF demand increases above what Q̇T is able to provide while still maintaining an
adequate MAP (~100 mmHg during HVY whole-body exercise; Clausen, 1976), the
response of sympatholysis (i.e., vasodilation in the active musculature) is overridden by the
SNS such that BF is attenuated in those areas despite the metabolic need (Calbet et al., 2004,
Dela et al., 2003, Laughlin et al., 1996, Mortensen et al., 2008, Secher & Volianitis, 2006).
The redistribution of BF to the active musculature requires an increase in the vessel radius
of the arteries/arterioles that are supplying those muscles. However, there is much discussion
as to which mechanism(s) cause(s) vasodilation, with potential mediators needing to possess
the ability to cause SMC relaxation, as well as respond in proportion to exercise intensity
(i.e., metabolic demand), and in a timely manner. While some studies have suggested that
vasodilation can be mediated by a neural component (Eklund & Kaijser 1978, 1976, Eklund
et al., 1974, Rusch et al., 1981, Sanders et al., 1989), several others have found that blocking
the neural signal with atropine had no effect on BF (Armstrong & Laughlin, 1986, Brock et
al., 1998, Buckwalter et al., 1997, Shoemaker et al., 1997), demonstrating that there is little
to no neural involvement in vasodilation. It has previously been suggested that acetylcholine
spillover from motor neurons at the neuromuscular junction could be implicated in the
vasodilatory response owing to involvement in muscle activation and proximity to resistance
vessels, concurrent timing with muscle contraction, and proportionality with exercise
intensity (Welsh & Segal 1997). However, similarly to the direct innervation of neural
activity on vasodilation mentioned previously, blocking of neural activity by atropine would
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also prevent acetylcholine release, and as this blockade has been shown to have no effect on
BF, acetylcholine spillover is also unlikely to be involved in regulating BF during exercise
(Dyke et al., 1998; Joyner & Halliwill, 2000). Although lactate- has been posited as a
possible cause for vasodilation, its contribution has been largely dispelled with the
observation of no vasodilation following exogenous infusion of lactate- (Keller et al., 1930).
At present, one of the most prevalent substances thought to play a role in vasodilation is K+
(Bohr & Goulet, 1961, Armstrong et al., 2007, Edwards et al., 1998). The release of K+ from
the myocyte in response to contraction has been shown to occur rapidly (Hnik et al., 1976),
allowing for it to play an immediate role in exercise hyperemia. Additionally, the release of
K+ from the muscle cell has been found to be proportional to both the intensity of contraction
(Hudlicka & el Khelly, 1985) and the increase in BF (Hilton et al., 1978, Hudlicka & el
Khelly, 1985, Mohrman & Sparks, 1974b), suggesting that this “metabolite” would allow
for effective coordination of BF with metabolic demand. The role of adenosine as a
vasodilator also has received a great deal of interest because of its buildup and release from
the muscle cell, particularly during times of metabolic stress when increased BF is needed
(Costa et al., 2000, Langberg et al., 2002, Duncker et al., 1993, Laxson et al., 1993), which
would allow its vasodilating capacity to be suitably linked with metabolic demand (Marshall,
2007). Similarly, the analogs of adenosine, ATP and ADP, have also been recognized to
induce vasodilation (Forrester et al., 1979), and with their concentration increasing with
exercise intensity (Forrester, 1972, Forrester & Lind, 1969, Hellsten et al., 1998), they also
would provide a direct link between BF and metabolic demand. In addition to its release
from the skeletal muscle, studies are also showing that ATP is released from the erythrocyte
when it is deoxygenated or mechanically deformed (Ellsworth et al., 2009, Ellsworth et al.,
1995). An increase in metabolic activity will lead to increased off-loading of O2 from the
erythrocyte (deoxygenation) and, in combination with more erythrocytes traversing the
microcirculation where capillary diameters are often smaller than erythrocytes – causing
physical deformation of the erythrocyte (Kaniewski et al., 1994) – more ATP will be released
from the erythrocyte to stimulate vasodilation, thus creating a potential link of BF, tissue O2
utilization and metabolic demand. Although each of the substances discussed above is
capable of causing vasodilation, many of these substances appear to work through one of the
most prominent vasodilators, nitric oxide. Produced by the endothelium (and synaptic
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terminal of the neuron) from O2 and L-arginine, nitric oxide diffuses from the endothelium
(or nearby neuron) to the SMC causing relaxation and, thereby, vasodilation (see Laughlin
et al., 2012 for review). Lastly, CO2 has been shown to be a potent vasodilator in the cerebral
circulation (Kety & Schmidt 1948, Reivich 1964), and while it is tempting to speculate that
CO2 could act in a similar manner in the systemic circulation, as an increase in metabolic
activity will produce more CO2 for greater vasodilation, this has not been shown to date.
While the above mentioned substances have the ability to cause vasodilation of the
microvasculature that is within the metabolically active muscle, those arterioles/arteries that
are upstream (and outside of the active musculature) must rely on other means for
vasodilation. To help meet the BF needs of the more distal vessels, BF through the upstream
vessels is increased in part by ‘conducted vasodilation’ in which a hyperpolarization signal
is passed proximally up the vasculature via gap junctions in the endothelium (and, less-so,
through SMCs themselves (Smith et al., 2008, Tran et al., 2009) causing the SMCs to relax
(Beach et al., 1998, Berg et al., 1997, Collins et al., 1998, Song & Tyml, 1993). In addition
to the transmission of the electrical signal up the vasculature through ‘conducted
vasodilation’, the vasodilatory response is also spread upstream via flow-mediated dilation.
This process is initiated with the vasodilation of the microvasculature within the active
muscle, which will increase the capacity for blood, leading to an increase of BF to perfuse
the “opened” vasculature of the area. In turn, this will cause blood in the arterioles/arteries
that are upstream to flow into the vessels downstream, producing friction along the
endothelium from the blood, an effect known as shear stress. This increased shear stress
stimulates the endothelium to release NO, which diffuses to the adjacent SMCs causing them
to relax, and thus, causing vasodilation. This newly dilated segment, in turn, will generate
more shear stress further upstream by the rush of blood to fill the newly expanded area,
causing vasodilation to continually progress upstream, and allowing BF to increase to the
active muscle. This process of flow-mediated dilation is aided by the vasculature of the larger
arterioles (where shear stress will have a greater influence) being more responsive to shear
stress than the smaller vessels of the arteriolar tree (Kuo et al., 1995). Furthermore, there are
differences in the type of α-adrenergic receptors that are present along the arteriolar tree,
with the distal (and smaller) arterioles containing predominantly α2 receptors, which show
an inhibited response to vasoconstriction during muscle contraction, while the more
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proximal (and larger) arterioles/arteries have predominantly α1 receptors, which are still
capable of vasoconstriction during muscle contraction (Anderson & Faber, 1991, Faber,
1988, Faber & Meininger, 1990, Nishigaki et al., 1991, Ohyanagi et al., 1991). In line with
this, Thijssen et al. (2008) found that artery size impacted a vessel’s vasoactivity, with larger
arteries having a blunted vasodilatory response compared to smaller arteries. These
differences would be expected to have an impact on the overall outcome of sympatholysis,
as the smaller arterioles (with α2 receptors) would be able to dilate in response to muscle
contraction to redistribute BF to the areas within the muscle that it is needed, while a
maintenance in constriction of the larger arterioles (with α1 receptors) would help prevent a
decrease in MAP.
Although the various substances discussed previously are able to induce vasodilation, many
studies have shown that removing or inhibiting the pathway of one of these vasodilators does
not affect the vasodilatory response. This is likely attributable to a redundancy in the
vasodilatory response, which confounds the ability to ascribe the vasodilatory response to
any single vasodilator. Furthermore, several of these vasodilators can be influenced by pH
(Stowe et al., 1975), which further confounds the ability of studies to determine the effect of
a particular vasodilator in the exercise BF response, as a particular vasodilator’s influence
on BF could be dependent upon the metabolic state of the tissue. The vasodilatory response
is also complicated by some vasodilators exhibiting a ‘summing effect’ in which they
increase the effect of other vasodilators (see Laughlin et al., 2012 for review).
In addition to the metabolic contributions on the BF response to exercise, there are also
mechanical contributions from the contracting muscle which cause repetitive changes in
intramuscular pressure (Radegran & Saltin, 1998). These changes in intramuscular pressure
cause the vasculature within the muscle to compress and expand which forces blood out of
and draws blood into the vasculature, respectively, thereby increasing muscle BF via a
‘pumping’ action (i.e., a ‘muscle pump’). In addition to the contracting musculature creating
a ‘pumping’ action to increase BF, there is potentially also a myogenic contribution of the
active muscle on exercise hyperemia. By this mechanism, mechanical compression of the
vasculature (a decrease in the transmural pressure – e.g., muscle contraction) has been shown
to cause vasodilation, while a decrease in mechanical compression (an increase in transmural
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pressure – e.g., muscle relaxation) has been shown to cause vasoconstriction (Mohrman &
Sparks, 1974a, Clifford et al., 2006).
It is through the effect of these many redundant, synergistic, and competing exercise-related
responses on the vasculature of the whole body that MAP is maintained during exercise.
Furthermore, this balance between vasoconstriction and vasodilation results in a ‘finetuning’ of O2 (and nutrient) delivery to meet the precise metabolic demands of the muscle.
Oxygen Uptake Kinetics
A step-increase in external work rate (WR) necessitates an instantaneous increase in ATP
regeneration to satisfy the greater rate of ATP utilization consequent to the increased work
performed by the involved muscles. While oxidative phosphorylation is the most efficient
ATP-regenerating pathway due to its ability to maximize ATP regeneration by fully
oxidizing macronutrients, the ability of oxidative phosphorylation to immediately meet the
muscle’s energy needs upon a change in WR is delayed. This delay in oxidative
phosphorylation causes the muscle to rely on PCr breakdown and glycolysis to support any
deficits in ATP regeneration in response to immediate increases in energy requirement at
exercise onset. This period of delayed activation of oxidative phosphorylation is termed the
O2 deficit, and as a result of the increased reliance on anaerobic energy sources, there is an
increased production and accumulation of fatigue-inducing metabolites (e.g., lactate-, H+,
Pix-, reactive oxygen species, and ADP) which are associated with exercise intolerance
(Allen et al., 2008). Therefore, it is beneficial to exercise performance to keep the O2 deficit
as small as possible. A substantial amount of research has focused on identifying the reason
for this delay in increasing the activity of oxidative phosphorylation, with research
suggesting that ‘sluggishness’ in the metabolic activation of oxidative regulatory (ratelimiting) enzymes and substrate delivery (besides O2), or in convective or diffusive O2
delivery (i.e., BF) to the muscle, alone or in combination, might be responsible for delays in
attaining “steady-state” conditions (see Poole & Jones 2012, Rossiter 2011 for review).
Due to the invasive nature of measuring O2 uptake (V̇O2) and utilization at the level of the
muscle (V̇O2m), studies utilize pulmonary V̇O2 (V̇O2p), which, after correcting for the
muscle-to-lung transit time of deoxygenated blood, has been shown to closely reflect V̇O2m
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(Barstow et al., 1990, Grassi et al., 1996, Rossiter et al., 1999, Krustrup et al., 2009). After
the time delay (TD, phase I – discussed below), V̇O2p increases in an exponential-like
manner, with the rate of this change being quantified by the time constant (τ). It is the
characterization of this response that defines V̇O2 kinetics, with those individuals that have
fast V̇O2p kinetics (a small τ) having a smaller O2 deficit, and thereby less accumulation of
fatigue-inducing metabolites and thus greater metabolic stability (Grassi et al., 2011), than
those individuals that have slow V̇O2p kinetics (a larger τ).
The V̇O2p response profile differs in its response to exercise transitions of different
intensities. For those WRs within the moderate- (MOD, below lactate threshold (LT)) and
heavy-intensity domains (HVY, above LT, but below critical power), the contribution of
oxidative phosphorylation to energy production continues to increase throughout the O2
deficit phase and eventually reaches a ‘steady-state’) in which oxidative phosphorylation is
providing ‘all’ of the ATP regeneration in the muscle, and muscle O2 consumption (V̇O2m)
is unchanging (i.e., “steady”). For all transitions there is an initial rapid increase in V̇O2p
(phase I), which is caused by a rapid increase in the influx of deoxygenated blood through
the pulmonary circulation (caused by an increase in Q̇T). Following this ‘cardiodynamic’
phase, for those transitions to a WR in the MOD, V̇O2p increases in a monoexponential
manner (primary component (phase II)) to its new steady-state (phase III). For transitions
into HVY, following the TD and primary component, there is a delay in the attainment of
steady-state due to the manifestation of a gradual increase in V̇O2p termed the ‘slow
component’ (phase III). This slow component creates a V̇O2 response that is greater than
predicted from the sub-LT, linear, V̇O2 – WR relationship and comprises a larger proportion
of the overall V̇O2p response the higher the WR is into the HVY domain (see Figure 1.1). It
was formerly theorized that the slow component could be the result of the increased work
(and energy expenditure) being performed by accessory muscles (lungs, heart, etc.), or the
accumulation of various metabolites or catecholamines and other factors and their effect on
the metabolic rate (see Gaesser & Poole 1996, Poole & Jones 2012). However, Poole et al.
(1988, 1991) revealed that ~85% of the response is attributable to the working muscle, and
may be the result of the recruitment of additional muscle fibres (Krustrup et al., 2004),
although this is contested (Zoladz et al., 2008, Scheuermann et al., 2001). This ‘excess’
V̇O2m, therefore, represents an inefficiency in the muscle of either the ATP-to-WR ratio
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Figure 1.1. V̇O2p response profile for heavy-intensity (HVY) exercise with the cardiodynamic component (phase I), primary
component (phase II), and slow component (phase III) shown. TD, time delay; b, baseline. Reprinted with permission from Jones
et al., 2003.
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(P/W; i.e., an increased cost of ATP for muscle contraction) or the ATP-to-O2 ratio (P/O;
i.e., an increased cost of O2 to resynthesize ATP). While a V̇O2p and metabolic “steady-state”
is achieved with exercise within the MOD and HVY domains, in the very heavy-intensity
domain (VH, where the primary component projects above critical power, but below
V̇O2max), V̇O2p continues to increase towards V̇O2max and, if exercise is tolerated, eventually
will reach V̇O2max. These non-steady-state conditions with continued rise in V̇O2p and
metabolic “instability” are associated with fatigue (i.e., an inability to generate muscle
force/power (Keir et al., 2016c)) and exercise intolerance (Murgatroyd et al., 2011).
Although the V̇O2p response profile, when considered in its entirety, is different between
these intensity domains, when analyzing only the primary (phase II) component of the V̇O2p
response, kinetics can be either similar or different between intensity domains. While many
studies have reported τV̇O2p to be similar between MOD and HVY exercise transitions
(Nyberg et al., 2017, Jones et al., 2012, Koga et al., 2005, Ozyener et al., 2001, Scheuermann
et al., 2001, Koga et al., 1997) or for different WR increments (ΔWR) within MOD ( Keir et
al., 2016b, Spencer et al., 2013, MacPhee et al., 2005), this is not unanimous (Koga et al.,
2001, Koga et al., 1999, Engelen et al., 1996, Paterson & Whipp 1991).
In order to determine the underlying factors that influence V̇O2p kinetics, studies have used
a plethora of investigative techniques, such as: different gas concentrations (e.g., hypoxia,
hyperoxia, hypercapnia, hyperventilation); ‘priming’ exercise; different ΔWRs; elevated
baseline WRs (WRbl); training; nutritional changes; pharmacological interventions; aging;
etc., all of which challenge/alter the V̇O2p response. However, despite all of these
interventions it remains very difficult to separate out the roles of metabolic sluggishness and
O2 delivery to decisively determine the cause of the delayed activation of oxidative
phosphorylation. For instance, while exercise training commonly results in a speeding of
V̇O2p kinetics (Williams et al., 2013, Murias et al., 2010a/b & 2011, McKay et al., 2009), it
is well known that there are both metabolic and cardiovascular improvements that occur with
training (see Hellsten & Nyberg, 2016 and Earnest et al., 2018 for review), meaning that
either factor could be contributing to the faster kinetic response. Likewise, following a bout
of HVY ‘priming’ exercise, V̇O2p kinetics are sped on the subsequent exercise bout
(Scheuermann et al., 2002, DeLorey et al., 2004 & 2007, Gurd et al., 2005 & 2006, Murias
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et al., 2011b/c, Spencer et al., 2012 & 2013, Nederveen et al., 2017). However, ‘priming’
exercise is also known to cause an increase in both BF (O2 delivery) to the area (Murias et
al., 2011b/c, Spencer et al., 2012) as well as a heightened activation of enzymes (such as the
carbohydrate rate-limiting enzyme pyruvate dehydrogenase (Gurd et al., 2006, 2008, 2009))
and oxidative substrate provision (Gurd et al., 2006, Howlett et al., 1999, Timmons et al.,
1996 & 1998a/b) along the oxidative phosphorylation pathway in the active muscle. These
results again preclude the ability to differentiate which mechanism is contributing to the
speeding of V̇O2p kinetics. A well designed study by Spencer et al. (2012) gave good insight
into the mechanism contributing to the speeding of V̇O2p kinetics with ‘priming’ exercise
when they showed that in normoxia there was a significant speeding of kinetics following
‘priming’ exercise. However, when the subsequent bout of exercise following ‘priming’ was
done in hypoxia, there was an elimination of the effect of ‘priming’. This would implicate a
role of O2 delivery (i.e., BF) in the speeding of kinetics following ‘priming’, as the speeding
of the metabolic pathways that would have occurred as a result of the ‘priming’ bout was not
able to cause a speeding of V̇O2p kinetics.
In addition to the above observation, Spencer et al. (2012) also found that kinetics were only
sped when τV̇O2p for the first exercise bout (unprimed) was > 20 s, a finding that supports
the theory of an “O2 delivery dependence/independence ‘threshold.’” This theory posits that
beyond a certain point the limitation on V̇O2p kinetics shifts from an O2 independent
limitation (metabolic ‘sluggishness’) when τV̇O2p is small (e.g., < ~20 s), to an O2 dependent
limitation (O2 delivery) when τV̇O2p is larger (e.g., > ~20 s) (Poole & Musch, 2010).
More recently, studies investigating the effect of an elevated WRbl on V̇O2p kinetics have
consistently shown that τV̇O2p is larger when transitioning from an elevated WRbl
(Nederveen et al., 2017, Keir et al., 2016a/b, Bowen et al., 2011, MacPhee et al., 2005,
Brittain et al., 2001), with a concomitant increase in V̇O2p gain (ΔV̇O2p/ΔWR) of both the
primary component (Gp) and total response (GT; Nederveen et al., 2017, Keir et al., 2016a/b,
Bowen et al., 2011, MacPhee et al., 2005, Brittain et al., 2001). Furthermore, in recent studies
from our lab, Keir et al. (2016a/b) revealed that with increasing WRbl τV̇O2p increased in a
curvilinear fashion (τV̇O2p increased to a larger extent than the increase in WRbl) with Gp
increasing linearly. This linear increase in Gp could be the result of the recruitment of less
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efficient muscle fibres (type IIa & IIb/x), or a decrease in the Gibbs free energy released
from ATP hydrolysis of those muscle fibres that were already recruited prior to the elevated
WRbl (Wust et al., 2014, Bowen et al., 2011), or some other presently unknown factor(s). In
addition to the potential role that type IIa & IIb/x fibres play on the Gp response, the more
glycolytic nature of these fibres than type I (oxidative) fibres, also may serve to augment the
metabolic sluggishness of the oxidative pathways (Crow & Kushmerick 1982, Pringle et al.,
2003a/b) causing a slower kinetic response. Furthermore, BF to muscles that are composed
of predominantly type II fibres is lower compared to those muscles that are primarily
composed of type I fibres (McDonough et al., 2004, Behnke et al., 2003). Therefore, in
addition to being less efficient, type IIa & IIb/x muscle fibres also may have slower kinetics
because of a metabolic sluggishness or a less than adequate O2 delivery.
Blood Flow Kinetics
To investigate the role of O2 delivery on V̇O2p kinetics, studies have often utilized Doppler
ultrasound to continuously monitor blood velocity and vessel diameter for the calculation of
bulk BF at the level of the conduit artery (Gill et al., 1979, Hoskins et al., 1990). However,
quantifying the BF response is confounded by asynchronous changes in the blood velocity
profile that are brought about by changes in the driving pressure from the cardiac cycle (HR;
i.e., systole and diastole) and changes in the intramuscular pressure from the muscle
contraction-relaxation cycle (CR; Radegran 1997, Radegran & Saltin 1998, Osada 2004).
Owing to these fluctuations, the blood velocity signal is typically averaged over either the
duration of the HR cycle (MacDonald et al., 1998 & 2001, Hughson et al., 1996) or the
duration of the muscle CR cycle (MacPhee et al., 2005, duManoir et al., 2010). However,
both of these techniques still produce considerable variability of the BF profile. For instance,
when analyzing by HR cycle, if an entire HR cycle occurs within the muscle relaxation phase
(when BF is unimpeded by high intramuscular pressure) it will result in a much greater blood
velocity than when a HR cycle occurs during the muscle contraction phase (when BF is
occluded by the increased intramuscular pressure compressing the vasculature) (see Figure
1.2). Alternatively, when blood velocity is averaged over the muscle CR cycle, the blood
velocity values will be greater if there are more systolic phases (e.g., four), than a CR cycle
that has fewer systolic phases (e.g., three) (see Figure 1.2). This variation in the number of
13

R-spike
Blood Velocity (cm/s)

Cadence

C

140
120
100
80
60
40
20
0
-20
-40
-60

A

B

2 3

2

1

0

1

2

3

3

1

4

4

5

6

D

7

8

9

10

11

12

13

Time (s)

Figure 1.2. Blood velocity tracing displaying muscle contraction cadence and R-spike of heart rate (HR). Note the boxes
displaying a single contraction-relaxation (CR) cycle in which there are four (box A) or three (box B) systolic phases of HR; Also,
note the boxes displaying a single HR cycle during a muscle contraction phase (low velocity signal; box C) and muscle relaxation
phase (high velocity signal; box D).

14

14

15

systolic phases during a muscle CR cycle will commonly occur due to the variability of HR,
especially during increasing exercise intensities when the R-R interval durations of the HR
cycle are reduced. In an effort to reduce this variability in the blood velocity values, it has
become common practice to average the blood velocity signal over multiple consecutive HR
or CR cycles (Holland et al., 1998, Shoemaker et al., 1996), which has been shown to
decrease the coefficient of variation of the BF response (Osada 2004). However, these
studies evaluated “steady-state” exercise, and therefore, it is unknown how these different
analysis techniques will influence the BF profile during non-steady-state conditions when
having good temporal resolution of the BF signal is crucial. Therefore, while the methods of
averaging over multiple CR or HR cycles provides a steady and reliable BF signal,
consideration must be given to the effect that this may have on the non-steady-state phase of
BF. Due to the transitory nature of this phase, an increase in the duration of the averaging
cycle will result in the inclusion of data that is on either side of the exercise transition, as
well as a decrease in the number of data points in the transition phase. These issues may then
affect the ability to confidently and accurately characterize BF kinetics.
To facilitate the increased demands of the muscle mitochondria, O2 delivery (via BF) has
been shown to increase in a linear manner with metabolic demand (i.e., V̇O2p) at a ratio of
approximately 5-to-1 (Andersen & Saltin 1985). This increase in BF to the active
musculature is accomplished ‘centrally’ by an increase in Q̇T (HR and stroke volume) and
‘peripherally’ by an increase in vascular conductance (VC, principally by vasodilation).
These central and peripheral factors create an increase in MAP, through the combination of
an increase in Q̇T and vasoconstriction in the less metabolically active tissues, which further
augments BF to the active musculature. In response to a step-increase in exercise intensity,
BF to the exercising muscle has been shown to increase in an exponential-like manner
towards a new steady-state. This increase in BF is similar to the response profile of V̇O2p,
which means that quantifying its kinetic response will give valuable insight into O2 delivery
and its role on V̇O2p kinetics (Saltin 1985, Wesche 1986, Wesche & Walloe 1988). Upon the
initiation of rhythmic exercise, there is an immediate increase in BF (phase I), which after a
brief period (~15-20 s) gives rise to a secondary rise in the BF response (phase II) before
achieving a steady-state (phase III) (Shoemaker & Hughson, 1999). Unlike the response of
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V̇O2p in which the initial rapid increase (phase I) in the response is attributable to increased
pulmonary BF, and is temporally dissociated from V̇O2m by the time it takes blood to transit
from the muscle to the lungs, the initial increase in BF (phase I) occurs in real time. This
initial increase in BF is attributed to the mechanical action of the active musculature on the
vasculature (a ‘muscle pump’; Tschakovsky & Hughson, 2000, Folkow et al., 1970, Sheriff
et al., 1993, Stegall 1966) and to a rapid vasodilatation within the active muscle due to the
effect of metabolites from the active muscle on the vasculature (Corcondilas et al., 1964,
Shoemaker et al., 1998, Tschakovsky et al., 1996 & 2004). The increase in BF during phase
II has been attributed to vasodilation that matches the metabolic demand of the muscle (for
potential contributing vasodilators, see the Exercise Blood Flow section). In phase III,
however, the characterization of BF kinetics is complicated when exercise is performed in
the HVY domain. While there is a clear slow component in the V̇O2p response in the HVY
domain, for the BF response some studies report the presence of a slow component (Jones
et al., 2012, DeLorey et al., 2007, Koga et al., 2005, Paterson et al., 2005b), while others
report no discernible slow component (Nyberg et al., 2017, Fukuba et al., 2004). These
inconsistent findings further demonstrate the need for good temporal resolution of BF in
response to exercise.
In those studies that quantify both V̇O2p and BF kinetics, the response of conduit artery BF
has often been seen to be faster than that of V̇O2p (MacDonald et al., 1998, Fukuba et al.,
2004, MacPhee et al., 2005, Koga et al., 2005, Endo et al., 2005, Harper et al., 2006, Jones
et al., 2012, Schlup et al., 2015), which would seem to shift the limiting factor on V̇O2p
kinetics away from O2 delivery and toward a metabolic sluggishness. However, this is not a
unanimous finding as several studies have observed no difference between τV̇O2p and τBF
(Grassi et al., 1996, Hughson et al., 1996, MacPhee et al., 2005, Paterson et al., 2005a,
duManoir et al., 2010, Jones et al., 2012, McNarry et al., 2014, Nyberg et al., 2017),
suggesting that O2 delivery to the muscle could be controlling the rate of adjustment of V̇O2p.
While the response of V̇O2p to varying ΔWRs has received a great deal of attention, relatively
few studies have investigated the response of BF to increasing ΔWRs. Those studies that
have investigated BF kinetics of exercise transitions to different ΔWRs have reported no
difference in the values for τBF across ΔWRs (Murphy et al., 2018, Nyberg et al., 2017,
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MacPhee et al., 2005, Hughson et al., 1996), even when ΔWRs were compared between
MOD and HVY (McNarry et al., 2014, Jones et al., 2012, Koga et al., 2005). However,
several of these studies utilized protocols in which a small muscle mass is examined (forearm
or calf; Hughson et al., 1996, Saunders et al., 2005, Nyberg et al., 2017, Murphy et al., 2018),
and therefore, there is little challenge to central haemodynamics. Furthermore, most of these
studies use only two different transitions, which limits the ability to resolve the behaviour of
BF kinetics within and across different exercise-intensity domains. Presently, the only
known studies that have investigated more than two transitions (3 transitions: 60%, 80%,
100% maximal WR (WRmax; Nyberg et al., 2017); and 30%, 50%, 70% maximal voluntary
contraction (MVC; Murphy et al., 2018)), showed no difference in BF kinetics. However, as
both of these studies used a small muscle mass (calf (Murphy et al., 2018) and forearm
(Nyberg et al., 2017)), it is uncertain whether these findings would apply across dynamic
exercise for a large muscle mass. Additionally, apart from their findings on kinetics, Nyberg
et al. (2017) also noted that BF amplitude (ΔBF) did not increase proportionately between
WRs, with ΔBF increasing from 60% to 80% WRmax, but no difference was seen in ΔBF
between 80% and 100%, implying that the relationship between WR and BF may not be
linear. It also should be noted, however, that all of these aforementioned studies investigated
BF kinetics at the level of the conduit artery, and therefore, do not necessarily reflect what
is happening with O2 delivery at the site of O2 exchange in the microvasculature.
In the only study at present to directly investigate the effect of an elevated WRbl on bulk BF,
MacPhee et al. (2005) found that the kinetics of femoral artery BF were slowed, along with
slowed V̇O2p kinetics, when alternate-leg KE exercise was initiated from an elevated WRbl.
This finding could, therefore, suggest that either a delayed utilization of O2 in the muscle
results in a slowed delivery of O2 (i.e., BF) to the muscle, or that the rate of increase in BF
is insufficient, yielding a delayed attainment of V̇O2p steady-state. MacPhee and colleagues
(2005) also found that HR, VC, and deoxy[Hb + Mb] kinetics were slower from an elevated
WRbl, with a smaller increase in leg BF for a given increase in V̇O2p (ΔBF/ΔV̇O2p) also seen
when WRbl was elevated. However, in a study by Saunders et al. (2005) investigating
forearm VC there was no difference seen between a low or high WRbl on the phase II τ of
forearm VC, although phase I τ was larger when WRbl was elevated.
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Muscle Deoxygenation
The use of near-infrared spectroscopy (NIRS) allows for the quantification of muscle
deoxygenation through the emitting of near-infrared light into the skeletal muscle. This nearinfrared light is able to detect both oxygenated (Oxy[Hb + Mb]) and deoxygenated (deoxy
[Hb + Mb]) haemogolbin and myoglobin within the field of interrogation of the NIRS probe
(see Mancini et al., 1994, Boushel & Piantadosi 2000 for review). Any change in the
deoxy[Hb + Mb] signal, therefore, is indicative of a change in the balance of the local O2
delivery-to-O2 utilization ratio, with an increase in the deoxy[Hb + Mb] signal indicating an
increase in O2 utilization without a proportionate increase in O2 delivery, leading to an
increase in O2 off-loading from haemoglobin and myoglobin. This makes deoxy[Hb + Mb]
a feasible, and commonly employed surrogate measure, for O2 extraction within the muscle.
During a step-transition in WR, deoxy[Hb + Mb] increases in an exponential-like manner to
a new steady-state (for those WRs in MOD or HVY). However, prior to this increase in the
deoxy[Hb + Mb] signal, there is typically a brief period (termed the TD) in which the
deoxy[Hb + Mb] signal remains unaltered from baseline, or exhibits a slight undershoot
(duManoir et al., 2010). In this phase of the response, V̇O2m (O2 utilization) is increasing,
but an unchanging deoxy[Hb + Mb] signal would suggest that there is equal or, when an
‘undershoot’ is present, greater increase in O2 delivery (BF) to the area. Following the
exponential-like increase in deoxy[Hb + Mb], an ‘overshoot’ in the response is frequently
observed in which the deoxy[Hb + Mb] signal briefly exceeds its ultimate steady-state value.
Such a response is indicative of a slow O2 delivery to the area, necessitating that the muscle
rely more heavily on O2 extraction for its O2 needs for a brief period of time (Bauer et al.,
2007, Barbosa et al., 2011, Bowen et al., 2012, 2013). When used in combination with V̇O2p,
the analysis of the deoxy[Hb + Mb] signal, and its kinetics, assists in elucidating the role of
O2 delivery on V̇O2p kinetics. Previous studies employing NIRS have shown that when an
exercise transition is initiated from a common low WRbl to increasing ΔWRs there is an
increase in the amplitude of deoxy[Hb + Mb] (Δdeoxy[Hb + Mb]) along with the increase
in ΔV̇O2p (MacPhee et al., 2005, Keir et al., 2016b), implying an increased reliance on O2
extraction to help meet the O2 demand of the muscle with larger ΔWRs. However, the rate
of adjustment of V̇O2p and deoxy[Hb + Mb] to increasing ΔWRs is not different, with τV̇O2p
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and mean response time (MRT; TD + τ) of deoxy[Hb + Mb] being similar across different
ΔWR transitions (MacPhee et al., 2005, Keir et al., 2016b). This could suggest that a larger
ΔWR does not influence the contribution of O2 extraction to the V̇O2p response, implying
that O2 delivery is not limiting in this situation. Alternatively, when a WR transition is
initiated from an elevated WRbl, while keeping a constant ΔWR, there is a higher ΔV̇O2p
while Δdeoxy[Hb + Mb] is either similar across transitions (Keir et al., 2016b, Nederveen et
al., 2017) or increases with increasing WRbl (MacPhee et al., 2005). Such findings suggest
that either O2 delivery increases sufficiently such that there is not an increased reliance on
O2 extraction to meet O2 needs between transitions, or there is an insufficient increase in BF
(O2 delivery) causing the muscle to extract more O2 to meet O2 demand. While τV̇O2p has
been consistently seen to increase with increasing WRbl, deoxy[Hb + Mb] kinetics generally
show a decrease in TD and increase in τdeoxy[Hb + Mb] resulting in either no difference in
MRT deoxy[Hb + Mb] across WRbls (Keir et al., 2016b, Nederveen et al., 2017), or an
increase in MRT deoxy[Hb + Mb] with increasing WRbl (MacPhee et al., 2005). An
unchanging or increasing MRT deoxy[Hb + Mb] relative to an increasing τV̇O2p suggests
that O2 delivery to the muscle is more than sufficient throughout the transition such that there
is not an increased reliance on O2 extraction. This would then suggest that the slowing of
V̇O2p kinetics with increasing WRbl is due to a limitation within the cell, a metabolic
‘sluggishness.’ However, as deoxy[Hb + Mb] is a means of quantifying the ratio of O2
delivery-to-O2 utilization, caution should be taken when using it to infer BF.
Microvascular Blood Flow
While conduit artery BF gives an indication of overall O2 delivery to the whole muscle,
determination of the role of O2 delivery on V̇O2m kinetics requires an understanding of the
pressure gradient for O2 at the site of O2 exchange with the muscle, the microvasculature. A
higher partial pressure of O2 (PO2) in the blood of the microvasculature will increase the
diffusivity of O2 into the muscle for use in oxidative phosphorylation. However, while bulk
(conduit artery) BF can be reliably and non-invasively measured by Doppler ultrasound, due
to issues of practicality, the quantification of microvascular/capillary BF (Q̇cap) is much more
challenging to measure in humans, especially during exercise. To this end, the use of NIRS
has been used as an indirect way of determining Q̇cap. By using the deoxy[Hb + Mb] signal
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as a surrogate for O2 extraction (a-vO2diff; Grassi et al., 1996), and coupling this with V̇O2p
(a proxy for V̇O2m), Q̇cap to the area of interrogation can be estimated through rearrangement
of the Fick equation as shown (Ferreira et al., 2005d):

Qcap =

𝑉𝑂2𝑝
[𝐻𝐻𝑏]

Using this method, several studies have reported the response of Q̇cap to be slower than that
of V̇O2p (Schlup et al., 2015, Harper et al., 2006) or tightly coupled to the V̇O2p response
(Ferreira et al., 2005d, Buchheit et al., 2009). Additionally, coupled with the results that bulk
BF kinetics were faster than both V̇O2p and Q̇cap kinetics, these findings also show that Q̇cap
and conduit artery BF are not equivalent. Therefore, efforts should be made to accurately
estimate both bulk BF and Q̇cap kinetics when investigating the role of O2 delivery on V̇O2p
kinetics.
Overview of Studies
Numerous studies have been undertaken to investigate the contributing factors to the delayed
activation of oxidative phosphorylation during exercise. These studies have come to the
general consensus that V̇O2 kinetics are limited by a metabolic sluggishness of activation
and metabolic “instability” along the oxidative pathways inside the muscle cell, to
insufficient O2 delivery to the active muscle, or to a combination of these factors. Recent
studies from our lab and others have utilized the forcing functions of elevated WRbls and
different ΔWRs to investigate the effect of differing muscle recruitment patterns on V̇O2p
kinetics. However, these studies have focused mainly on the V̇O2p response, with relatively
few studies having directly looked at the role of BF (O2 delivery) on V̇O2p kinetics during
the various WRbl and ΔWR transitions. In addition, those studies that have investigated BF
kinetics typically have used only one or two transitions within the MOD or HVY domain.
Therefore, the primary objective of this thesis is to investigate the relationship amongst BF,
V̇O2p, and deoxy[Hb + Mb] by using multiple WRbl and ΔWR transitions throughout the
intensity domains to more fully characterize the effect of BF kinetics on V̇O2p kinetics.
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Chapter II of this thesis investigates the efficacy of different analysis techniques on
predicting the BF kinetic parameter estimates. While the V̇O2p signal is commonly calculated
breath-by-breath, there has not been a consensus on how to quantify the BF signal. Most
studies average the BF signal over the duration of either the HR cycle or the muscle CR
cycle to compensate for the fluctuations in BF caused by both processes. However, the effect
of each of these averaging techniques on BF kinetics has not been investigated. Therefore,
before examining the effect of different metabolic perturbations on BF kinetics, it was
necessary to discern an appropriate method for quantifying the BF response.
Chapter III examines the effect of transitions from a common baseline metabolic rate using
multiple ΔWRs on BF, V̇O2p, and deoxy[Hb + Mb] kinetics and describes the relationship
of these variables across the different ΔWRs that were used. Additionally, this study sought
to determine whether the associations between conduit artery BF, deoxy[Hb + Mb], Q̇cap,
HR, MAP, and VC change in their influences on the BF and V̇O2p response. It was
hypothesized that when exercise transitions are initiated from a common low WRbl, the
primary component of V̇O2p and BF kinetics would be similar across a broad range of
increasing ΔWRs. Furthermore, it was expected that the amplitude of the response for V̇O2p,
bulk BF, deoxy[Hb + Mb], HR, MAP, Q̇cap, and VC will all increase proportionally with
increases in ΔWR.
Chapter IV examines the effect of common exercise transitions (i.e., same WR) initiated
from increasing baseline metabolic rates on BF, V̇O2p, and deoxy[Hb + Mb] kinetics and
describes the relationship of these variables across the many WRbls investigated.
Furthermore, this study again explores the relationship of bulk BF and V̇O2p with deoxy[Hb
+ Mb], Q̇cap, HR, MAP, and VC. It was hypothesized that both BF and V̇O2p kinetics would
become progressively slower with increasing WRbl, with the gain of these responses also
becoming progressively larger.
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CHAPTER II: Data analysis technique influences blood flow
kinetics parameter estimates for moderate- and heavyintensity exercise transitions
Introduction
With an increase in muscle oxygen utilization (V̇O2m) brought about by exercise, there is an
increase in convective (bulk) muscle blood flow (BF) and O2 diffusion to facilitate a greater
delivery of O2 to the muscle mitochondria. Muscle conduit artery BF can be assessed
continuously and noninvasively using Doppler ultrasonography, which provides measures
of conduit artery blood velocity and diameter (Gill 1979 & 1985, Hoskins 1990). Although
conduit arteries interrogated by ultrasonography (e.g., femoral, brachial) demonstrate very
little variation in diameter during dynamic exercise (MacPhee et al., 2005, Fukuba et al.,
2004), the instantaneous blood velocity fluctuates with the cardiac cycle and muscle
contraction-relaxation (CR) cycles, consequent to variations in arterial driving pressure,
intramuscular pressure and conductance changes within the smaller resistance vessels
(Radegran 1997, Radegran & Saltin 1998, Osada 2004). In this way, the instantaneous blood
velocity during rhythmic exercise is greatest when systole (high arterial pressure) coincides
with muscle relaxation (low intramuscular pressure and resistance) and lowest when diastole
occurs during muscle contraction (Osada & Radegran 2006, Radegran & Saltin 1998).
Furthermore, the time course of these fluctuations can change in response to a change in
heart rate (HR) or CR cadence, with a speeding of either HR or CR producing shorter interval
durations, and thereby more frequent fluctuations in blood velocity during exercise (Osada
2004). To minimize the phasic effect of the heart and skeletal muscle CR cycles on BF
measurements, it is common practice to integrate the blood velocity signal over a single or
multiple CR or cardiac cycles (using the beat-by-beat (R-R interval) HR). This decreases the
variability of the BF-time response (less variability with averaging more cycles) during
steady-state exercise conditions (Osada 2004, Holland et al., 1998, Shoemaker et al., 1996)
independent of whether CR cycle or HR are used (Osada & Radegran 2006). In examining
these averaging techniques, Osada (2004) found that BF averaged over many (10-30) CR
cycles resulted in less variability than those BF values determined by either HR or over fewer
(1-2) CR cycles, concluding that at least 10-CR cycles should be used to obtain accurate
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steady-state BF values. While these established methods provide a good estimation of BF
during steady-state exercise, it presently is unclear how averaging affects the dynamic profile
of BF during the non-steady-state where greater temporal resolution of the signal is required.
During a step-transition in exercise intensity, V̇O2m and pulmonary V̇O2 (V̇O2p) increase in
an exponential-like manner to meet the increased metabolic demands of the active skeletal
muscle (Krustrup et al., 2009). The time course of adjustment of V̇O2 reflects aerobic system
dynamics and can be described by the time constant of the fundamental (phase II) V̇O2
response (i.e., V̇O2) or by the mean response time of the overall V̇O2 response (MRT =  +
TD). Like V̇O2, with step-changes in work rate (WR), BF also increases in an exponentiallike manner and thus quantification of its kinetics provide valuable insight into the muscle
bulk O2 delivery and the relationship between BF and V̇O2 (Saltin 1985, Wesche 1986,
Walloe & Wesche 1988). With transitions into both moderate- (MOD, below lactate
threshold (LT)) and heavy-intensity domains (HVY, above LT) the V̇O2p increases to a new
“steady-state,” but in HVY, the “steady-state” is delayed compared to MOD because of an
additional V̇O2p requirement compared to MOD. This extra O2 cost of exercise, termed the
‘V̇O2p slow component,’ reflects a decrease in exercise efficiency. Although these differing
responses are well-recognized for V̇O2p, the observed response of BF to HVY exercise is
much more ambiguous on the existence of a slow component-like response, with some
studies quantifying a slow component in the BF response (Paterson et al., 2005a/b), while
others are not able to discern a BF slow component (Fukuba et al., 2004). In order to
accommodate this uncertainty in the existence of a BF slow component, some authors have
used the same time frame as that of the V̇O2p slow component in order to quantify a slow
component in BF (Endo et al., 2005, DeLorey et al., 2007), while others have chosen to not
quantify a BF slow component (Nyberg et al., 2017).
In those studies investigating BF kinetics, the blood velocity profile has been analyzed by
either the HR cycle (MacDonald et al., 1998 & 2001, Hughson et al., 1996) or the muscle
CR cycle (MacPhee et al., 2005, duManoir et al., 2010). However, both of these techniques
are affected by the interaction of various factors including arterial and intramuscular pressure
fluctuations as well as reductions in interval duration brought about by exercise-induced
increases in HR or an increase in CR cadence (i.e., decreased R-R interval or CR interval,
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respectively). As with steady-state exercise, to reduce the variability in the BF signal caused
by the interaction of these factors, the data can be averaged over several HR or CR ‘cycles’.
However, during the “non-steady-state” associated with exercise transitions, as the
averaging “window” is widened to include more HR or CR cycles, the fidelity of the
transition profile is reduced which impairs the characterization of the BF kinetic response.
The different sources of variability in the blood velocity signal amongst these analysis
techniques could distort the profile and thus, the estimation of the rate of adjustment of the
BF response, and the confidence in the estimated parameters (e.g., 95% confidence interval
(CI95), a measure of the goodness of fit of the modeled response to the data). Therefore, the
purpose of the present study was to determine whether: i) parameter estimates for BF kinetics
(baseline, steady-state, amplitude, MRT, and CI95) are altered consequent to HR and CR
induced “distortions” in blood velocity and analysis technique used; ii) different averaging
periods (1 vs 2 vs 5 HR or CR cycles; ‘binned’ vs. ‘rolling’ averages) produce different
kinetics parameter estimates, and; iii) each analysis technique can similarly predict kinetic
parameter estimates between moderate- (MOD) and heavy-intensity (HVY) exercise
transitions.
Methods
Subjects
Eight healthy men (age, 26.8 ± 4.3 yrs (mean ± SD); mass, 83.5 ± 8.3 kg; height, 182.8 ± 5.1
cm) volunteered to participate in this study. Participants were informed of the experimental
protocol and provided written informed consent for all procedures that had been approved
previously by The University of Western Ontario Ethics Committee for Research on Human
Subjects in accordance with the Declaration of Helsinki.
Protocol
All participants were familiarized with ‘knee-extension’ (KE) exercise on a custom-built
alternate-leg knee-extension ergometer (see MacPhee et al., 2005) where muscle activity
was confined mainly to the quadriceps muscle group, with minimal contribution from other
muscle groups. A seatbelt was fastened around the participant’s waist to minimize hip
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movement during exercise. Participants maintained a cadence of 30 contractions per minute
(cpm), with feedback displayed on a computer screen in front of them. Each participant
performed an incremental KE exercise test to the limit of tolerance for determination of
V̇O2peak and estimated LT (the point at which V̇CO2, ventilation and end-tidal PO2 began to
increase out of proportion to V̇O2 without a concomitant decrease in end-tidal PCO2). The
LT was used to identify the moderate- (MOD, < LT) and heavy-intensity (HVY, > LT)
exercise domains to better study intensity-specific physiological and metabolic responses.
After 4 min of baseline (3 W) KE exercise, the WR increased by 3 W each minute until a
cadence of 30 cpm could no longer be maintained. The WRs corresponding to MOD and
HVY in this study were 24 W and 66 W, respectively. Each exercise transition protocol
began with 6 min of baseline KE exercise at 3 W followed by an instantaneous increase in
WR to either MOD or HVY, with each transition lasting 8 min. Each protocol was repeated
3-4 times to increase the signal-to-noise ratio (Gill 1985).
Measurements
Pulsed-wave and echo-Doppler ultrasound (GE Vingmed, System Five, 4-5MHz, 60° angle
of insonation) were used to continuously monitor muscle conduit artery blood velocity and
artery diameter, respectively, throughout the exercise protocol. The ultrasound probe was
held over the common femoral artery, 2-3 cm proximal to the artery bifurcation to minimize
turbulence, but distal to the inguinal ligament to avoid BF to the inguinal region as previously
suggested (MacDonald et al., 1998, Radegran & Saltin 1998). The ultrasound gate was
positioned in the center of the artery and maximized for complete insonation of the vessel
cross-section. Mean blood velocity (MBV) measures were processed by a Neurovision
Transcranial Doppler System (Multigon Industries Inc.) and saved on a separate computer
using PowerLab (ADInstruments, LabChart 7) for offline analysis. Echo-Doppler ultrasound
was continuously recorded throughout the protocol and later used to determine artery
diameter. Every 60 s measures of artery diameter were taken in triplicate during a diastole
in the muscle relaxation phase and averaged to yield a single vessel diameter at each time
point.
Data Analysis
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For each individual trial, the instantaneous MBV signal (antegrade and retrograde combined)
was integrated in correspondence to a single R-R interval (HR1) and muscle CR cycle (CR1)
using PowerLab software (see Figure 2.1). The BF data generated from these methods were
averaged subsequently into: i) ‘bins’ of 2 and 5 cycles (e.g., 2 and 5 CR cycles (CR2b and
CR5b)) and; ii) ‘rolling’ averages of 2 and 5 cycles, with the averaging ‘window’ progressing
by a single cycle for each new point (e.g., HR2r, HR5r). This resulted in 10 different data
processing techniques.
Leg femoral artery BF was calculated as:
BF (L/min) = πr2 • MBV (cm/s) • 0.6
where r is the femoral artery radius (cm), MBV is the mean blood velocity (cm/s), and 0.6 is
a factor to correct units to L/min.
Single exercise transitions were edited and data lying 3 SDs outside the local mean were
removed (Keir et al., 2014, MacPhee et al., 2005, Lamarra et al., 1987). Trial repetitions for
each subject were linearly interpolated on a second-by-second basis, ensemble-averaged to
yield a single response for each transition (MOD and HVY), time-aligned and subsequently
averaged into 5 s time bins. Data were modeled using a monoexponential nonlinear, least
squares regression fitting function:
BF(t) = bl + amp (1-e-[(t-TD)/τ])
where BF(t) is blood flow at any time, t; bl is baseline BF (BFbl; at 3 W); amp is the amplitude
of the increase in BF (ΔBF) above BFbl; TD is the time delay; and τ is the time constant
(equivalent to the time it takes to reach 63% of ΔBF). End-exercise BF values were
determined over the last 2 min of the transition. No discernible ‘slow component’ was seen
in any of the HVY transitions, therefore both transitions (MOD and HVY) were fit with a
monoexponential function from the first data point following the imposition of the higher
WR to the end of exercise (8 min). The TD was locked at ‘0’ to prevent negative values for
this parameter. Because these fitting boundaries were used (i.e., fitting the entire transition,
and no TD), it was decided to report the time course of BF adjustment as MRT rather than
τ.
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The coefficient of variation of BFbl (CVbl) was calculated from the ensemble averaged BF
profile over the 2 min period prior to the transition.
Statistics
The kinetic parameter estimates for each condition were analyzed by a two-way repeated
measures ANOVA (exercise intensity x analysis technique). A significant F ratio was further
analyzed using Tukey’s post hoc analysis to determine where differences were located. All
statistical analyses were performed using SigmaPlot (Systat Software Inc., San Jose, CA,
USA). Statistical significance was accepted at p < 0.05. All values are reported as mean ±
SD.
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Figure 2.1. Overview of analysis techniques. HR1, integrating blood velocity within a single heart rate (HR) cycle; HR2b,
integrating blood velocity within 2 consecutive HR cycles then moving the window forward to the next 2 consecutive HR cycles
and integrating those 2 consecutive HR cycles; CR2r, integrating blood velocity signal within 2 consecutive muscle contractionrelaxation (CR) cycles then moving the window forward by a single CR cycle and integrating those 2 consecutive CR cycles.
See text for further explanation. CR, contraction-relaxation cycles; HR, R-R intervals of heart rate; r, rolling average; b, binned
average.
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Results
The raw data response profiles for each of the CR and HR analysis techniques of a
representative subject are shown in Figure 2.2. Subject characteristics are presented in Table
2.1 (with V̇O2p and WR values determined from the step-incremental KE exercise protocol).
Steady-state BF and parameter estimates for BF kinetics are presented in Table 2.2. For
analysis of BFbl and CVbl, MOD and HVY trials were combined together as both transitions
were initiated from the same 3 W baseline and no between-condition differences for BFbl
were observed (p > 0.05). In general, CVbl was similar amongst conditions with the exception
that CVbl was smaller (p < 0.05) for CR5b than nearly all other conditions (except CR5r, in
which there was only a trend; p = 0.07).
Values for ΔBF from the modeled best-fit response (i.e., not calculated by end-exercise
minus BFbl) are displayed in Table 2.2. As expected, ΔBF was greater (p < 0.05) in HVY
than MOD across all analysis techniques. In HVY, ΔBF tended to be higher in the CR
compared to the HR analysis techniques (with the highest ΔBF found in CR1 (1.86 ± 0.41)
and the lowest found in HR2r (1.68 ± 0.45)) There were no differences in ΔBF values
between analysis techniques in MOD (p > 0.05).
The estimated MRT BF in MOD was 30% smaller (p < 0.05) for CR1 compared to most
other analysis techniques (Table 2.2; a trend (p < 0.10) was seen between CR1 vs. CR2r and
HR2b). In HVY, the MRT BF was similar ( 39 s) amongst all analysis techniques (Table
2.2).
The CI95, which provides a measure of confidence in the estimated parameters, tended to be
lower (or at least similar) in the CR compared to the HR analyses. From Table 2.2 it can be
seen that the CI95 for CR1 tended to be lowest (p < 0.05), while HR1 was highest (p < 0.05)
amongst analysis techniques for both MOD and HVY.
The difference between the “model-derived” end-exercise BF and the actual “datadetermined” end-exercise BF responses, reflecting the accuracy of the model prediction, was
 60 mL/min (range: 30-100 mL/min) in MOD and  130 mL/min (range: 80-210 mL/min)
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in HVY (Table 2.2), with none of the analysis techniques achieving a value of ‘0’ (which
would be indicative of modeling technique precisely predicting the ‘true’ end-exercise BF
values). In comparing the difference between the ‘model-determined’ steady-state BF value
and the ‘data-determined’ end-exercise BF value (the average from the data points in the last
30 s of the transition) within each analysis technique, there were no differences amongst
analysis techniques within MOD or HVY (p > 0.05; Table 2.2). However, in comparing how
well the modeled data predicted the end-exercise data between MOD and HVY exercise
within each technique, those analysis techniques that used a ‘rolling’ average (HR2r, HR5r,
CR2r, and CR5r) were significantly closer in predicting the end-exercise BF value in MOD
(“missing the mark” by only 30-40 mL/min) compared to HVY (“missing the mark” by 140210 mL/min; p < 0.05; Table 2.2).
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Table 2.1. Subject characteristics.
Age
(yrs)

V̇O2peak
(L/min)

WRpeak
(W)

LT
(L/min)

MOD WR
(% LT)

RCP
(L/min)

HVY WR
(% RCP)

26.8 (4.3)

1.78
(0.21)

83 (8)

1.03
(0.26)

84 (71-99)

1.42
(0.18)

95 (74-103)

LT, lactate threshold; WR, work rate; RCP, respiratory compensation point. Values are: mean (SD; except for MOD WR and
HVY WR: mean (range)).
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Table 2.2. Values of baseline blood flow (BFbl), baseline coefficient of variation (CVbl), blood flow amplitude (ΔBF), mean response
time (MRT), MRT confidence interval (CI95), and difference between model-derived (steady-state) and data-derived (end-exercise;
SS-EE) across the different analysis techniques for moderate- (MOD) and heavy-intensity (HVY) exercise.
Variable
BFbl
(L/min)

Avg

CVbl
(%)

Avg

ΔBF
(L/min)

MRT
(s)

CI95
(s)

SS – EE
(L/min)

MOD
HVY δ

MOD
HVY

MOD
HVY

MOD
HVY

HR1
0.99
(0.29)

HR2r
0.98
(0.28)

HR2b
0.98
(0.29)

HR5r
0.98
(0.28)

HR5b
0.98
(0.28)

CR1
0.97
(0.28)

CR2r
0.97
(0.27)

CR2b
0.97
(0.27)

CR5r
0.97
(0.27)

CR5b
0.97
(0.27)

5.1 *
(1.2)

5.3 *
(1.9)

5.2 *
(2.0)

5.2 *
(1.8)

4.8 *
(1.6)

5.3 *
(1.9)

5.2 *
(1.8)

5.2 *
(1.6)

4.7
(1.7)

4.1
(1.5)

0.78
(0.16)
1.71 *†
(0.36)

0.74
(0.16)
1.68 *†‡#
(0.45)

0.75
(0.16)
1.73 *
(0.40)

0.75
(0.17)
1.76 *
(0.47)

0.76
(0.17)
1.76 *
(0.41)

0.77
(0.20)
1.86
(0.41)

0.76
(0.18)
1.77
(0.45)

0.76
(0.18)
1.81
(0.42)

0.76
(0.18)
1.75 *
(0.45)

0.77
(0.18)
1.78
(0.45)

44 *
(32)
37
(14)

42 *
(25)
37
(14)

41
(24)
33
(11)

43 *
(26)
41
(13)

42 *
(24)
39
(14)

30
(20)
40
(9)

41
(24)
40
(13)

39
(23)
40
(13)

43 *
(26)
40
(14)

42 *
(25)
41
(14)

19
(11)
21
(5)

15 *
(9)
17 *
(6)

15 *
(8)
15 *
(4)

15 *
(9)
14 *
(6)

14 *
(8)
14 *
(4)

11 *†‡#
(4)
11 *†‡
(4)

14 *
(9)
12 *†
(6)

13 *
(9)
11 *†‡
(4)

13 *
(8)
12 *†
(6)

12 *†‡
(8)
10 *†‡#
(5)

0.10
(0.09)
0.12
(0.09)

0.03
(0.02)
0.21 δ
(0.15)

0.08
(0.07)
0.08
(0.05)

0.04
(0.02)
0.17 δ
(0.13)

0.09
(0.09)
0.11
(0.11)

0.06
(0.05)
0.12
(0.10)

0.03
(0.02)
0.15 δ
(0.12)

0.07
(0.07)
0.11
(0.10)

0.04
(0.02)
0.14 δ
(0.13)

0.07
(0.07)
0.11
(0.15)

Significantly different (p < 0.05) from the: *, largest value (or smallest value for CVbl Avg and MRT MOD) within that work rate
(MOD or HVY) for that variable; †, 2nd largest value within that work rate (MOD or HVY) for that variable; ‡, 3rd largest value within
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that work rate (MOD or HVY) for that variable; #, 4th largest value within that work rate (MOD or HVY) for that variable; δ,
significantly different from MOD for that analysis technique. CR, contraction-relaxation cycle; HR, heart rate cycle; r, rolling average;
b, binned average. Values are: mean (SD).
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Figure 2.2. The raw data response profiles for each of the analysis techniques for a single
moderate- (MOD) and heavy-intensity (HVY) exercise trial of a representative subject.
CR, blood flow averaged over the contraction-relaxation cycle; HR, blood flow averaged
over the cardiac cycle; 1, single cycle average; 2b, blood flow averaged over 2 cycles
‘binned’ together; 2r, blood flow averaged over 2 cycles ‘rolled’ together, etc.
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Discussion
When fitting the dynamic profile of the BF response, a central goal is collecting good data
to accurately quantify the true physiological response. However, despite the variability in
the blood velocity signals and vascular diameter caused by underlying HR and CR cycles,
there does not appear to be an accepted “gold standard” method for analyzing (or
quantifying) the blood velocity or BF signal, and thus establish a “true” profile in blood
velocity or BF. To help elucidate a prospective ‘best method’ for BF analysis, this study used
the same data sets collected during transitions to a MOD and HVY WR, to investigate the
effect of different data sorting techniques (based on heart rate (HR) or contraction-relaxation
(CR) cycles) and data averaging “intervals” (a single cycle, or using ‘binned’ or ‘rolling’
averages over 2 or 5 HR or CR cycles) on estimates of steady-state BF and the parameters
associated with the dynamic adjustment of BF during transitions to constant-load exercise
(i.e., BF kinetics). The main findings of the present study were: i) MRT BF estimated using
a single muscle contraction-relaxation cycle (CR1) was smaller than most other analysis
techniques in MOD, but no other differences in BF kinetics were seen amongst any of the
other analysis techniques for both MOD and HVY; ii) the steady-state CI95 was largest when
using a single cardiac cycle (HR1) and lowest when using a single contraction-relaxation
cycle (CR1) for BF analysis compared to all other analysis techniques in both MOD and
HVY; iii) analysis by CR1 resulted in a higher (or similar) ΔBF response than the other
analysis techniques in HVY, but not in MOD; and iv) analyzing data using the ‘rolling’
average techniques (HR2r, HR5r, CR2r, CR5r) resulted in a significant difference between
MOD and HVY protocols when looking at the difference between the ‘model determined’
and the ‘data determined’ steady-state BF values.
The variability of the BFbl signal revealed that the analysis technique using the longest
averaging periods (i.e., CR5b, ~10 s interval durations) was associated with the smallest
CVbl (4.1%) compared to the other analysis techniques. This agrees with findings of previous
studies showing that longer averaging periods resulted in less variability in the BF signal
(Osada & Radegran 2006, Osada 2004, Shoemaker et al., 1996). However, although
variability in BF values was lowest in CR5b, the steady-state BFbl was similar amongst all
analysis techniques (Table 2.2). This agrees with previous studies in which steady-state BF
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during exercise was similar when assessed using a single HR or CR cycle (Osada &
Radegran 2006, Radegran 1997). Therefore, during “steady-state” conditions, the calculated
BF appears independent of the analysis technique.
In addition to estimating the steady-state BF responses to a given V̇O2 or WR, quantifying
the dynamic profile of BF during transitions between the steady-states of V̇O2 or WR
provides additional information on BF control, but requires more care with the analysis due
to the changing HR and BF requirements associated with the exercise transient. In the present
study during MOD transitions, the estimated MRT BF was smallest (30 s) when analyzed
using a single contraction-relaxation cycle (CR1) compared to the other analysis techniques
(~42 s; range: 39-44 s). However, during HVY transitions, the estimated MRT BF was
similar (~39 s; range: 33-41 s) independent of the analysis technique used (Table 2.2). That
an analysis-related difference in estimated MRT BF was seen in MOD, but not in HVY,
could potentially be attributed, in part, to the higher ΔBF in HVY compared to MOD. It
previously was suggested for V̇O2 that a small response amplitude is associated with a lower
signal-to-noise ratio, which makes it difficult to accurately or confidently model the data
response profile (Casaburi et al., 1989, Fawkner & Armstrong 2007). Therefore, the smaller
ΔBF associated with MOD may adversely impact the modeling and confidence in estimating
the parameters for BF kinetics in this exercise domain. Alternatively, this analysis-related
difference between MOD and HVY for quantifying MRT BF may be influenced by the
fitting equation used in HVY, as a monoexponential may not accurately represent this
response. However, in the present study, there were no trials in which there was a discernible
slow component (or phase I), and thereby a monoexponential fit was deemed the most
appropriate option.
The ΔBF values in MOD were similar across all analysis techniques, whereas in HVY ΔBF
was generally greater when using CR than HR analysis techniques, with CR1 being the
largest while HR2r was smallest amongst ΔBF values (Table 2.2). These findings imply that
either BFbl values or end-exercise steady-state BF values were different between analysis
techniques. While there were no significant differences in any BFbl values across analysis
techniques, CR1 steady-state BF values were significantly greater than HR2r (data not
shown). While the reason for this finding is not readily apparent, it is possible that a wider
49

spread of data (i.e., a larger CI95) around the local mean for HR analysis techniques compared
to CR analysis techniques may have skewed the steady-states to be lower or higher,
respectively.
The CI95 characterizes the uncertainty about the true value of a population parameter
(Curran-Everett & Benos 2004), and therefore, in the present study, provides some indication
of the variability in the BF response. The CI95 for HR1 in both MOD and HVY was
significantly larger than seen in any of the other analysis techniques. Overall, in both MOD
and HVY, the CI95 for the CR analysis techniques were generally smaller than those for HR.
These findings are likely due to the HR analysis techniques having shorter – and changing –
time intervals within which BF is analyzed, which may lead to more frequent and larger
fluctuations in the BF signal because of rhythmic changes in intramuscular pressure related
to the CR cycle (see Figure 1.2 ‘box C’ and ‘box D’) (Osada & Radegran 2006). If so, this
response might become more pronounced during the transition period when HR is adjusting
to the new, higher WR. With the CR analysis techniques, longer averaging periods (e.g.,
minimum ~2 s) – relative to the R-R intervals of the cardiac cycle (e.g., HVY minimum
~0.52 s (HR ~115 bpm) and MOD minimum ~0.73 s (HR ~82 bpm)) – will attenuate the
size and frequency of fluctuations in MBV and BF. These findings agree with previous
studies that have shown that analyses based on HR compared to CR tend to be more variable
(Osada & Radegran 2006, Radegran 1997). Furthermore, Osada & Radegran (2006) found
a negative linear correlation (r = 0.995) between the coefficient of variation (CV) for BF and
the duration of a single beat-to-beat cardiac cycle. In contrast, there was no relationship when
the CV of BF was analyzed with respect to the duration of a single muscle CR cycle, with
the CV tending to be lower when analyzed using the CR duration compared to the HR
duration (Osada & Radegran 2006). Similarly, the present study found a trend for a negative
correlation between CI95 and interval duration for both MOD (p = 0.10; data not shown) and
HVY (p = 0.06; data not shown). Although much of the variability in the BF signal is
attributable to physiological sources (e.g., cardiac cycle, vascular occlusion from muscle
contraction), variability also can be ascribed to the data collection process. Radegran (1997)
stated that while insonation failures are readily detected and edited (or removed) when
analyzing with a single CR cycle, when analyzing with a single HR cycle these errors are
‘hidden’ within the large natural variability of the BF signal (see Figure 2.2 – HR1), and
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therefore are incorporated into the response profile. In contrast, although a single CR cycle
can allow for easier detection of insonation failures, it would be plausible that over multiple
cycles these same errors from insonation failures could be incorporated into the overall BF
response. When averaging over longer time periods (e.g., ~10 s (CR5r and CR5b)) the
negative impact caused by a brief technical measurement failure (e.g., ~1-2 s) could be
‘minimized’ by inclusion of error-free signal of longer duration (~8-9 s). Nonetheless, aside
from eliminating these errors, a goal in fitting the dynamic profile of a response is collecting
good data such that the resulting profile is representative of the underlying ‘true’
physiological response, allowing one to have confidence in the modeled parameter estimates.
The finding that BF kinetics estimates had less variability and a smaller CI95 for analyses
based on CR rather than HR provides support for its use in fitting BF kinetics.
The issue of variability in the BF signal during the non-steady-state phase is clearly seen by
its effect on the ‘model-determined’ steady-state BF compared to the ‘data-determined’
average end-exercise BF within each analysis technique. While the differences between
‘model’ and ‘end-exercise’ steady-state BF responses were similar across analysis
techniques within MOD and HVY, the difference was greater in HVY compared to MOD
when using a ‘rolling’ average (HR2r, HR5r, CR2r, and CR5r; Table 2.2). This “variability”
in the predictive ability of ‘rolling’ averages between MOD and HVY exercise would
suggest that these techniques are less reliable for fitting BF responses when comparing
transitions across more than one exercise intensity domain.
An underlying limitation in the present study is that the modeling of the BF responses in
MOD and HVY are restricted by the lack of a ‘gold standard’ for quantifying BF kinetics
and thus comparing the accuracy of different methods. Therefore, the present study chose to
gauge the accuracy of these various analysis techniques based on data variability (e.g., CI95)
and by observing whether there were any statistical ‘outliers’ between analysis techniques
for the different parameter estimates (e.g., BFbl, ΔBF, MRT). However, it should be noted
that, while desirable, having BF fitting techniques that agree with each other or produce less
variability does not denote that a fitting technique is ‘correct.’ Nevertheless, the findings of
this study show that certain BF analysis techniques can produce different kinetic parameter
estimates, and therefore consideration to how BF is quantified is warranted.
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In the present study the TD was constrained to ‘0.’ This seemed reasonable as the MRT
values for BF were uncharacteristically large with negative TDs – when TD was free to vary
– which cannot be representative of the true physiological response. While this approach is
not desirable, as it eliminates a fitting parameter from a study investigating fitting techniques
and simultaneously constrains the remaining parameters (i.e., ΔBF and MRT), it has been
supported previously (McNarry et al., 2014). It is suggested that future studies take this
limitation into consideration when fitting the BF response, and that by not constraining the
TD to ‘0’ there may be either an inflated MRT (with a large, negative TD), or an alternative
analysis technique that may be more accurate in fitting the BF data.
The effect of contraction frequency was not investigated in the present study but has been
shown to impact BF variability, with higher contraction frequencies (60 cpm) showing
greater variability than lower frequencies (30 cpm) at low WRs (10-20 W), but not at higher
WRs (30-40 W; Osada 2004). In the present study a contraction frequency of 30 cpm was
used, as this has been consistently used in our lab (Chin et al., 2013, 2010, duManoir et al.,
2010, DeLorey et al., 2007, MacPhee et al., 2005, Paterson et al., 2005a/b), and so care
should be taken when fitting BF responses using other contraction frequencies, especially at
lower WRs. In the present study, averaging periods of up to 5 CR cycles were chosen so as
to limit the maximum duration of averaging periods to no more than 10 s (2 s duty cycle x 5
cycles = 10 s), as longer averaging periods will result in i) fewer data within the transition
phase, and ii) more ‘mixing/crossover’ of baseline and steady-state data with data from the
transition phase. Shoemaker et al. (1996) drew attention to this by showing that BF
variability was significantly decreased by averaging over their 3 s duty cycle compared to
averaging with HR, but that no further improvements were seen by averaging over 5-60 s.
These authors point out that averaging over the duty cycle “reduced the exercise-induced
variability optimally while maintaining sufficient time resolution for time course studies.”
Although there are many options for both cadence and duty cycle beyond the parameters
used in the present study (one cadence (30 cpm) and three averaging periods (1, 2, and 5
cycles)), the present study has, nonetheless, provided good criteria for consideration (e.g.,
HR vs. CR, ‘binned’ vs. ‘rolling’, single vs. multiple cycle averaging) when estimating BF
kinetics.
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In conclusion, the results of the present study extend upon the findings of previous studies,
which have looked at steady-state BF values, by investigating the effect of different analysis
techniques (“triggered” by HR and CR) and averaging methods (‘binned’ or ‘rolling’ over 2
or 5 cycles) on the non-steady-state, transition, phase of the BF response profile. While there
is no ‘gold standard’ for BF analysis that could be used to verify the best estimate of BF and
whether any of the present analysis techniques is ‘correct’ or ‘better’ than the others, the
findings of the present study strongly suggest that analysis technique can influence BF
kinetics parameter estimates. Based on the findings of this study, it is suggested that CR1
may be a good analysis technique as CR analysis techniques were associated with lower
variability (small CI95) than HR analysis techniques. Furthermore, those techniques using
‘rolling’ averages resulted in discrepancies between model- and data-determined endexercise BF values between MOD and HVY exercise, meaning that within the CR analysis
techniques, the methods of CR2r and CR5r may be poor analysis techniques. Lastly, a shorter
averaging period (1 vs. 2 or 5) will also serve to minimize the ‘overlap’ of data in steadystate and non-steady-state phases of the transition.
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CHAPTER III: The effect of increasing work rate amplitudes
from a common metabolic baseline on the kinetic response of
V̇O2p, blood flow, and muscle deoxygenation
Introduction
During exercise there is an increase in ATP utilization by the active skeletal muscle, with a
larger increase in exercise intensity necessitating a larger energy requirement. The greater
energy needs ultimately are provided by oxidative phosphorylation, which relies on the
delivery of O2 to the muscle via blood flow (BF). During steady-state exercise there is a
linear relationship between muscle O2 utilization (V̇O2m) and BF (Andersen & Saltin 1985).
However, upon a step-increase in external work rate (WR), pulmonary O2 utilization (V̇O2p;
reflective of V̇O2m) does not increase instantaneously, but instead increases in an exponential
manner towards a new steady-state (Whipp & Wasserman 1972, Grassi et al., 1996 Rossiter
2011, Poole & Jones 2012), with the rate of this response quantified by the time constant (τ).
The delay in attaining steady-state V̇O2p is believed to be due to either a delay in the
activation of oxidative enzymes (metabolic ‘sluggishness’) or an inadequate delivery of O2
to the muscle (i.e., BF) or some combination of both (for review see Poole & Jones 2012,
Rossiter 2011, Tschakovsky & Hughson 1999).
The use of Doppler ultrasound allows for the continual monitoring of both blood velocity
and vessel diameter for the determination of conduit artery (bulk) BF (Gill 1979 & 1985,
Hoskins 1990). BF also is described as increasing exponentially to meet the increased
metabolic demands of the active skeletal muscle, in a fashion similar to the V̇O2p response
(Saltin 1985, Wesche 1986, Walloe & Wesche 1988). This increase in BF is accomplished
‘centrally’ by an increase in cardiac output (Q̇T; via an increase in heart rate (HR) and stroke
volume) and mean arterial pressure (MAP), and ‘peripherally’ by an increase in vascular
conductance (VC; via an increase in vasodilation) (for review see Saltin et al., 1998, Joyner
& Casey 2015). In general, many studies (MacDonald et al., 1998, Fukuba et al., 2004,
MacPhee et al., 2005, Koga et al., 2005, Endo et al., 2005, Harper et al., 2006, Jones et al.,
2012, Schlup et al., 2015), but not all (Grassi et al., 1996, Hughson et al., 1996, MacPhee et
al., 2005, Paterson et al., 2005a, duManoir et al., 2010, Jones et al., 2012, McNarry et al.,
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2014, Nyberg et al., 2017), report muscle conduit artery BF kinetics as being faster than
V̇O2p kinetics. The assessment of BF and BF kinetics in many of these studies commonly is
made at the level of the conduit artery, and thus the dynamic changes may not accurately
reflect BF and O2 delivery responses occurring in the muscle microcirculation at the red
blood cell–myocyte interface. Measures of local muscle oxy-/deoxygenation changes during
transitions to exercise can be studied noninvasively using near-infrared spectroscopy
(NIRS). NIRS-derived muscle deoxygenation (deoxy [Hb + Mb]; reflecting deoxygenated
haemoglobin and myoglobin) provides information on muscle fractional O2 extraction, or
local microvascular O2 delivery-to-local V̇O2m ratio, within the volume of muscle
interrogated by NIRS (DeLorey et al., 2003, Grassi et al., 2003, Grassi & Quaresima 2016).
Ferreira et al. (2005b) demonstrated that deoxy[Hb + Mb] in combination with V̇O2p (as a
proxy for V̇O2m) could provide an estimate of microvascular/capillary BF (Q̇cap) kinetics.
Using this method, Barstow and colleagues (Harper et al., 2006; Schlup et al., 2015) reported
that at the onset of knee-extension exercise, the kinetics of femoral artery blood flow
(measured using Doppler ultrasonography) were faster than the adjustment of V̇O2p, however
the kinetics of Q̇cap were either slower (Harper et al., 2006) or similar to V̇O2p kinetics
(Ferreira et al., 2005b; Schlup et al., 2015). These findings of similar or slower Q̇cap kinetics
suggest that in order for V̇O2p to increase faster than the rate at which O2 is being delivered
to the muscle there would have to be a significant deoxygenation within the muscle
microvasculature which presumably slows O2 diffusion into muscle.
Although the kinetics of V̇O2p during transitions to increasing ΔWRs has received a great
deal of attention, the dynamics of BF adjustments during these transitions has received less
attention. Those studies that have examined BF responses to different intensities, generally,
report no difference in BF kinetics between transitions of increasing ΔWRs (Nyberg et al.,
2017, McNarry et al., 2014, Jones et al., 2012, Koga et al., 2005, MacPhee et al., 2005,
Radegran & Saltin 1998, Hughson et al., 1996), with no difference in V̇O2p kinetics across
these different ΔWRs either (Nyberg et al., 2017, Jones et al., 2012, Koga et al., 2005,
MacPhee et al., 2005). However, several of these studies investigated exercise using a small
muscle mass (e.g., forearm, calf) in which there is little challenge to central haemodynamics
(Hughson et al., 1996, Saunders et al., 2005, Nyberg et al., 2017, Murphy et al., 2018).
Additionally, nearly all of these studies have investigated transitions of only two different
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ΔWRs (with only a few investigating the differences between MOD and HVY (McNarry et
al., 2014, Jones et al., 2012, Koga et al., 2005) and, therefore, it is not known whether these
findings hold true for transitions extending beyond two different ΔWRs, or if there is a
hitherto unseen relationship (e.g., linear, curvilinear, sigmoidal, parabolic, etc.) between
increasing ΔWRs and kinetics. In one of the few studies that has investigated more than two
transitions (3 transitions; 60, 80, 100% max WR) it was found that although the kinetic
response of BF amongst WRs did not differ, and the BF amplitude (ΔBF) was greater for
exercise at 80% compared to 60% max WR, there was no difference in ΔBF for exercise at
80 and 100% WR max (Nyberg et al., 2017). However, in this study small muscle mass
exercise (i.e., forearm) was performed, and whether findings of similar kinetics and an
attenuated increase in ΔBF with increasing ΔWR persists in a larger muscle mass is not
known. In a study using single leg knee-extension exercise, Radegran & Saltin (1998)
reported no difference in the BF time constant (τBF) during exercise transitions to four
different ΔWRs (10, 30, 50, 70 W), although they did report a tendency (not significant) for
the time to reach 50% of the response amplitude to be longer at higher ΔWRs.
Studies from our lab investigating exercise transitions from a common light-intensity
baseline metabolic rate, but increasing WRs for leg-cycling exercise, reported that although
the phase II V̇O2p amplitude increased progressively with increasing WR, the V̇O2p time
constant did not change (being 22 s; Keir et al., 2016b; Spencer et al., 2013). However, BF
was not measured in these studies. Therefore, the purpose of the present study was to
investigate, using alternate-leg knee-extension exercise, the kinetics of V̇O2p and conduit
artery BF initiated from a common light-intensity baseline metabolic rate, but with
increasing ΔWRs encompassing a range of moderate- to very heavy-intensity domains of
exercise. We hypothesized that when exercise transitions were initiated from a common
light-intensity baseline, the time constant (τ) for the primary component of both BF and V̇O2p
would be unchanging across increasing ΔWRs, but τBF would be consistently smaller than
τV̇O2p within the different transitions. Similarly, it was hypothesized that within each of the
variables of deoxy[Hb + Mb], HR, MAP, Q̇cap, and VC, the rate of adjustment would be
similar across increasing ΔWRs.
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Methods
Subjects
Ten healthy male volunteers (25.6 ± 4.5 yrs (mean ± SD); 85.5 ± 8.6 kg; 184.1 ± 5.3 cm)
participated in this study. Subjects were informed of the experimental protocol and were free
to withdraw at any time without penalty. Subjects gave written informed consent with all
procedures approved by The University of Western Ontario Ethics Committee for Research
on Human Subjects in accordance with the Declaration of Helsinki.
Protocol
All participants were familiarized with ‘knee-extension’ on a custom-built alternate-leg
knee-extension (KE) ergometer (see Bell et al., 2001) in which muscle activity was confined
to the quadriceps muscle group while the hamstrings were relaxed throughout exercise. A
seatbelt was fastened around the participant’s waist to minimize hip movement during
exercise. Participants were instructed to maintain a cadence of 30 contractions per minute
(cpm) which was visualized on a computer screen in front of them. Each participant
performed an incremental KE exercise test to the limit of tolerance which consisted of 4 min
baseline (3 W) KE exercise, after which the WR increased by 3 W each minute until a
cadence of 30 cpm could no longer be maintained. On a separate day, each subject also
performed a ramp incremental exercise test to the limit of tolerance on a cycle ergometer
(see Keir et al., 2016b). Each incremental test was used to determine V̇O2peak, estimated LT
(the point at which V̇CO2, ventilation and end-tidal PO2 (PETO2) began to increase out of
proportion to V̇O2 without a concomitant decrease in end-tidal PCO2 (PETCO2)), and
respiratory compensation point (RCP; the point at which ventilation and PETO2 displayed a
sharper increase, and PETCO2 displayed a decrease, relative to V̇O2) for each mode of
exercise. These boundaries were used to identify the moderate- (MOD; < LT), heavy- (HVY;
> LT to < RCP), and very heavy-intensity (VH; primary component > RCP, but < V̇O2peak)
exercise domains. Five different exercise transitions were performed on the KE ergometer
in which each transition began with 6 min KE exercise from a common baseline WR of 3 W
followed by an instantaneous increase to a ΔWR of either 21 (Δ21), 30 (Δ30), 42 (Δ42), 51
(Δ51), or 63 (Δ63) W (see Figure 3.1), with each transition lasting 8 min. The order of
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transitions was randomized and at least 24 hrs was allowed between trials. Each transition
was repeated 3-5 times to increase the signal-to-noise ratio (Gill 1985).
Measurements
V̇O2p: Gas exchange was measured breath-by-breath using volume turbinometry and mass
spectrometry as described previously (Keir et al., 2016a/b). Briefly, inspired and expired
airflow and volumes were measured by a bidirectional turbine and pneumotach (Hans
Rudolph, model 4813; total dead space was 150 mL) which were calibrated before each test
with a syringe of known volume (3.0 L) and the pneumotach was adjusted for zero flow. Gas
concentrations were sampled continuously and measured by a mass spectrometer (AMIS
2000, Innovision, Lindvedvej, Denmark) which was calibrated before each test using
precision-analyzed gas mixtures. The time delay between an instantaneous square-wave
change in gas concentration and its detection by the mass spectrometer was determined
electronically by computer. Data were collected at a frequency of 100 Hz and transferred to
a computer which aligned gas concentrations and expired volumes to build a profile of each
breath. Breath-by-breath alveolar gas exchange was calculated by using the algorithms of
Swanson (1980).
BF: Pulsed-wave and echo-Doppler ultrasound (GE Vingmed, System Five, 4-5MHz, 60°
angle of insonation) were used to continuously monitor blood velocity and artery diameter,
respectively, throughout the exercise protocol. The ultrasound probe was held over the
common femoral artery, 2-3 cm proximal to the artery bifurcation to minimize turbulence,
but distal to the inguinal ligament to avoid BF to the inguinal region as previously reported
(MacDonald et al., 1998, Radegran & Saltin 1998). The ultrasound gate was positioned in
the center of the artery and maximized for complete insonation of the vessel cross-section.
Mean blood velocity measures were processed by a Neurovision Transcranial Doppler
System (Multigon Industries Inc.) and saved on a separate computer using PowerLab
(ADInstruments, LabChart 7) for later analysis. Echo-Doppler ultrasound was continuously
recorded throughout the protocol, saved and used to determine artery diameter. Every 60 s
measures of artery diameter were taken in triplicate during diastole in the muscle relaxation
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phase and averaged to yield a single vessel diameter at each time point. BF was calculated
by the equation:
BF (L/min) = blood velocity (cm/s) • π • (diameter (cm)/2)2 • 0.12
where 0.12 is the conversion factor of ‘s’ into ‘min’ (i.e., x 60) for, mL/min into L/min (i.e.,
÷ 1000), and BF for both legs (i.e., x 2). Due to the inherent variability in blood velocity
from the cardiac cycle and muscle contraction (Radegran 1997, Osada & Radegran 2006),
the present study calculated BF by taking an average of blood velocity over a single muscle
contraction-relaxation cycle which has been proposed as an appropriate technique to
determine BF kinetics (see Chapter II).
NIRS and microvascular blood flow (Qcap): Local deoxy [Hb + Mb] (in addition to
oxyhaemoglobin (and myoglobin; oxy[Hb + Mb]), total haemoglobin (and myoglobin;
TOT[Hb

+ Mb]), and tissue oxygenation index (TOI)) was measured in the vastus lateralis

muscle using NIRS (Oxiplex TS, Model 92505, ISS, Champaign, USA) as described
previously (Keir et al., 2016b). Briefly, NIR optodes were housed in a rigid optically dense
plastic holder (connected to laser diodes and photomultiplier tube by optical fibers) with two
parallel rows of light emitter fibers (one row emitting at a wavelength of 690 nm and the
other row at 828 nm) and one detector fiber bundle; the source-detector separations for this
probe were 2.0, 2.5, 3.0, and 3.5 cm for both wavelengths. The NIRS probe was secured to
the skin overlying of the proximal portion of the vastus lateralis muscle (approximately 1/3rd
the distance from the greater trochanter to the lateral epicondyle of the femur), with great
care taken to ensure the same placement for all trials. An optically-dense black vinyl cover
and elastic wrap were used to minimize the intrusion of extraneous light and prevent
movement of the probes, while allowing free leg movement. The raw signals for deoxy[Hb
+ Mb], oxy[Hb + Mb], TOT[Hb + Mb], and TOI were corrected for skin and adipose tissue
thickness (which were measured by Doppler ultrasound) by linear regression of the Hbtot
signal against adipose tissue thickness, in accordance with the method of Bowen et al.
(2013). Microvasclar BF (Q̇cap) was calculated by rearranging the Fick equation, using V̇O2p
(after correcting for the cardiodynamic component (phase I)) to quantify V̇O2m, and
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deoxy[Hb + Mb] as a surrogate for a-vO2diff (Q̇cap = V̇O2p/deoxy[Hb + Mb]), as described
previously (Harper et al., 2006, Ferreira et al., 2005b).
HR: A Polar HR monitor connected to Powerlab (ADInstruments Inc., Colorado Springs,
CO) was used to continuously record HR.
MAP: Systolic and diastolic blood pressure (SBP and DBP) were measured manually on the
left arm (at the level of the heart) by a trained technician using a sphygmomanometer and
stethoscope, and were used to calculate MAP, where MAP = 1/3 SBP + 2/3 DBP. Measures
of BP were taken at rest, twice during baseline KE (at 2 min and 5 min), and at the 30 s time
point of each minute during the transition. BP values were corrected to the level of the
common femoral artery by an adjustment of 2 mmHg per inch vertical difference between
the level of the heart and the common femoral artery (Sia 2003). Femoral artery VC was
calculated as BF/MAP. Due to the infrequent measures of MAP and issues of precisely timealigning both BF and MAP, the iterated fits of BF and MAP were used to calculate VC.
Lactate: Blood was sampled from the earlobe during one of the transitions for each of the
individual WRs – at a timepoint 2 min prior to the completion of the exercise transition – for
determination of the blood lactate concentration using a lactate analyzer (Lactate Scout,
Sports Resource Group, Hawthorne, NY).
Data Analysis
Individual trials for V̇O2p and BF were edited for aberrant data (lying 3 SDs outside the local
mean were removed; Lamarra et al., 1987). Data for all variables were linearly interpolated
on a second-by-second basis, with data from like transitions for each subject then being
ensemble-averaged to yield a single response for each transition and subsequently averaged
to 5 s time bins. Data were modeled by a monoexponential nonlinear, least squares regression
fitting procedure:
Y(t) = bl + amp (1-e-[(t-TD)/τ])
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where Y represents V̇O2p, BF, deoxy[Hb + Mb], MAP, VC, or HR at any time (t); bl is the
steady-state baseline of Y; amp is the “steady-state” increase in Y above bl; TD is the time
delay; and τ is the time constant (equivalent to the time taken to reach 63% of amplitude).
For V̇O2p, only data within the primary (phase II) component were included in the fitting
window (i.e., excluding the ‘cardiodynamic’ component (phase I) and the ‘slow component’
when exercise was above LT). Phase I was determined by extending the fit window
backward from ~35 s until τ, χ2, and confidence interval began to increase, as described
elsewhere (Rossiter et al., 2001). Similarly, for those transitions into HVY and VH
(determined from analyzing the LT in the ramp incremental test, and confirmed by lactate
values), the slow component was determined by extending the fit window forward from ~90
s (a time point that was clearly a part of the primary component) until τ, χ2, and confidence
interval began to increase. The V̇O2p slow component was quantified as the difference
between the phase II steady-state V̇O2p and end-exercise V̇O2p (averaged over the last 30 s
of the exercise transition).
Data for BF were fit from the first time point after the transition to the time point that
corresponded with the end of the phase II V̇O2p response (τBF), with TD fixed at 0 s.
Additionally, because previous studies have suggested uncertainty on the manifestation of a
slow component in the BF profile (Endo et al., 2005, Fukuba et al., 2004), BF data were also
fit to the end of the exercise transition for quantification of the mean response time (MRT),
with both measures (τBF and MRT) being commonly reported in the literature (Jones et al.,
2012, Koga et al., 2005, Endo et al., 2005, Fukuba et al., 2004).
The deoxy[Hb + Mb] response was fit from the end of the calculated TD (CTD; the first
value after the transition in which deoxy[Hb + Mb] increased 1 SD above the pre-transition
baseline value) to one of three options depending on the deoxy[Hb + Mb] response profile:
1) if an ‘overshoot’ was present, the response was fit to the peak before the decline in the
profile; 2) for those profiles displaying a constant gradual increase after an initial plateau in
the response, the response was fit until just prior to the gradual increase; 3) for those profiles
not displaying an ‘overshoot’ or a discernible gradual increase, the response was fit to ~90
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s, a method that has been employed previously (Buchheit et al., 2009, Ferreira et al., 2005a).
The kinetics of deoxy[Hb + Mb] was quantified by the MRT (CTD + τ).
Data for all transitions of HR were fit from the first time point after the transition to 92 s, as
this time point produced the most consistent fit for all trials of all subjects. To avoid negative
time delays the TD was locked at ‘0’ for every fit.
The MAP profile was fit from the first data point after the transition (30 s) until the last data
point in the transition (450 s).
The VC profile was fit from the beginning of the transition to either the end of exercise or to
the peak of the overshoot (if an overshoot was present). When an overshoot was present its
amplitude was calculated as the difference between the peak of the response and endexercise.
A ratio of the increase in BF relative to the increase in V̇O2p (ΔBF/ΔV̇O2p) was calculated
by dividing the amplitude of the full response of BF by the amplitude of the full response of
V̇O2p.
Statistics
The kinetic parameters for each variable were analysed by a one-way repeated measures
ANOVA. A significant F ratio was further analysed using Tukey’s post hoc analysis to
determine where differences were. All statistical analyses were performed using SigmaPlot
(Systat Software Inc., San Jose, CA, USA). Statistical significance was accepted at p < 0.05.
All values are reported as mean ± SD.
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Figure 3.1. Protocol schematic.
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Results
Values for V̇O2p and WR from the incremental KE exercise test are displayed in Table 3.1,
along with blood [lactate-] from the constant-intensity exercise trials. An incremental
exercise test on a cycle ergometer resulted in a peak V̇O2p of 3.99 ± 0.86 L/min at a peak
WR of 378 ± 72 W, with a LT and RCP of 2.30 ± 0.53 L/min and 3.11 ± 0.62 L/min,
respectively.
V̇O2p: The group mean V̇O2p profiles for each exercise transition are displayed in Figure
3.2A. Baseline V̇O2p (~0.55 ± 0.003 L/min) was similar (p > 0.05) for all transitions. As
expected, the phase II V̇O2p amplitude (ΔV̇O2p) increased linearly with increasing ΔWR (p
< 0.05; Figure 3.3A). The primary V̇O2p gain (Gp) was similar amongst exercise transitions
(p > 0.05; Figure 3.3B), however, due to an increase in the slow component amplitude at the
larger ΔWRs (p < 0.05; Figure 3.3C) the overall V̇O2p gain (GT) was greater at the larger
ΔWRs (p < 0.05; Figure 3.3D). The phase II τV̇O2p was similar at lower exercise transitions,
but increased (p < 0.05) at the higher exercise transitions (p < 0.05; Figure 3.3E).
BF: The group mean BF response profiles for each transition are displayed in Figure 3.2B.
Baseline BF was similar (p > 0.05) across all transitions (~1.96 ± 0.04 L/min). There was a
linear increase in ΔBF with ΔWR (p < 0.05; for both phase II (Figure 3.4A) and over the
entire transition (data not shown)). However, when comparing the steady-state or endexercise BF vs. V̇O2p relationship, a curvilinear increase in BF was observed (Figure 3.5A).
This relationship was similarly seen when the increase in ΔBF was adjusted relative to the
increase in metabolic demand (i.e., ΔBF/ΔV̇O2p), in which transitions Δ51 and Δ63 both had
smaller increases in BF relative to metabolic demand than transitions Δ21, Δ30, and Δ42 (p <
0.05; Figure 3.5B). The MRTs for the overall BF response were greater for the two largest
(Δ51 and Δ63) than the two smallest transitions (Δ21 and Δ30; p < 0.05; Figure 3.4B), however,
when only the ‘primary component’ for BF was considered the τBF was similar across all
transitions (Figure 3.4C). For most transitions τBF was smaller than τV̇O2p (p < 0.05), the
exception being the Δ21 transition where only a trend was observed (p = 0.08; Figure 3.5C).
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deoxy[Hb + Mb]: The group mean response profiles of deoxy[Hb + Mb] for each transition
are shown in Figure 3.2C. The baseline values for deoxy[Hb + Mb] were not different
between exercise transitions (~41.7 ± 0.6 μM; p > 0.05). There was a gradual increase in the
‘primary’ deoxy[Hb + Mb] amplitude (Δdeoxy[Hb + Mb]) with increasing ΔWR, with the 3
highest ΔWRs being larger than the lowest ΔWR (p < 0.05; Figure 3.6A). The overall
deoxy[Hb + Mb] GT (end-exercise minus baseline) was similar across all exercise transitions
(p > 0.05; Figure 3.6B). The MRT deoxy[Hb + Mb] was smaller (p < 0.05) for higher (Δ51,
Δ63) than lower (Δ21) transitions (p < 0.05; Figure 3.6C), but the τdeoxy[Hb + Mb] was
similar amongst all exercise transitions (data not shown; p > 0.05).
[Hbtot]: The group mean response profiles for [Hbtot] are shown in Figure 3.2D. The baseline
values for [Hbtot] were similar between exercise transitions (~81 µM; p > 0.05). While the
amplitude of [Hbtot] (Δ[Hbtot]) was greater (p < 0.05) in Δ63 than most other transitions
(Figure 3.7A), there were no differences in end-exercise [Hbtot] values across transitions (p
> 0.05; data not shown). As a result, the GT for [Hbtot] was smaller at the larger ΔWRs than
the lower ΔWRs (p < 0.05; Figure 3.7B).
HR: The group mean HR response profiles for each transition are show in Figure 3.8A.
Baseline HR was similar across all exercise transitions (~72 ± 1 bpm; p > 0.05). The
amplitude of HR (ΔHR) for the ‘primary’ component increased linearly with increasing
WR (p < 0.05; Figure 3.9A). The τHR was similar across all exercise transitions (p > 0.05;
Figure 3.9B).
MAP: The group mean response profiles for MAP are shown in Figure 3.8B. Baseline MAP
was similar across all transitions (93 ± 1 mmHg; p > 0.05). The amplitude of MAP (ΔMAP)
was larger (p < 0.05) at higher than lower ΔWRs (p < 0.05; Figure 3.10A), while the MAP
GT was larger at Δ51 and Δ63 than Δ30 (p < 0.05; Figure 3.10B). Although an ANOVA showed
no differences (p > 0.05) in MRT MAP across ΔWRs, a significant linear correlation was
observed between MRT MAP and ΔWR (Pearson correlation coefficient, r2 = 0.31; p < 0.05;
Figure 3.10C).
VC: The group mean response profiles for VC are shown in Figure 3.8C. Baseline VC was
similar across all exercise transitions (~15.7 ± 0.3 mL/min/mmHg; p > 0.05). The VC
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‘primary’ amplitude (ΔVC) increased linearly with increasing ΔWR (p < 0.05; Figure
3.11A). The overall VC GT was greater in the two smallest (Δ21, Δ30) compared to the two
largest transitions (Δ51, Δ63; p < 0.05; Figure 3.11B). A small ‘overshoot’ in the VC response
was observed which was more apparent at the highest (Δ63) compared to lower transitions
(Δ21, Δ30, Δ42; p < 0.05; Figure 3.11C). In general, the MRT VC was variable and similar for
all transitions (Figure 3.11D).
Q̇cap: The group mean response profiles for Q̇cap are shown in Figure 3.8D. Baseline Q̇cap was
not different amongst transitions (~0.028 ± 0.001 arbitrary units; p > 0.05). The Q̇cap
amplitude (ΔQ̇cap; determined as the difference between baseline and end-exercise) was
larger at the higher ΔWRs (p < 0.05; Figure 3.12A). No differences were seen in the Q̇cap GT
values across exercise transitions (p > 0.05; Figure 3.12B).

69

Table 3.1. Values from incremental exercise test and lactate values at various work rates for knee-extension (KE) exercise.

WRpeak
(W)

V̇O2peak
(L/min)

LT
(L/min)

RCP
(L/min)

87
(15)

1.84
(0.28)

1.03
(0.26)

1.42
(0.18)

Lactate (mM)
3W

24
W

33
W

45
W

54
W

66
W

1.6
(0.2)

1.8
(0.4)

2.0
(0.5)

2.6
(0.5)

3.0
(0.6)

4.5
(1.1)

Values are mean (SD). WR, work rate; LT, lactate threshold; RCP, respiratory compensation point.
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Figure 3.2. Group mean responses (with SD bars; note, SD bars were removed on deoxy[Hb + Mb] and TOT[Hb + Mb] for clarity)
of: A, pulmonary O2 uptake (V̇O2p); B, blood flow; C, muscle deoxygenation (deoxy[Hb + Mb]); and D, total haemoglobin +
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various work rate amplitudes (ΔWR) of each trial (Δ21-Δ63) for, A: VC amplitude of the
‘primary’ component; B: gain of VC for the entire transition; C: amplitude of the overshoot
of VC; D: time constant of the VC response. Significant difference (p < 0.05) from: *, Δ21;
†, Δ30; ‡, Δ42; δ, Δ51. Gp, gain of the primary component of the response; MRT, mean
response time.

82

*†‡

A

B 0.0007

*†

0.04

0.0006

Qcap (a.u.)

Qcap GT (a.u./W)

*

0.03

0.02

0.0005

0.0004

0.0003

0.01

0.0002

0.00

0.0001
15

20

25

30

35

40

45

50

55

60

WR (W)

65

70

15

20

25

30

35

40

45

50

55

60

WR (W)

Figure 3.12. Calculated microvascular blood flow (Q̇cap) parameter estimates from a 3 W
baseline to the various work rate amplitudes (ΔWR) of each trial (Δ21-Δ63) for, A: Q̇cap
amplitude; B: gain in Q̇cap for the entire transition. Significant difference (p < 0.05) from: *,
Δ21; †, Δ30; ‡, Δ42. GT, gain of the total response; a.u., arbitrary units.

83

65

70

Discussion
In the present study, alternate-leg, knee-extension (KE) exercise was used to study steptransitions of progressively higher WRs all initiated from the same, common low baseline
metabolic rate. With this approach we were able to study, in an integrative manner, the
dynamic adjustments of V̇O2p, femoral (conduit) artery BF, and deoxy[Hb + Mb]. Also, by
including measures of MAP, we were able to calculate VC and Q̇cap. Combined, these
measures provided information on the relationship amongst muscle O2 utilization and muscle
O2 delivery during exercise transitions spanning across multiple exercise domains (i.e., from
MOD to HVY to VH). The main findings of the present study were that during transitions
in KE exercise from a light-intensity baseline, but increasing WRs to within the MOD-toVH-intensity domains: i) the kinetics of V̇O2p became progressively slower, without
corresponding changes in femoral artery BF kinetics (τBF), (although there was a trend for
BF kinetics to become slower when measured over the entire transition (MRT BF)); ii) while
the amplitude of both V̇O2p (V̇O2p) and femoral artery BF (BF) increased with increasing
ΔWR, the BF/V̇O2p became smaller, which coincided with a greater increase in muscle
deoxygenation amplitude (increased deoxy[Hb + Mb]) and a more rapid rate of muscle
deoxygenation (lower MRT deoxy[Hb + Mb]) iii) τHR was similar across ΔWRs; and iv)
MRT VC tended to become larger with increasing ΔWR.
V̇O2p
The finding in the present study that phase II τV̇O2p becomes larger (i.e., kinetics become
slower) during transitions to increasing ΔWRs is in agreement with some (Koga et al., 2001,
Koga et al., 1999, Engelen et al., 1996, Paterson & Whipp 1991), but not all studies (Nyberg
et al., 2017, Keir et al., 2016b, Spencer et al., 2013, Jones et al., 2012, Koga et al., 2005,
MacPhee et al., 2005, Ozyener et al., 2001, Scheuermann et al., 2001, Koga et al., 1997). In
many previous studies where no differences in V̇O2p kinetics were reported between MOD
and HVY, leg cycling exercise was used (Keir et al., 2016b, Spencer et al., 2013, Ozyener
et al., 2001, Scheuermann et al., 2001, Koga et al., 1997) which involved a relatively larger
muscle mass and several other muscle groups including the quadriceps, hamstrings, and
gluteal muscles, and the muscles of the anterior and posterior lower leg (Hug & Dorel 2009).
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In the present study, the KE exercise involved a much smaller muscle mass which was
restricted mainly to the quadriceps (Koga et al., 2019, Richardson et al., 1998, Andersen et
al., 1985). Different exercise modalities may affect the fibre recruitment such that, for the
same absolute or relative WR, a greater proportion of type I and (possibly) type II muscle
fibres would be required to satisfy force/power requirements during KE compared to leg
cycling exercise. Koga et al. (2005) suggested that an increased recruitment of both efficient
and less efficient muscle fibres could explain their findings of a larger primary gain in the
V̇O2p response of KE vs. cycling exercise. In addition to some fibres being less efficient
(particularly type II fibres), studies on isolated fibre types in rodents (Crow & Kushmerick
1982) and different fibre compositions in humans (Pringle et al., 2003a/b, Barstow et al.,
2000, Barstow et al., 1996) have shown that type II fibres have slower V̇O2p kinetics. These
slower kinetics in type II fibres could be due to mechanisms intrinsic to the muscle, or an O2
delivery limitation as type II fibres have been shown to have a lower BF supply than type I
fibres (McDonough et al., 2004, Behnke et al., 2003). This could then suggest that V̇O2p
kinetics would be slower if a greater proportion of these type II fibres were to be recruited
during an exercise. Additionally, during muscle contraction there likely will be an
intramuscular pressure-induced compression of the vasculature causing BF occlusion
(especially with isometric contraction (Bigland-Ritchie et al., 1995) and with increasing
intensities of dynamic contractions (Radegran & Saltin 1998, Kagaya & Homma 1997,
Walloe & Wesche 1988)). Although KE exercise is “dynamic”, for similar WRs, BF may be
more restricted in KE than in cycling exercise because of a more pronounced isometric
component and greater intramuscular pressures within the involved muscles during the
contraction phase resulting in a lower local Q̇O2-to-V̇O2m (Koga et al., 2005). At higher WRs
where a more forceful contraction is needed there may be greater occluding of BF,
attenuating the local Q̇O2-to-V̇O2, and thereby contributing to slowing of V̇O2p kinetics due
to the impedance of O2 delivery. Indeed, the findings in the present study of a smaller
increase in [Hbtot] GT with increasing ΔWR would seem to corroborate an attenuated increase
in O2 delivery at higher WRs. In addition, Hoelting et al. (2001) reported that BF was
attenuated at higher intensities, with a plateau in BF reached despite continued increases in
WR. Contrary to these potential differences in perfusion between exercise modes, Koga et
al. (2019) reported greater muscle perfusion during HVY exercise in KE – as evidenced by
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a smaller Δdeoxy[Hb + Mb], slower deoxy[Hb + Mb] kinetics, and a larger TOT[Hb + Mb]
amplitude in the vastus lateralis muscle – compared with leg cycling. Despite these findings
of greater perfusion in KE than cycling exercise, Koga et al. (2019) found V̇O2p kinetics to
be similar between the two modes of exercise. Additionally, Koga et al. (2005) and Rossiter
et al. (2001), both discuss finding that τV̇O2p was similar between cycling and KE exercise,
whereas in an earlier study by Shoemaker et al. (1994), V̇O2p kinetics were found to be
slower in KE than cycling exercise when exercising at the same absolute WR ( 40-45 W).
Koga et al. (2005) suggested that the slower V̇O2p kinetics in KE reported by Shoemaker et
al. (1994) were attributable to intensity domain differences since the KE WR was performed
in the HVY domain while the cycling WR was in MOD. However, Koga et al. (2005)
examined KE and leg cycling exercise in both the MOD and HVY intensity domains and
reported that while the V̇O2p MRT (for the entire response profile) was longer in KE than
cycling in both the MOD and HVY domains, the primary τV̇O2p was not different amongst
modalities and intensities. Taken together, these findings of similar V̇O2p kinetics between
KE and cycling exercise seem to suggest that perfusion differences between the two modes
did not influence V̇O2 kinetics. However, in their more recent study, Koga et al. (2019) also
noted faster deoxy[Hb + Mb] kinetics in the rectus femoris muscle, and despite baseline
values for V̇O2p, absolute WR, and TOT[Hb + Mb] being similar between exercise modes, the
baseline deoxy[Hb + Mb] was higher in both the vastus lateralis and rectus femoris in KE
compared with cycling exercise. These findings indicate a smaller Q̇O2-to-V̇O2 ratio in KE
vs. cycling exercise, suggesting that further study on muscle perfusion between the two
exercise modes is needed.
The present study has the advantage of examining V̇O2p and BF kinetics across a range of
intensities spanning the MOD, HVY, and VH exercise intensity domains. Overall, the phase
II τV̇O2p (i.e., primary component) was not different with transitions to lower (MOD) WRs,
but became larger with transitions to the highest (HVY or VH) WRs (see Figure 3.3E). For
exercise transitions into the HVY and VH domains, there is a delayed onset ‘slow
component’ that develops with time, with this slow component representing a larger
proportion of overall V̇O2p with progressively higher WRs (Figure 3.3C). Given that the
V̇O2p slow component contributes to a slowing of the overall V̇O2p response, care was taken
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to exclude this component and focus only on the phase II V̇O2p component. That this
approach was successful is supported by the constancy of the V̇O2p Gp (ΔV̇O2p/ΔWR) across
WRs, which would not have been the case if the V̇O2p slow component was included in the
response.
BF
One of the main goals of the present study was to investigate the kinetic response of bulk
(conduit artery) BF to increasing ΔWRs. We observed a slower response of BF kinetics to
the larger ΔWRs, with an overall increase in MRT BF (and a trend for an increase in τBF)
with increasing ΔWR. This is somewhat contrary to the findings of previous studies which
report no differences in BF kinetics in response to transitions of different ΔWRs (Nyberg et
al., 2017, McNarry et al. 2014, Jones et al., 2012, Koga et al., 2005, MacPhee et al., 2005).
However, in studies that found no differences in BF kinetics, the group average values tended
to be slower (by 2-12 s) for larger ΔWR transitions (McNarry et al., 2014; Jones et al., 2012,
Koga et al., 2005, Hughson et al., 1996). The slower BF responses at higher WRs in the
present study could be related to higher intramuscular pressures, and thus greater resistance
to BF, with higher muscle forces required of the higher intensities. Indeed, previous studies
have shown a rapid, large increase in BF immediately after the cessation of exercise,
consistent with a significant reduction in impedance to BF (van Beekvelt et al., 2001,
Shoemaker et al., 1994). Alternatively, rather than a mechanical limitation to flow, the
slower BF response may be a consequence of the slower V̇O2m kinetics associated with the
higher WRs. A slower response of V̇O2m by recruited muscle fibres would be expected to
result in a delayed increase in microvascular BF to those areas in the muscle. This may then
slow the BF response upstream at the conduit artery where BF was measured in the present
study. This slowing of bulk BF kinetics coincides well with the slowing of V̇O2p kinetics
observed in the present study, suggesting that the two variables could be influencing each
other during the transitory phase of exercise. However, in the present study the kinetics of
conduit artery BF were faster than, or similar to, those of V̇O2p (Figure 3.5C), which agrees
with previous findings reported in the literature in which BF kinetics are faster (Schlup et
al., 2015, Jones et al., 2012, Harper et al., 2006, Endo et al., 2005, Koga et al., 2005, MacPhee
et al., 2005, MacDonald et al., 1998) or similar to V̇O2p kinetics (Nyberg et al., 2017,
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McNarry et al., 2014, Jones et al., 2012, duManoir et al., 2010, Paterson et al., 2005a/b,
MacPhee et al., 2005). The finding that conduit artery BF kinetics are faster than or similar
to V̇O2p kinetics (and thus V̇O2m kinetics) suggests that at the level of the whole muscle there
is adequate O2 delivery for metabolic demand. However, from the conduit artery at the level
of the whole muscle, this O2 delivery must be subsequently distributed within the
microvasculature to the active muscle fibres where O2 exchange with the myocyte occurs.
At the level of the microvasculature, Barstow and colleagues have demonstrated that
estimated Q̇cap kinetics are slower than both conduit artery BF kinetics (Schlup et al., 2015,
Harper et al., 2006) and V̇O2p kinetics (Schlup et al., 2015, Harper et al., 2006, Ferreira et
al., 2005), suggesting that the dynamics of local muscle BF and O2 delivery potentially might
be limiting to V̇O2m.
V̇O2p and BF
The present study also found that the increase in BF was not proportional to the increase in
metabolic demand across exercise intensity domains, with the ΔBF/ΔV̇O2p ratio decreasing
linearly from ~7-to-1 to ~4.5-to-1 as ΔWR increased from 21 W to 63 W (Fig 3.5B). While
the increase in the BF signal reflects conduit artery (bulk) BF to primarily the active knee
extensor muscles in both thighs, the increase of the V̇O2p reflects increases in O2 utilization
of the working quadriceps muscles and, to a lesser extent, the increasing O2 utilization of the
cardiac and respiratory muscles. Therefore, it is possible that the decrease in ΔBF/ΔV̇O2p is
due to an increased O2 utilization of the cardiac and respiratory muscles brought about by
the higher WRs. However, even at the highest WR in the present study, HR and ventilation
values were still well below the maximal values attained by these subjects on a cycle
ergometer (~70% maximal HR and 35% maximal ventilation; data not shown), indicating
that their contribution to V̇O2p should still be quite small. Accepting this decrease in the BFto-V̇O2p ratio as emanating primarily from the exercising muscle, the attenuation of an
increase in bulk BF with increasing ΔWR may be related to an increase in sympathetic
activity that accompanies higher WRs. An increase in sympathetic activity with increasing
ΔWR would cause increased vasoconstriction, particularly in the non-exercising
muscle/tissues (see Delp & O’Leary 2004 for review), which would cause a decrease in BF
to those areas. In the present exercise model, in which BF to the entire lower limb is being
88

measured, but only the quadriceps are exercising, it would be expected that the vasculature
in the quadriceps would undergo vasodilation (as a result of metabolic factors ‘overcoming’
the sympathetic drive for vasoconstriction; i.e., “sympatholysis” (see Joyner & Casey 2015
for review)), while the relatively large amount of non-exercising muscle in the lower limbs
(e.g., hamstrings, calves, etc.) would be expected to undergo vasoconstriction as a result of
increased sympathetic output. This could create a situation in which a considerably greater
proportion of the vasculature in the lower limbs that is undergoing vasoconstriction than
vasodilation, leading to an overall attenuation of the increase in BF at higher ΔWRs.
Alternatively, this reduction of the BF-to-V̇O2p ratio with increasing ΔWR may be related to
an attenuated increase in BF associated with greater muscle tensions and mechanical
compression of the vasculature, as suggested by Hoelting et al. (2001). In line with this,
Shoemaker et al. (1994) observed an increase in BF following exercise cessation, suggesting
that BF was inadequate during exercise because of an impedance created by the contracting
muscle. Van Beekvelt et al. (2001) found a similar increase in BF at the cessation of exercise,
with this hyperemia being larger following a higher WR, indicating that higher muscle
tension causes greater vascular occlusion. Therefore, as a result of these factors, or other
unknown factors affecting BF, there may not be a proportional increase in bulk BF with
metabolic rate.
MAP and VC
In the present study, there was an increase in MAP with exercise, with the rate of this
adjustment being similar amongst the various ΔWRs. While kinetics were unchanged, there
was a linear increase in ΔMAP with ΔWR, with MAP GT (= ΔMAP/ΔWR) also showing a
larger increase at higher ΔWRs (see Figure 3.10B). This increase in MAP GT is likely
attributable to increased sympathetic output at higher ΔWRs causing an increase in both Q̇T
(due to an increase in HR and stroke volume), as well as an increase in resistance (due to
vasoconstriction; see Delp & O’Leary 2004 for review). Reciprocal to this increase in MAP
GT, was a decrease in VC Gp with increasing ΔWR. This finding is not unexpected as
vascular resistance would be increasing in other parts of the body in an effort to redistribute
the body’s BF to the area(s) where it is needed most (i.e., quadriceps). Consequently, the
much larger area of the body that is undergoing vasoconstriction compared to the relatively
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smaller proportion of the body that is vasodilating, would lead to an overall decrease in VC
Gp with increasing ΔWR. The present study also saw an ‘overshoot’ in the VC response,
reflecting an early, transient excess in BF, which was greater at higher ΔWRs (see Figure
3.11C). This VC overshoot is due to the conflation of the two factors used in the estimation
of VC, BF and MAP. While BF is relatively quick in its response to reach a new steadystate, as seen by faster BF than V̇O2p kinetics in the present study (~20-35 s; Figure 3.5C)
and others (Schlup et al., 2015, Harper et al., 2006, Koga et al., 2005, MacDonald et al.,
1998), the response of MAP is much slower to reach its new steady-state (~80-120 s; Figure
3.10C). The slower response of MAP may be partly attributable to the sympathetic nervous
system (SNS) and its relatively slow increase in activity, which thereby, results in a slower
increase in vascular resistance (i.e., vasoconstriction). Indeed, previous studies have shown
sympathetic nerve activity to be unchanged during the 1st min of exercise before showing an
increase in the 2nd minute of exercise (Hansen et al., 1994), with Hohimer & Smith (1979)
showing that it took 1.5 min to observe a decrease in renal BF with exercise in baboons.
Furthermore, although the present study did not find a significant difference amongst MRT
MAP values, there was a positive linear correlation seen between MRT and ΔWR, which
could suggest that the relatively slow adjustment of the SNS, which will be contributing to
a larger degree at higher WRs, may also be affecting MAP kinetics. However, future studies
with more detailed kinetic analysis of MAP are necessary to substantiate these observations.
deoxy[Hb + Mb]
In the present study muscle deoxygenation, deoxy[Hb + Mb], was used as a surrogate for avO2diff. The deoxy[Hb + Mb] amplitude (Δdeoxy[Hb + Mb]; O2 extraction) increased with
increasing ΔWR reflecting a progressively widening mismatch amongst local microvascular
O2 delivery and local muscle O2 utilization. This increase in Δdeoxy[Hb + Mb] could be
associated with the muscle fibres already recruited, as they would have a higher metabolic
rate, and therefore, a higher O2 demand. Additionally, a higher ΔWR would be expected to
cause a greater recruitment of less efficient muscle fibres, with these fibres known to have a
smaller BF supply and rely more on O2 extraction than more efficient muscle fibres (Ferreira
et al., 2006, McDonough et al., 2005 & 2004). In line with this, Behnke and colleagues
(2003) reported a faster decline in PO2 in type II fibres than type I fibres during exercise,
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which indicates a slower adjustment of O2 delivery relative to O2 utilization. This suggests
that not only is BF supply lower in those fibres that are less efficient compared to more
efficient fibres, but BF kinetics may also be slower in the less efficient fibres.
According to the Fick equation, for a given V̇O2, a decrease in BF (and O2 delivery) would
necessitate a greater O2 extraction, and thus increase in Δdeoxy[Hb + Mb]. While the
observed increase in Δdeoxy[Hb + Mb] with increasing ΔWR and the decrease in the conduit
artery BF-to-whole body V̇O2p ratio with increasing ΔWR (Figure 3.5B) agrees well with
the Fick equation, it must be underscored that deoxy[Hb + Mb] represents the microvascular
O2 delivery-to-local muscle O2 utilization, while BF-to-V̇O2p represents muscle conduit
artery (bulk) BF-to-whole body V̇O2. Therefore, the two measures, while related, must be
interpreted with caution as these two sites are not equivalent, with conduit artery BF
indicative of the gross delivery of O2 to the whole muscle, while microvascular BF indicates
what is occurring at the site of O2 exchange with the myocyte.
The finding in the present study that [Hbtot] GT decreased with increasing ΔWR (Figure 3.7B)
would seem to further support the notion of an overall attenuation of O2 delivery within the
microvasculature at higher ΔWRs, and necessitate that the muscle rely more on O2
extraction. As an increase in TOT[Hb + Mb] is indicative of an increase in the volume of red
blood cells (haemoglobin) within the area of interrogation of the NIRS probe, a relative
decrease in this signal would suggest a lessening of the functional capillary surface area.
This would then impact the ability of O2 to diffuse into the myocyte, which could create a
situation in which O2 delivery is limiting to the V̇O2p response. However, in the present study
the kinetics of

TOT[Hb

+ Mb] were not analyzed as the profile did not reliably resemble a

monoexponential response. Therefore, the role that O2 diffusivity plays in the V̇O2p kinetic
response across different ΔWRs cannot be ascertained from the present study.
In addition to the greater increase in Δdeoxy[Hb + Mb] as ΔWR increased, the MRT
deoxy[Hb + Mb] (reflecting O2 extraction kinetics) became progressively smaller (i.e.,
faster; Figure 3.6C) despite the dynamics of V̇O2p (reflecting muscle O2 utilization kinetics)
becoming slower at higher ΔWRs (Figure 3.2A). This suggests that at larger ΔWRs there is
an inadequate microvascular BF and O2 delivery response to the muscle, necessitating an
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increased reliance on O2 extraction to meet the metabolic demands of the muscle. This
finding agrees well with Jones et al. (2012) who found that the MRT for a-vO2diff (a measure
of O2 extraction) was faster at high-intensity vs. low-intensity single-leg KE exercise
transitions, while kinetics of the V̇O2m primary component were similar between the two
intensities. Furthermore, several studies also observed smaller MRT deoxy[Hb + Mb] (by
~5 s) when ΔWR was greater (i.e., faster kinetics with a larger ΔWR), although their values
did not reach statistical significance (Keir et al., 2016b, MacPhee et al., 2005, Ferreira et al.,
2005b). These findings seem to support the assertion that at higher WRs, where there is an
increased recruitment of less efficient fibres which may have an inadequate O2 delivery-toO2 utilization response, there will be an increased reliance on O2 extraction during the
transitory phase.
Q̇cap
In the present study Q̇cap was calculated by rearranging the Fick equation, using V̇O2p and
deoxy[Hb + Mb] as surrogates for V̇O2m and a-vO2diff, respectively, such that Q̇cap =
V̇O2p/deoxy[Hb + Mb]. Analysis of the Q̇cap profiles revealed that for many of the transitions
the profiles did not resemble a monoexponential response, in agreement with the Q̇cap
response profiles reported by Barstow and colleagues (Schlup et al., 2015, Harper et al.,
2006), with Ferreira et al. (2005b) questioning whether the Q̇cap profile is best quantified by
a simple exponential equation. This may be a consequence of data handling and the natural
conflation of the deoxy[Hb + Mb] (which reflects local deoxygenation within the largely
superficial active muscle fibres, and often presents with a short time delay followed by a
rapid increase in deoxy[Hb + Mb] (duManoir et al., 2010, DeLorey et al., 2007, MacPhee et
al., 2005)) and V̇O2p (after being corrected for phase I) profiles. Therefore, due to the
characteristics of the Q̇cap profiles, and the uncertainty in proper fitting technique, Q̇cap
kinetics were not analyzed in the present study. Nonetheless, it was found that the endexercise ΔQ̇cap increased with increasing ΔWR, while the Q̇cap GT was similar across all
ΔWRs. This suggests that while the bulk BF GT decreases, at the level of the
microvasculature, BF is redistributed such that there is a maintenance of the O2 delivery-toO2 utilization ratio within the exercising muscle across different ΔWRs. This finding could
support the idea that an increase in bulk BF is modulated by the muscle pump and rapid
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vasodilation (Tschakovsky & Sheriff 2004), while microvascular BF is regulated more so by
the metabolic demand of the muscle (Ferreira et al., 2005b).
Limitations
The present study sought to investigate the response of V̇O2p and several cardiovascular
parameters to predetermined ΔWRs and did not adjust for the intensity domains of the
individual subjects. The ΔWRs chosen provided a large amplitude change, and thus a large
signal-to-noise ratio, were tolerated such that all subjects were able to complete the entire 8
min transition at the highest WR, and allowed comparisons across a range of WRs (i.e., 5
in total). However, a disadvantage of this protocol was that the same absolute WR could
have represented a transition into a different exercise-intensity domain for different subjects
(MOD vs. HVY vs. VH; see APPENDIX III for individual subject intensity domains at
various ΔWRs), with different metabolic and cardiovascular response profiles. To best
compensate for this issue, care was taken to isolate the primary V̇O2p and BF components
when analyzing the kinetics of the response profiles, as it has been suggested that the
parameter estimates for the primary component of V̇O2p is comparable amongst intensity
domains (see Poole and Jones 2012 for review). For future studies comparisons across
multiple common end-transition intensity domains might be considered.
Although commonly used in the literature, NIRS does have several assumptions and
limitations in its use, which have been well described (Barstow 2019, Grassi & Quaresima
2016, Ferrari & Quaresima 2012). Firstly, the depth of penetration of the NIRS signal into
muscle tissue is dependent on and attenuated by increasing thickness of skin and adipose
tissue. This and the low output power of many NIRS units restricts the volume of NIRS
interrogation to the more superficial muscle fibres which have been shown to have a greater
proportion of type II fibres (Lexell et al., 1983, Johnson et al., 1973), and therefore the
deoxy[Hb + Mb] signal will represent a greater contribution from type II fibres.
Nevertheless, the probe was carefully placed over the same area of muscle for each trial, and
therefore the response, although perhaps restricted more so to type II fibres, will still reflect
what is happening to deoxy[Hb + Mb] as ΔWR increases. Secondly, the field of interrogation
for NIRS is small in comparison to the whole muscle and in the present study only the vastus
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lateralis muscle of the quadriceps was examined, with Koga and colleagues showing that the
muscles which comprise the quadriceps have differing perfusion responses (Koga et al.,
2019, Okushima et al., 2015), with differences also seen between superficial and deep
portions of the same muscle (Okushima et al., 2015). Because of these issues, the NIRS
signal cannot be inferred as representative of the whole muscle. Thirdly, although
representative of the microvasculature, the relative contribution of arterioles, venules, and
capillaries to the NIRS signal cannot be ascertained. However, their contribution to tissue
saturation appears to remain the same across various O2 saturation levels (Chance et al.,
2003). Additionally, the temporal profile of deoxy[Hb + Mb] has been shown to closely
resemble that of a-vO2diff, indicating that deoxy[Hb + Mb] provides a good estimation of O2
extraction (Grassi et al., 1996). Lastly, the dissociation curves for Hb and Mb differ, with
oxy-haemoglobin having a sigmoidal relationship in which O2 off-loading being greater
when microvascular PO2s are between 60-10 mmHg, whereas oxy-myoglobin has a
hyperbolic relationship in which O2 off-loading does not significantly occur until very low
intracellular PO2s (P50 ≈ 2.5 – 3 mmHg; Schenkman et al., 1997, Richardson et al., 1995).
Due to these differences, Hb and Mb will each be desaturated to different extends depending
on the microvascular and intracellular PO2 levels. Therefore, it is difficult to determine the
contribution of Mb to the deoxy[Hb + Mb] signal as we do not have reliable values for
intracellular PO2 levels during exercise. However, this should not affect the integrity of using
NIRS to look at the O2 delivery-to-O2 utilization ratio, as the O2 diffusion pathway as a
whole should be unaffected.
However, at present, we do not have reliable values of intracellular PO2 levels during
exercise, making it difficult to determine the contribution of deoxy-Mb to the NIRS signal.
While it has been shown that myoglobin contributes ~50-70% of the NIRS signal at rest, and
~70% of the change in the NIRS signal from rest to maximal exercise is from myoglobin
(Davis & Barstow 2013), the diffusion pathway as a whole would be unaffected, and
therefore, this should not compromise the use of NIRS in looking at the O2 delivery-to-O2
utilization ratio.
BP measures were taken manually using a sphygmomanometer which limited the frequency
of measures to 1 min intervals. Although MAP was modeled well as a monoexponential
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response, the low frequency of data collection early in the exercise transition reduced the
confidence in the kinetics analysis. In addition to MAP analysis, this low frequency of data
collection will also impact the confidence of fitting the VC response as MAP was required
for this calculation (i.e., VC = BF/MAP).
The present study required the use of high WRs in order to achieve sufficient amplitudes
(increasing the signal-to-noise ratio) as well as provide a sufficient number of transitions to
compare. These high WRs meant that participants had to have a relatively high level of
fitness. This is particularly pertinent when considering that those with a higher fitness
(trained) have faster kinetics than less fit (untrained) individuals (Murias et al., 2011, Phillips
et al., 1995, Bell et al., 2001). Further to this, some authors have proposed a “boundary” for
V̇O2p kinetics in which those subjects with a larger τV̇O2p (e.g., >20 s) may be in a range in
which BF is limiting to V̇O2, while those with a smaller τV̇O2p (e.g., <20 s) have kinetics
that are likely limited by a metabolic ‘sluggishness’ in the myocyte (see Poole & Jones 2012
for review). Therefore, the results of this study cannot be easily transferred to a less fit
population, as there may be differing degrees to which BF is influencing V̇O2 kinetics in
these instances. Additionally, due to the high WRs and the many repetitions needed in this
study, consideration must also be given to the potential for a training-induced speeding of
kinetics. We attempted to minimize the possibility of inducing a training response by
alternating trials of higher and lower WRs throughout the study such that high WR trials
were not performed on consecutive days, but the large volume (~30-35 trials) would make
it hard to avoid a training effect. However, a comparison of the individual trials within each
transition revealed no observable differences in V̇O2p, BF, or HR. Additionally, by
randomizing the trials such that each of the 5 protocols was performed once before
performing a second trial for each of the protocols, if any training effect were present it
should be dissipated evenly across the different protocols, making between trials
comparisons valid.
Conclusion
The present study investigated the effect that exercise transitions initiated from a common
low WR baseline (3 W) to WRs spanning across the MOD, HVY, and VH domains would
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have on the kinetic response and interaction between V̇O2p, BF, deoxy[Hb + Mb], HR, MAP,
Q̇cap, and VC during KE exercise. With this approach, it was found that V̇O2p kinetics became
progressively slower as ΔWR increased, with BF kinetics tending to slow with increasing
ΔWRs. Although it is not possible to determine what might be contributing to the slowing
of O2 delivery with increasing ΔWR, the observed speeding of deoxy[Hb + Mb] kinetics
would seem to suggest that the metabolic pathways within the myocyte are able to utilize O2
more rapidly than it is delivered, with this increased reliance on O2 extraction during the
transition possibly providing some compensation to the slowing of bulk O2 delivery. There
also was a progressive decrease in the bulk BF-to-V̇O2p ratio as ΔWR became larger. In
accordance with the Fick equation, this decrease in bulk BF-to-V̇O2p ratio appears to be
‘offset’ by an increase in O2 extraction (Δdeoxy[Hb + Mb]). Further research is warranted
to elucidate the contributions of bulk and microvascular BF on O2 delivery to the muscle in
response to exercise transitions of different ΔWRs.
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CHAPTER IV: The effect of increasing baseline metabolic
rate on the kinetic response of V̇O2p, blood flow, and muscle
deoxygenation
Introduction
Upon a step-transition in work rate (WR), pulmonary O2 uptake (V̇O2p; reflective of muscle
O2 utilization (V̇O2m)) increases in an exponential manner towards a new steady-state
(Whipp & Wasserman 1972, Grassi et al., 1996). This response defines V̇O2p kinetics, with
the rate of this response being quantified by the time constant (τ). The cause of this delay in
the V̇O2p response is considered to be due to a delayed activation of oxidative enzymes (a
metabolic ‘sluggishness’) or an inadequate blood flow (BF) and delivery of O2 to the muscle,
or a combination of both (see Poole & Jones 2012, Rossiter 2011, Tschakovsky & Hughson
1999 for review).
When the exercise transition is initiated from a common, light-intensity baseline WR, the
rate of adjustment of the primary, phase II, component of the V̇O2p response remains
relatively constant across a range of WR amplitudes (ΔWR) (Nyberg et al., 2017, Keir et al.,
2016a/b, Spencer et al., 2013, Jones et al., 2012, MacPhee et al., 2005, Koga et al., 2005,
Ozyener et al., 2001), although this is not a consistent finding (Koga et al., 2001, Koga et
al., 1999, Paterson & Whipp 1991). However, when exercise transitions of similar ΔWRs
are initiated from elevated baseline metabolic rates, V̇O2p kinetics become progressively
slower (i.e., phase II V̇O2p becomes larger) as the baseline metabolic rate increases
(Nederveen et al., 2017, Keir et al., 2016a/b, Bowen et al., 2011, MacPhee et al., 2005,
Brittain et al., 2001). Concomitant with the slowing of V̇O2p kinetics, there also is an increase
in the steady-state V̇O2p gain (ΔV̇O2p/ΔWR) of both the primary component (Gp) and total
response (GT) even for exercise transitions constrained within the moderate-intensity (MOD)
domain (Nederveen et al., 2017, Keir et al., 2016a/b, Bowen et al., 2011, MacPhee et al.,
2005, Brittain et al., 2001). The increase in GT at intensities above the lactate threshold (LT)
(i.e., in the heavy-(HVY), and very heavy-(VH) intensity domains) is further augmented by
an additional, delayed, increase in V̇O2p (and V̇O2m), the ‘V̇O2 slow component’, which is
not present at intensities below LT (i.e., in MOD). Recent studies by Keir et al. (2016a/b)
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revealed that the slowing of V̇O2p kinetics with increasing baseline metabolic rates occurred
in a curvilinear fashion within intensities spanning the MOD, HVY, and VH domains, while
the increases in Gp and GT were linear (at least within MOD and HVY).
During transitions to exercise, conduit artery (bulk) BF, like V̇O2p, increases in an
exponential-like manner towards a new, higher, “steady-state” level to meet the elevated
metabolic demands of the active muscle (Saltin 1985, Wesche 1986, Walloe & Wesche
1988). For transitions from a low, baseline metabolic rate, conduit artery BF kinetics
compared to V̇O2p kinetics are reported to be either faster (MacDonald et al., 1998, Fukuba
et al., 2004, MacPhee et al., 2005, Koga et al., 2005, Endo et al., 2005, Harper et al., 2006,
Jones et al., 2012, Schlup et al., 2015), suggesting that bulk BF and O2 delivery do not limit
the adjustment of V̇O2p, or are not different (Grassi et al., 1996, Hughson et al., 1996,
MacPhee et al., 2005, Paterson et al., 2005, duManoir et al., 2010, Jones et al., 2012,
McNarry et al., 2014, Nyberg et al., 2017), suggesting a close matching between BF
dynamics and O2 utilization. However, in many of these studies, conduit artery, bulk, BF
supplying active muscle was investigated, whereas BF in the microvasculature, where actual
exchange of O2 between the capillary and myocyte occurs, was not determined. Measures of
V̇O2p (a proxy for V̇O2m) combined with near-infrared spectroscopy (NIRS)-derived
measures of muscle microvascular deoxygenation (HHb), reflecting the balance between
local muscle O2 delivery and O2 utilization and thus fractional O2 extraction, can be used to
provide an estimate of microvascular BF (Q̇cap) by rearranging the Fick equation (Ferreira et
al., 2005b; Harper et al., 2006). Using this technique, Harper et al. (2006) and Schlup et al.
(2015) both reported that estimated Q̇cap kinetics were slower than both V̇O2p and conduit
artery BF kinetics suggesting the possibility that local muscle O2 delivery at sites distal to
the main conduit artery could limit the adjustment of V̇O2m.
In a previous study, Keir et al. (2016b) reported that τdeoxy[Hb + Mb] became larger when
exercise transitions were initiated from an increasing baseline metabolic rate, but the time
delay (TD) prior to the deoxy[Hb + Mb] increase became smaller, resulting in no change to
the overall kinetics (mean response time (MRT)). This unchanging MRT deoxy[Hb + Mb]
between the different transitions (indicating that the microvascular O2 delivery-to-O2
utilization ratio was similar amongst transitions), coupled with a slowing of V̇O2p kinetics
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with increasing baseline WR, lead the authors to conclude that O2 delivery is not limiting to
V̇O2p kinetics in this situation. However, these authors lacked a direct measure of BF to more
directly assess the role of O2 delivery in this situation.
MacPhee and coworkers (2005) examined the effect of an elevated baseline metabolic rate
on V̇O2p and BF responses during alternate-leg knee-extension exercise and reported that the
adjustment of both V̇O2p and bulk BF were slowed when the transition was initiated from an
elevated compared to a lower baseline metabolic rate. Additionally, these authors also found
a smaller increase in BF for a given increase in V̇O2p (ΔBF/ΔV̇O2p) when the transition was
initiated from an elevated baseline. However, in that study, only two transitions were used
and both were constrained within the MOD domain where BF should not be restricted as
sometimes is seen with HVY or VH exercise where O2 delivery may be attenuated (i.e., the
gain in BF is less than in MOD) based on calculations from data in previous studies (Koga
et al., 2005, Van Beekvelt et al., 2001, MacDonald et al., 1998). Therefore, the purpose of
the present study was to investigate the effect of increasing baseline metabolic rates spanning
the MOD to HVY to VH domains with transitions of a common WR on the adjustments
and interrelationships between BF and V̇O2p at exercise onset. Furthermore, we sought to
characterize the dynamics of both the deoxy[Hb + Mb] and Q̇cap responses across increasing
baseline WR (WRbl). Based on the studies of Keir et al. (2016a/b), we hypothesized that both
V̇O2p and BF kinetics would become progressively slower with an increasing WRbl and that
this would be accompanied by a progressively rising gain for both V̇O2p and BF. Also, in
line with Keir et al. (2016b), we hypothesized that MRT deoxy[Hb + Mb] would be similar
across transitions, which would be consequent to a slowing of Q̇cap kinetics with increasing
WRbl. Furthermore, it was hypothesized that the V̇O2p Gp would become greater with
increasing WRbl.
Methods
Subjects
Ten healthy male volunteers (mean ± SD; 25.6 ± 4.5 yrs; 85.5 ± 8.6 kg; 184.1 ± 5.3 cm)
participated in this study. Subjects were free to withdraw at any time without penalty.
Subjects provided written informed consent with all procedures approved by The University
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of Western Ontario Ethics Committee for Research on Human Subjects in accordance with
the Declaration of Helsinki.
Protocol
All trials were performed on a custom-built alternate-leg knee-extension (KE) ergometer
(see MacPhee et al., 2005) in which the subjects were familiarized with the ‘kicking’ motion.
A restraining belt was fastened around the participant’s waist to minimize hip movement
during each trial such that the quadriceps muscle group performed the work solely while the
hamstrings were relaxed throughout exercise. Participants maintained a cadence of 30
contractions per minute (cpm) which was displayed continuously on a screen in front of
them. A step-incremental KE exercise test was performed for estimation of LT (the point at
which there was an inflection in V̇CO2, ventilation, and end-tidal PO2 (PETO2) relative to
V̇O2, without a decrease in end-tidal PCO2 (PETCO2)) and respiratory compensation point
(RCP; the point at which there was a steeper increase in ventilation and PETO2 relative to
V̇O2 with a decrease in PETCO2). These boundaries were used to differentiate between the
MOD (< LT), HVY (> LT, but < RCP), and VH (> RCP, but < V̇O2peak) intensity domains.
This test began with baseline (3 W) ‘kicking’ for 4 min, after which the WR was increased
by 3 W each minute until a cadence of 30 cpm could no longer be maintained (i.e., limit of
tolerance). Five different exercise transition protocols were performed, with each protocol
beginning with 6 min of baseline ‘kicking’ at either 3 (bl3), 12 (bl12), 24 (bl24), 33 (bl33), or
45 (bl45) W followed by an instantaneous increase in ΔWR of 21 W (see Figure 4.1) for each
transition; each transition lasted 8 min. To increase the signal-to-noise ratio, each transition
was repeated 3-5 times (Gill 1985), with the order of transitions being randomized and at
least 24 hrs between trials.
Measurements
V̇O2p: A volume turbine and mass spectrometer were used to measure breath-by-breath gas
exchange as described previously (Keir et al., 2016a/b). Briefly, a bidirectional turbine and
pneumotach (Hans Rudolph, model 4813; total dead space was 150 mL) to measure inspired
and expired airflow and volumes were calibrated before each test with a syringe of known
volume (3.0 L) and the pneumotach adjusted for zero flow. A mass spectrometer (AMIS
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2000, Innovision, Lindvedvej, Denmark), which was calibrated before each test using
precision-analyzed gas mixtures, was used to continuously sample gas concentrations. The
time delay was determined electronically by computer by measuring the time between an
instantaneous square-wave change in gas concentration and its detection by the mass
spectrometer. Data were collected at a frequency of 100 Hz and transferred to a computer
which aligned gas concentrations and expired volumes to build a profile of each breath.
Alveolar gas exchange was calculated breath-by-breath using the algorithms of Swanson
(1980).
BF: Blood velocity and arterial diameter were monitored continuously throughout the
exercise protocol using pulsed-wave and echo-Doppler ultrasound, respectively (GE
Vingmed, System Five, 4-5MHz, 60° angle of insonation). The ultrasound probe was held
over the common femoral artery, 2-3 cm proximal to the artery bifurcation to minimize
turbulence, but distal to the inguinal ligament to avoid BF to this area as previously reported
(McDonald et al., 1998, Radegran & Saltin 1998). The ultrasound gate was positioned in the
center of the artery and maximized for complete insonation of the vessel cross-section. Mean
blood velocity measures were processed by a Neurovision Transcranial Doppler System
(Multigon Industries Inc.) and analyzed on a separate computer using PowerLab
(ADInstruments, LabChart 7). Arterial diameter was measured in triplicate during a diastole
in the muscle relaxation phase and averaged to yield a single vessel diameter every 60 s. BF
was calculated by the equation:
BF (L/min) = blood velocity (cm/s) • π • (diameter (cm)/2)2 • 0.12
where 0.12 is the conversion factor of ‘s’ into ‘min’ for BF in both legs (i.e., 60 x 2) and
mL/min into L/min (i.e., ÷ 1000). The blood velocity signal was averaged over a single
muscle contraction-relaxation cycle, as this method has been proposed as an acceptable
technique to analyze BF kinetics (see Chapter II) by taking into account the variability in the
blood velocity signal created by muscle contraction and the cardiac cycle (Radegran 1997,
Osada & Radegran, 2006).
NIRS and microvascular blood flow (Q̇cap): Local deoxy[Hb + Mb] (in addition to oxy[Hb +
Mb], TOT[Hb + Mb], and tissue oxygenation index (TOI)) was measured in the vastus lateralis
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muscle using NIRS (Oxiplex TS, Model 92505, ISS, Champaign, USA). Briefly, NIRS
optodes were housed in a rigid optically-dense, plastic holder (connected to laser diodes and
photomultiplier tube by optical fibers) with two parallel rows of light emitter fibers (one row
emitting at a wavelength of 690 nm and the other row at 828 nm) and one detector fiber
bundle; the source-detector separations for this probe were 2.0, 2.5, 3.0, and 3.5 cm for both
wavelengths. An elastic strap was used to secure the NIRS probe over the vastus lateralis
muscle approximately 1/3rd the distance between the greater trochanter and the lateral
femoral condyle. The probe was then covered with an optically-dense black vinyl sheet, and
wrapped with a tensor bandage to minimize the intrusion of extraneous light and prevent
movement of the probes. The raw signals from NIRS (deoxy[Hb + Mb], oxy[Hb + Mb],
TOT[Hb

+ Mb], and TOI) were corrected for skin and adipose tissue thickness (which were

measured by echo-Doppler ultrasound) by linear regression of the Hbtot signal against
adipose tissue thickness, in accordance with the method of Bowen et al. (2013). By using
V̇O2p (after correcting for the cardiodynamic component (phase I)) as a representation of
V̇O2m, and deoxy[Hb + Mb] as a surrogate for arterial-venous O2 difference (a-vO2diff), Q̇cap
was calculated by rearranging the Fick equation (Q̇cap = V̇O2p/deoxy[Hb + Mb]), as
previously described (Harper et al., 2006, Ferreira et al., 2005b).
Heart Rate (HR): A Polar HR monitor was used to continuously record HR to Powerlab
(ADInstruments Inc., Colorado Springs, CO).
Mean Arterial Pressure (MAP) and Vascular Conductance (VC): A sphygmomanometer and
stethoscope were used to measure systolic and diastolic blood pressure (SBP and DBP) on
the left arm (at the level of the heart) by a trained technician, with MAP being calculated as:
1/3 SBP + 2/3 DBP. Blood pressure was measured at rest, at 2 min and 5 min of baseline
exercise, 30 s into the transition and at one minute intervals thereafter. To correct for
hydrostatic pressure, all BP values were adjusted by 2 mmHg per inch vertical difference
between the level of the heart and the common femoral artery (Sia 2003). Due to the
infrequent measures of MAP, and issues of precisely time-aligning both BF and MAP,
vascular conductance in the femoral artery (VC = BF/MAP) was calculated using the iterated
fits of BF and MAP.
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Lactate: Blood was sampled from the earlobe 2 min prior to the end of each transition for
determination of the blood lactate concentration using a lactate analyzer (Lactate Scout,
Sports Resource Group, Hawthorne, NY).
Data Analysis
The V̇O2p and BF data for individual trials were cleaned by removing aberrant data points
(lying 3 standard deviations outside the local mean) (Lamarra et al., 1987), linearly
interpolated to second-by-second values, and like transitions were ensemble averaged to
yield a single response for each transition in each subject. Data for each trial were
subsequently averaged to 5 s time bins and modeled using a monoexponential nonlinear,
least squares regression equation:
Y(t) = bl + amp (1-e-(t-TD)/τ)
where Y represents V̇O2p, BF, deoxy[Hb + Mb], Q̇cap, MAP, VC, or HR at any time (t); bl is
the steady-state baseline of Y; amp is the “steady-state” increase in Y above bl; TD is the
time delay; and τ is the time constant (equivalent to the time taken to reach 63% of
amplitude).
Baseline for each variable (except MAP) was quantified by averaging data 2 min prior to the
increase in WR. For MAP, the 2 values recorded prior to each step-transition were averaged
together and reported the baseline value data (as MAP was only measured once every minute
throughout the exercise trial).
For V̇O2p data, the ‘cardiodynamic’ component (phase I) and the ‘slow component’ (phase
III) were excluded from the model fit leaving only the primary component (phase II). Each
of these phases was determined by extending the fit window backward from ~35 s (to
determine phase I) or extending the fit window forward from ~90 s (to determine phase III)
until τ, χ2, and confidence interval began to increase, as described by Rossiter et al. (2001).
Transitions into HVY, in which a slow component would appear, were determined from
analyzing the LT in the ramp incremental test, and confirmed by blood lactate values.
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For BF, the TD was fixed at 0 s (to prevent negative values), and transitions were fit from
the first time point in the transition to the time point that corresponded with the end of phase
II for V̇O2p (with this fitting strategy referred to as τBF). However, due to uncertainty on
whether the BF profile contains a slow component (Endo et al., 2005, Fukuba et al., 2004),
the mean response time (MRT) of the BF profile was also determined by extending the fit to
the end of the exercise transition, with both measures (τBF and MRT) being commonly
reported in the literature (Jones et al., 2012, Koga et al., 2005, Endo et al., 2005, Fukuba et
al., 2004).
The TD for deoxy[Hb + Mb] was excluded from the response profile by fitting from the first
data point in which deoxy[Hb + Mb] increased 1 SD above the pre-transition baseline value.
The end-point of the deoxy[Hb + Mb] model fit was either: 1) the peak of the ‘overshoot’,
if an ‘overshoot’ was present; or 2) the end of an initial plateau in the profile, for those
profiles that displayed a continual gradual increase in the deoxy[Hb + Mb] response; or 3)
~90 s for those profiles not displaying an ‘overshoot’ or a discernible gradual increase, as
has been done previously (Buchheit et al., 2009, Ferreira et al., 2005a). The kinetics of
deoxy[Hb + Mb] were quantified by the MRT (CTD + τ). For those profiles that had an
‘overshoot,’ the ‘overshoot’ was quantified by summing together those data points that were
in the ‘overshoot’ region. For those profiles that displayed a gradual increase in deoxy[Hb +
Mb] after the fitting window (i.e., a slow component-like response), the amplitude of this
‘slow component’ was calculated as the difference between the ‘phase II’ model-fit and the
end of the transition.
The profiles for HR and MAP were fit from the first data point in the transition until ~90 s
for HR, or end-exercise for MAP. For both HR and MAP the TD was locked at ‘0’ for every
fit to avoid negative TD values.
The VC profile was fit from the first point after the transition to either the end of exercise
or, when an overshoot was present, to the peak of the overshoot. When an overshoot was
present its size was calculated as the difference between the peak of the overshoot and the
end-exercise VC.
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The BF-to-V̇O2p ratio was calculated by dividing the amplitude of the full response of BF
by the amplitude of the full response of V̇O2p.
Statistics
A one-way repeated measures ANOVA was used to analyze the kinetic parameters for each
variable. When a significant F ratio was found, it was further analysed using Tukey’s post
hoc analysis to determine where differences were. All statistical analyses were performed
using SigmaPlot (Systat Software Inc., San Jose, CA, USA). Statistical significance was
accepted at p < 0.05. All values are reported as mean ± SD.
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Figure 4.1. Protocol schematic.
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Results
V̇O2p and WR values from the incremental KE exercise test are displayed in Table 4.1, along
with lactate values that were taken at each of the baseline (3 and 12 W) and end-exercise
WRs (24, 33, 45, 54, and 66 W). For comparison, with cycle ergometry, the RI peak V̇O2p
was 3.99 ± 0.86 L/min (48.2 ± 9.0 mL/kg/min), and peak WR (WRpeak) was 378 ± 72 W.
V̇O2p: The group mean V̇O2p profiles for each exercise transition are displayed in Figure
4.2A. Baseline V̇O2p increased linearly with increasing WRbl (p < 0.05; Figure 4.3A).
Despite ΔWR being the same for all transitions, the amplitude of the primary V̇O2p
component was larger for transitions initiated from WRs bl33 and bl45 compared to WRs bl3
and bl12 (p < 0.05; data not shown) such that the gain (V̇O2p/WR) of the primary V̇O2p
component (Gp) (p < 0.05; Figure 4.3B) and total V̇O2p response (GT) (p < 0.05; data not
shown), generally, were larger for higher compared to lower intensity transitions. The time
course of the primary component, τV̇O2p, were larger for transitions from higher compared
to lower WRbl’s (p < 0.05; Figure 4.3C).
BF: The group mean BF response profiles for each transition are displayed in Figure 4.2B.
Baseline BF increased linearly with increasing WRbl (p < 0.05; Figure 4.4A). End-exercise
BF values increased in a curvilinear fashion with end-exercise V̇O2p values at each WR, with
the increase in BF relative to V̇O2p decreasing at the higher transitions (Figure 4.5A). When
looking at the BF amplitude corresponding to the time period of the V̇O2p primary
component, the ΔBF was smaller in the highest compared to the lower transitions (p < 0.05;
Figure 4.4B). When the increase in ΔBF was adjusted relative to the increase in metabolic
demand (i.e., ΔBF/ΔV̇O2p) the ratio was smaller at the higher compared to the lower
transitions (p < 0.05; Figure 4.5B). When the estimation of BF kinetics was constrained to
the time frame associated with the V̇O2p primary component (τBF) or was fit across the entire
BF response profile (MRT BF), the BF kinetics tended to be slower for the mid-intensity
transitions (i.e., for transitions initiated from WRbls bl24 and bl33) compared to lower or
highest transitions (p < 0.05; Figures 4.4C & D). The τBF and τV̇O2p were similar for lower
exercise transitions, but at higher transitions τBF was lower than τV̇O2p (p < 0.05; Figure
4.5C).
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deoxy[Hb + Mb]: The group mean deoxy[Hb + Mb] profiles for each transition are shown
in Figure 4.2C. Baseline deoxy[Hb + Mb] (deoxy[Hb + Mb]bl) increased progressively with
increasing WRbl, and was significantly higher at the final two WRbls (p < 0.05; Figure 4.6A).
Although the ‘primary’ deoxy[Hb + Mb] amplitude (Δdeoxy[Hb + Mb]) was similar for all
exercise transitions (p > 0.05; data not shown), there was a greater slow component-like
deoxy[Hb + Mb] response for the transitions from a higher WRbl (p < 0.05; Figure 4.6B).
The gain of the full deoxy[Hb + Mb] response (deoxy[Hb + Mb] GT) was generally similar
between transitions, with the exception of bl24 being larger than bl3 (p < 0.05; Figure 4.6C).
There was a trend for the lowest WRbl to have an ‘overshoot’ that was larger than the two
highest WRbls (p = 0.06; Figure 4.6D). The MRT deoxy[Hb + Mb] was larger at the highest
(bl45) compared to the lower (bl3, bl12) transitions (p < 0.05; Figure 4.6E).
[Hbtot]: The group mean response profiles for [Hbtot] are shown in Figure 4.2D. Baseline
[Hbtot] ([Hbtot]bl) was higher (p < 0.05) for the higher WRbls (Figure 4.7A). Despite ΔWR
being the same amongst transitions, there was an attenuated increase in [Hbtot] amplitude
(Δ[Hbtot]) with increasing WRbl (p < 0.05; Figure 4.7B).
HR: Group mean HR profiles are shown in Figure 4.8A. Baseline HR increased with
increasing WRbls (p < 0.05; Figure 4.9A). The ‘primary’ ΔHR was similar amongst the
different transitions (p > 0.05; data not shown). The HR was smaller for the transition from
bl45 than bl12 (p < 0.05; Figure 4.9B), but no other differences were seen.
MAP: The group mean MAP responses are shown in Figure 4.8B. Baseline MAP increased
with increasing WRbl (p < 0.05; Figure 4.10A). Both MAP amplitude (ΔMAP; data not
shown) and MAP gain (Figure 4.10B) were larger (p < 0.05) at the higher WRbl’s (p < 0.05).
The MRT MAP was similar amongst all transitions (p > 0.05; Figure 4.10C).
VC: The group mean VC profiles are presented in Figure 4.8C. Baseline VC increased
linearly with increasing WRbl (p < 0.05; Figure 4.11A). The VC gain (GT; VC/WR)
decreased progressively with increasing WRbl and was significantly smaller at the highest
compared to all other transitions (p < 0.05; Figure 4.11B). There was often an ‘overshoot’
in the initial VC response that was followed by a small, gradual decrease throughout the
exercise transition. This ‘overshoot’ was significantly greater in bl45 than bl24 (p < 0.05;
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Figure 4.11C). The MRT VC was smaller in bl3 and bl45 than both bl24 and bl33 (p < 0.05;
Figure 4.11D).
Q̇cap: The Q̇cap response profiles for the group mean are shown in Figure 4.8D. Baseline Q̇cap,
generally, was higher at the higher compared to the lower WRbl’s (p < 0.05; Figure 4.12A).
The Q̇cap amplitude (ΔQ̇cap, Figure 4.12B) and Q̇cap gain (data not shown) were similar
amongst transitions (p > 0.05).
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Table 4.1. Values from incremental exercise test and lactate values at various work rates for knee-extension exercise.
Lactate (mM)

WRpeak
(W)

V̇O2peak
(L/min)

LT
(L/min)

RCP
(L/min)

3W

87
(15)

1.84
(0.28)

1.03
(0.26)

1.42
(0.18)

1.6
(0.2)

12
W
1.7
(0.3)

24
W
1.8
(0.4)

33
W
2.0
(0.5)

Values are mean (SD). WR, work rate; LT, lactate threshold; RCP, respiratory compensation point.
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Figure 4.2. Group mean responses (±SD; note that for clarity, deoxy[Hb + Mb] and TOT[Hb + Mb] SDs were not included) of:
A, pulmonary O2 uptake (V̇O2p); B, blood flow (BF); C, muscle deoxygenation (deoxy[Hb + Mb]); and D, total haemoglobin +
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Figure 4.11. Vascular conductance (VC) parameter estimates from increasing work rate
baselines (WRbl) with a common work rate amplitude (21 W) for each trial (bl3-bl63) for, A:
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Discussion
In the present study exercise transitions in response to a constant WR change (WR) were
initiated from different baseline metabolic rates which ranged in intensity across the MOD
to HVY to VH domains to examine the effect of metabolic rate on the kinetics and integration
amongst bulk arterial blood flow (BF), pulmonary V̇O2 (V̇O2p), and quadriceps muscle
deoxygenation (deoxy[Hb + Mb]), as well as heart rate (HR), mean arterial pressure (MAP),
and vascular conductance (VC) kinetics. To the best of the authors’ knowledge, only one
study has previously investigated the effect of an elevated WRbl on BF kinetics in humans,
with their findings limited to only two transitions which were constrained within the MOD
domain (MacPhee et al., 2005). The main findings of the present study were: i) τV̇O2p and
ΔV̇O2p generally increased with increasing WRbl (despite the same absolute step change in
ΔWR); ii) bulk BF kinetics (τBF, MRT BF) slowed with increasing WRbl with the exception
of the highest WRbl where there was a significant speeding compared to transitions from
lower WRbl’s; iii) the increase in BF amplitude (ΔBF) relative to the increase in metabolic
demand (ΔBF/ΔV̇O2p) became smaller as WRbl increased; iv) the MRT deoxy[Hb + Mb]
became progressively larger with increasing WRbl; v) the gain in MAP increased with
increasing WRbl; and vi) the gain in VC became smaller with increasing WRbl.
V̇O2p
Recent studies from our laboratory (Keir et al., 2016a/b) using leg cycling exercise reported
that a progressively increasing WRbl, while keeping ΔWR constant, results in a curvilinear
slowing of V̇O2p kinetics as evidenced by an increasing phase II τV̇O2p. The results of the
present study agree well with these previous findings, and those of others (Nederveen et al.,
2017, Bowen et al., 2011, MacPhee et al., 2005, Brittain et al., 2001), by also showing that
with knee-extension exercise, τV̇O2p becomes larger with increasing WRbl. This slowing of
V̇O2p kinetics with exercise transitions initiated from progressively higher baseline
metabolic rates has been suggested to be due to the progressive recruitment of less efficient
muscle fibres in order to support the metabolic requirements associated with the new stepincrease in WR (Nederveen et al., 2017, Keir et al., 2016a/b, Bowen et al., 2011, MacPhee
et al., 2005, Brittain et al., 2001) or to a greater muscle instability (Grassi et al., 2011) and
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decrease in Gibbs free energy associated with ATP hydrolysis in the newly and/or already
recruited muscle fibres (Wust et al., 2014, Bowen et al., 2011). A decrease in metabolic
efficiency is evidenced in the present study by the increase in the V̇O2p Gp (Figure 4.3B) and
overall V̇O2p GT (data not shown), which agrees well with the increased V̇O2p gain reported
previously (Nederveen et al., 2017, Keir et al., 2016a/b, Bowen et al., 2011, MacPhee et al.,
2005, Brittain et al., 2001). These less efficient type I and type II (especially type IIx) fibres
that are recruited, have a higher capacity for glycolytic metabolism and lower capacity for
oxidative metabolism, and are associated with slower V̇O2p kinetics (Crow & Kushmerick
1982, Pringle et al., 2003a/b). Additionally, in animal muscle, fast, glycolytic fibres are
supported by a lower muscle BF, and lower muscle O2 delivery-to-muscle O2 utilization
ratio, relative to more oxidative fibres (McDonough et al., 2004, Behnke et al., 2003), which
leads to greater microvascular O2 extraction and fall in PO2, thus lowering the driving
pressure (PO2) for O2 diffusion from the red blood cell into the myocyte. Furthermore,
McDonough et al. (2005) found that in response to muscle contraction in rat gastrocnemius
(primarily fast twitch fibres) compared to soleus (primarily slow twitch fibres) muscles,
microvascular PO2 was lower at rest, and in response to muscle contraction, the PO2
decreased at a faster rate and displayed a transient undershoot before reaching a significantly
lower “steady-state” value. These findings suggest that O2 delivery to the less efficient fast
twitch fibres is attenuated relative to the O2 requirement and that BF kinetics may be slower
to these fibre types. However, it is not clear from these data whether the slowing of V̇O2p
kinetics from elevated baseline metabolic rates is the result of ‘sluggishness’ in metabolic
activation of the newly recruited fibres or to a lower O2 delivery (i.e., BF) to these fibres, or
to some other presently unknown factor.
BF
Due to the lack of information on the BF response during exercise transitions in these
previous studies, one of the main goals of the present study was to investigate the effect of
increasing WRbl on BF kinetics. There was an increase in τBF (which was determined for
the same time period as the primary component for V̇O2p) with increasing WRbl, but a
constant ΔWR, for all but the highest WRbl, which generally confirms our hypothesis that
BF kinetics would be slowed with increasing WRbl, and agree with the findings of MacPhee
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et al. (2005) which were confined to the MOD domain. Peripherally, this slowing of BF
kinetics may be due to the recruitment of less efficient fibres that have a lower (McDonough
et al., 2004, Behnke et al., 2003), and possibly slower (McDonough et al., 2005), BF
response. In turn, a slowed response of the microvasculature surrounding these fibres, might
be expected to produce a slowed response to the resistance vessels upstream (via conducted
vasodilation (through the endothelium and/or smooth muscle cells), and/or flow-mediated
dilation (due to shear stress)), which will ultimately affect the conduit artery. Alternatively,
a slowed demand for O2 from less efficient fibres, or a decrease in metabolic efficiency of
already recruited fibres, may also translate into a smaller and/or slowed demand for
convective O2 delivery. Centrally, a slowing of BF kinetics could be due to a slowed
adjustment of cardiac output (Q̇T), as suggested by MacPhee et al. (2005), in which those
authors noted HR kinetics were slower when exercise was initiated from an elevated WRbl
in the MOD domain. However, the present study did not observe a slowing of HR kinetics
with increasing WRbl (see Figure 4.9B), suggesting that HR kinetics were unlikely to be
responsible for the slowing of BF kinetics.
In contrast to our hypothesis, the BF dynamics for the highest exercise transition were faster
than the previous transition, although this value only reached significance when BF kinetics
were estimated across the entire exercise transition (i.e., MRT BF). While the reason for this
speeding of BF kinetics at the highest WR, which has never been observed before, is not
readily elucidated, we do offer a possible explanation. At the various baseline metabolic
rates and exercise transitions studied in the present study, subjects were working within and
across different intensity domains such that the physiological responses associated with these
WR interventions might be expected to vary depending on the intensity domain into which
the transition is being made (e.g., sustainable (MOD and HVY) vs. unsustainable (VH and
severe) exercise). In the current study we did not make the WRs relative to each individual’s
intensity domains, deciding instead to use the same absolute WRs and a ΔWR that provided
a good signal-to-noise ratio for the variables, and allowed a relatively wide range of endWR intensities and a peak WR (i.e., 66 W) that could be completed by all participants. Based
on the intensity boundaries (i.e., LT, RCP) and blood [lactate-] measures determined from
the step-incremental KE exercise test, we were able to estimate, for each subject, in which
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intensity domain each of the WRs was being performed. Based on this, it was established
that for the final exercise transition, most subjects (7 of 10) were transitioning from the HVY
into the VH intensity domain. In the HVY domain there is an increased accumulation of
metabolites, many of which have been shown to induce vasodilation (e.g., H+, K+, adenosine,
prostaglandins, CO2, and nitric oxide). An enhanced vasodilatory response in the
microvasculature may result in a faster increase in microvascular blood volume and flow
during an exercise transition, with the dilatory signal extending upstream to facilitate bulk
BF. If metabolites are indeed involved in a quickened response, the question could be raised
as to whether it is the presence of these metabolites in the HVY baseline prior to the transition
or because of a rapid accumulation of these metabolites during the VH WR of the transition
that cause this response. Unfortunately, it is not possible to differentiate the contribution of
these two potential mechanisms in the present study. Therefore, further investigation into the
effects of HVY and VH exercise on bulk BF kinetics is warranted.
V̇O2p and BF
The finding that the relationship between increase in bulk BF relative to the increase in
metabolic demand (ΔBF/ΔV̇O2p) becomes smaller when WRbl is increased is similar to what
has been previously observed in our laboratory (MacPhee et al., 2005, Chapter III) and others
(Van Beekvelt et al., 2001, Koga et al., 2005). Furthermore, there was a progressive
attenuation of the increase in Δ[Hbtot] with increasing WRbl (Figure 4.7B), implying that
both bulk and microvascular BF were attenuated for transitions from an elevated baseline
metabolic rate. In accordance with the Fick equation, a decrease in ΔBF relative to a rise in
ΔV̇O2p would necessitate an increase O2 extraction and result in a widening of the a-vO2diff.
In the present study, despite the decrease in both the ΔBF-to-ΔV̇O2p ratio and [Hbtot] with
increasing WRbl (Figure 4.5B), the NIRS-derived deoxy[Hb + Mb] signal, which can be
considered a surrogate measure for a-vO2diff, generally did not show a greater increase in
amplitude with increasing WRbl (Figure 4.6C), which was unexpected according to the Fick
relationship. While these findings are not easily reconcilable, the discrepancy between ΔBFto-ΔV̇O2p ratio and O2 extraction may be partly explained by the fact that the Doppler
ultrasound measures muscle conduit artery (bulk) BF while the NIRS-derived deoxy[Hb +
Mb] measure reflects the local muscle microvasculature O2 delivery-to-O2 utilization
134

relationship. Therefore, a comparison of measures between these two sites should be made
cautiously.
While a progressive decrease in [Hbtot] GT with increasing WRbl does agree with the findings
of BF at the level of conduit artery, it also is possible that at such high WRs there is a
limitation of the NIRS, with the signal becoming ‘saturated.’ In such a situation, the [Hb tot]
(and other NIRS measures, deoxy[Hb + Mb] and oxy[Hb + Mb]) would be unable to increase
further, making the signal less reliable. In addition to this, there is a plateauing of the TOT[Hb
+ Mb] response profiles in the highest transition (bl45; Figure 4.2D) that is not present in any
of the previous transitions. While it is possible that this plateau, and decrease in

TOT[Hb

+

Mb] GT with increasing WRbl, is due to the large contractile forces at this WR which may
occlude BF to a greater degree than the prior transitions and prevent a further increase in
TOT[Hb

+ Mb], it also may be a result of a ‘saturated’ signal for NIRS. Indeed, the lack of an

increase in deoxy[Hb + Mb] GT with increasing WR could agree with a ‘saturation’ of the
NIRS signal. It also should be noted that

TOT[Hb

+ Mb] is already high at the baseline of

these higher WRbls, suggesting that diffusive capacity into the muscle is high and may not
have a substantial need for further increases during the transition.
deoxy[Hb + Mb]
The dynamics of muscle microvascular deoxy[Hb + Mb] were slowest (i.e., MRT deoxy[Hb
+ Mb] largest) at the highest WRbl, which suggests an increased BF and O2 delivery relative
to local muscle O2 utilization, and thus a lower fractional O2 extraction. In addition, there
was a small, transient overshoot in the deoxy[Hb + Mb] response at the lowest WRbl (bl3)
which tended to be smaller at the highest WRbl’s (p < 0.10; Figure 4.6D), indicative of an
improved matching of local microvascular BF and muscle O2 utilization during the exercise
transient of higher WRbls. Therefore, despite ΔWR being the same, when initiating an
exercise transition from a higher WRbl there may be a decreased reliance on widening the avO2diff in the transitory phase than when a transition is initiated from a lower WRbl, where
microvascular BF seemingly adjusts more slowly. While this finding seems to be at odds
with the decrease in [Hbtot] GT and ΔBF/ΔVO2p ratio discussed above, it should be noted that
these findings pertain to the kinetics rather than the overall response. Nevertheless, further
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research is needed to discern the limitations of BF and/or NIRS that are present at higher
WRbls.
HR
The adjustment of HR, which contributes to the adjustment of central Q̇T and thus peripheral
conduit artery BF, revealed that τHR was smaller in the highest WRbl (bl45) than bl12 (Figure
4.9B). This observation would seem to align well with the finding that BF kinetics were
faster at the highest WRbl (Figures 4.4C & D), suggesting that Q̇T could be partially
contributing to the faster rate of adjustment of bulk BF at this transition. Despite that, overall,
the kinetics of HR and BF were not related (data not shown), with τHR showing a general
decrease while τBF showed a general increase during the lower WRbl‘s, suggesting that the
adjustment of HR has little influence on the rate of adjustment of bulk BF. However, as Q̇T
also is determined by stroke volume (SV), it is possible that the rate of SV increase was
slower at the lower WRbls, due to a slower return of venous blood and/or a slower/smaller
activation of the sympathetic nervous system (SNS). However, there were no measures taken
for SV – or its influencing variables (venous return and SNS activity) – in the present study,
and therefore, the full contribution of Q̇T to the bulk BF response is unknown.
The increase in HR during exercise is determined by parasympathetic nervous system
(PSNS) withdrawal and SNS activation. In the present study the progressive increases in HR
associated with exercise transitions from the lowest to the highest WRbl ranged between 70
& 100 bpm. In this range, HR increases are determined more by withdrawal of the fasterresponding PSNS rather than by increases in SNS activation which is a slower process and
predominates at HRs > 100 bpm (see Karemaker 2017 for review). Therefore, the finding
of a speeding of HR kinetics with increasing WRbl is somewhat surprising given the known
dynamics of PSNS and SNS regulation of the heart and the expected reduction in PSNS
control of HR from an increased WRbl.
MAP
The MAP gain (MAP GT) increased with increasing WRbl (Figure 4.10B), which is expected
to contribute to the increase in the BF response to exercise (BF = MAP ‧ VC). However,
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despite the progressive increase in MAP GT there was a relative decrease in BF gain (and
ΔBF/ΔV̇O2p) with increasing WRbl, which implies some restraint in the BF response. An
increase in resistance to BF with increasing WRbl does seem plausible, as higher WRs result
in an increase in SNS output which causes an increase in vasoconstriction throughout the
body (see Delp & O’Leary 2004 for review), particularly the inactive musculature. Since the
present study has a relatively small active muscle mass (quadriceps only) that will be
vasodilating, this leaves a large proportion of muscle in the body undergoing
vasoconstriction, and thereby, increasing resistance. By this same premise, a high vascular
resistance from the large amount of inactive muscle mass in the lower limbs may also be
contributing to the decrease in ΔBF/ΔV̇O2p at higher WRbl’s. In addition to an increase in
sympathetic vasoconstriction, the increase in muscle force production required to overcome
the external resistance at higher WRs also would be expected to contribute to muscle BF
restriction due to occlusion of the vasculature within the active muscle by the contracting
fibres. Indeed, previous studies have shown that upon the cessation of exercise there is an
increase in BF to the muscle (Van Beekvelt et al., 2001, Shoemaker et al., 1994), suggesting
that BF is inadequate during the exercise period. Furthermore, the degree of this postexercise
hyperemia may be related to intensity, as Van Beekvelt et al. (2001) found that the
postexercise increase in BF following forearm exercise at 25% WRpeak was brief (~10 s) and
not significantly greater than BF during the exercise bout, while postexercise hyperemia
following a 75% WRpeak was significantly greater and longer (~90 s). These findings would
seem to imply that there is a greater occlusion of BF at higher WRs. Indeed, Lutjemeier et
al. (2005) reported that muscle contraction had a net increase in BF at low intensities, but a
negative effect on BF at the highest WRs studied as the force of contraction resulted in
greater impedance to BF. Taken together, these findings could suggest that the increase in
resistance may exceed the increase in MAP, which could provide rationale for the attenuated
increase in both bulk BF (Figure 4.5B) and [Hbtot] (Figure 4.7B) at higher WRs that were
observed in the present study.
VC
Coincident with this increase in MAP GT, there was a decrease in VC GT with increasing
WRbl. This attenuation in VC across increasing WRbl’s may be responsible for the smaller
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BF gains seen across increasing WRbl’s, as well as a possible contributor to the slowing of
BF kinetics during the initial WRbl’s. Additionally, in some, but not all subjects, an
‘overshoot’ in VC was present, with trial bl45 having a significantly greater ‘overshoot’ than
trial bl24 (Figure 4.11C). While the cause of this VC ‘overshoot’ is not evident, it may be
associated with an initial rapid increase in BF (caused by a rapid vasodilation, and/or the
‘muscle pump’) coupled with a gradual increase in resistance (caused by vasoconstriction).
With the concomitant measures of BF and MAP (and the calculation of VC), this study was
able to assess the contribution of both MAP and VC to the adjustment of BF across the
multiple different WRbl transitions used in this study. The finding that MRT MAP was not
significantly different between transitions (Figure 4.10C), while MRT BF became larger
with increasing WRbl before becoming significantly smaller at the highest WRbl (Figure
4.4D), would seem to suggest that MAP does not play a central role in determining the
overall kinetic response of BF. However, MRT VC became progressively larger with
increasing WRbl, before becoming significantly smaller at the highest WRbl (Figure 4.11D),
a finding which perfectly reflected MRT BF. This would seem to suggest that the speeding
of BF kinetics in the highest WRbl (bl45) was predominantly caused by a speeding of VC
kinetics. This could then suggest that vasodilation in the active musculature, rather than an
increase in BP, is a key control mechanism for BF kinetics.
Limitations
This study does present with several limitations. Due to the number of trial repetitions
needed to improve the signal-to-noise ratio, and the high intensity of some of the WRs, there
is a high potential of a training effect. As training has been shown to speed V̇O2p kinetics
(Murias et al., 2016, Phillips et al., 1995, Bell et al., 2001) and cause changes in both
metabolic (e.g., increased V̇O2 efficiency) and cardiovascular variables (e.g., increased
capillarization), this warrants careful consideration. While the number of repetitions needed
for each transition (3-6) was not reduced (so as to maintain a good signal-to-noise ratio),
repetitions of a particular WR transition were not performed until every other intensity had
been completed. By this design, if a training effect were to occur, it would be “distributed”
between all of the trials proportionally. Furthermore, no observable differences in V̇O2p, BF,
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or HR were found between the individual trials within each transition, suggesting little
evidence of a training effect throughout the study.
Blood pressure was taken manually at one minute intervals, and although the profiles
generated in our study closely resembled a monoexponential response, we recognize that
caution should be used when quantifying this response due to the prolonged time between
measurements (especially early in the transition). Similarly, as VC was calculated using the
iterated response of MAP, caution also should be used in quantifying the VC response due
to the large amount of generated data.
Lastly, the use of NIRS has several limitations which are well addressed by Schlup et al.
(2015). Firstly, the transmitted wavelength of light detects both haemoglobin and myoglobin
without knowing the proportion that each contributes to the overall signal. The oxyhaemoglobin dissociation curve displays a sigmoidal relationship which allows greater offloading of O2 for a given range of microvascular PO2s within the range of approximately 6010 mmHg (P50 ≈ 27 mmHg). In contrast, the intramuscular oxy-myoglobin curve displays a
hyperbolic relationship whereby significant O2 off-loading does not occur until very low
intracellular PO2s (P50 ≈ 2.5 – 3 mmHg; Schenkman et al., 1997, Richardson et al., 1995).
Therefore, microvascular and intracellular PO2 levels will effect the degree of desaturation
of haemoglobin and myoglobin to different extents. However, at present, we do not have
reliable values of intracellular PO2 levels during exercise, making it difficult to determine
the contribution of deoxy-Mb to the NIRS signal. While it has been shown that myoglobin
contributes ~50-70% of the NIRS signal at rest, and ~70% of the change in the NIRS signal
from rest to maximal exercise is from myoglobin (Davis & Barstow 2013), the diffusion
pathway as a whole would be unaffected, and therefore, this should not compromise the use
of NIRS in looking at the O2 delivery-to-O2 utilization ratio. Secondly, the NIRS signal
investigates a small volume of muscle, and with a limited depth of penetration of the NIR
light (~3.5 cm) and the distribution of muscle fibre types (type II fibres predominate in
superficial muscle and type I fibres predominated in deeper muscle regions (Lexell et al.,
1983, Johnson et al., 1973)), this signal should not be considered as representative of the
entire muscle. Thirdly, the contribution of each of the microvascular vessels (arterioles,
capillaries, venules) to the NIRS signal is not known. However, Poole et al. (1995) observed
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that the vast majority (~84%) of the microvascular volume in the rat diaphragm is comprised
of capillaries, suggesting that the deoxy[Hb + Mb] signal represents mainly capillary O2
extraction. However, to date, no studies have reproduced this, with several studies theorizing
a different composition of the microvasculature (arterioles vs. capillaries vs. venules)
without providing a source for these compositions, leaving the true division of the
microvasculature unknown at present (Barstow 2019). Nevertheless, care was taken to
ensure the same placement of the probes on each subject throughout the study, and therefore,
the differences observed between trials should represent true differences, albeit limited
perhaps to the muscle fibres investigated. Fourthly, the NIRS signal must pass through a
layer of skin and adipose tissue, which may have their own microvascular volumes and tissue
region-specific BF. However, the microvascular volume of these tissues is considerably less
than in skeletal muscle (Maehara et al., 1997), and little O2 extraction would be expected in
these tissues, making their contribution to the absolute deoxy[Hb + Mb] signal insignificant
(see Barstow 2019 for review).
Conclusions
In summary, this study examined the effect of exercise transitions from increasing baseline
metabolic rate, with a common ΔWR, on the responses of V̇O2p, BF, deoxy[Hb + Mb], HR,
MAP, Q̇cap, and VC. It was found that τV̇O2p became larger with increasing WRbl, a finding
which corroborates the results of Keir et al. (2016a/b) that V̇O2p kinetics become
progressively slower as baseline metabolic rate is elevated. However, although increasing
baseline metabolic rate resulted in a progressive slowing of conduit artery BF kinetics over
the lower four transitions investigated in this study, which was in line with our hypothesis,
there was a significant speeding of BF kinetics at the highest WRbl, which was contrary to
our hypothesis. The findings that BF kinetics follow a similar response to that of V̇O2p over
the lower exercise intensities (i.e., similar time constants and becoming slower with
increasing WRbl), suggests that conduit artery BF could be limiting to V̇O2p kinetics in this
situation. However, the finding of a disconnect between V̇O2p and BF kinetics at the higher
WRbls (i.e., a speeding BF kinetics with slowing V̇O2p kinetics), implies that conduit artery
BF kinetics cannot be limiting V̇O2p kinetics at these intensities. Furthermore, the slowing
of deoxy[Hb + Mb] kinetics with increasing WRbl implies that O2 delivery to the muscle is
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in excess of what is being utilized, and therefore, microvascular O2 delivery/diffusion is also
unlikely to be limiting V̇O2p kinetics. This would then suggest that in this situation (elevated
WRbl) the limitation on V̇O2p kinetics lies within the muscle (i.e., a metabolic
‘sluggishness’). Future studies should individualize the WRs to be within a given intensity
domain for each subject so as to gain a more accurate understanding on whether this
‘disconnect’ between BF and V̇O2p kinetics is a result of the physiological changes occurring
in these different intensity domains. Lastly, we observed a significant decrease in the
ΔBF/ΔV̇O2p ratio with increasing WRbl, showing that bulk BF does not increase in
proportion to metabolic demand. This may indicate a more ‘efficient’ distribution of BF
amongst the active muscle fibres in the leg when WRbl is elevated, but further investigation
is needed.
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CHAPTER V: Conclusions
Summary of Studies
This thesis investigated the role of V̇O2p, BF, deoxy[Hb + Mb], HR, MAP, Q̇cap, and VC,
and the integration amongst these variables, in response to step-transitions of multiple
different baseline metabolic rates (WRbl) and metabolic amplitudes (ΔWR) across the
MOD, HVY, and VH domains. While many studies have investigated the effect of different
ΔWRs (Nyberg et al., 2017, Keir et al., 2016b, Spencer et al., 2013, Jones et al., 2012,
Koga et al., 2005, MacPhee et al., 2005, Ozyener et al., 2001, Scheuermann et al., 2001,
Koga et al., 1997, Koga et al., 2001, Koga et al., 1999, Engelen et al., 1996, Paterson &
Whipp 1991) and WRbls (Nederveen et al., 2017, Keir et al., 2016a/b, Bowen et al., 2011,
MacPhee et al., 2005, Brittain et al., 2001) on V̇O2p kinetics, relatively few have looked at
the response of BF kinetics, or other physiological variables, to these same transitions.
Those studies that have investigated BF kinetics have often looked at only two ΔWRs
(McNarry et al., 2014, Jones et al., 2012, Koga et al., 2005, MacPhee et al., 2005, Hughson
et al., 1996), with the only study looking at BF kinetics from an elevated WRbl doing so
being constrained within the MOD domain (MacPhee et al., 2005). To expand upon these
previous studies, the present thesis investigated the contribution and interaction of many
physiological variables across multiple different WRbl and ΔWR transitions.
It was first necessary to discern how to properly (or best) quantify the BF signal, therefore,
Chapter II investigated the effect of some of the most prevalent analysis techniques on BF
kinetics by averaging the BF signal over 1, 2, or 5 cycles (‘binned’ and ‘rolling’) using
either the R-spike interval of the cardiac cycle (HR) or the contraction-relaxation (CR)
profiles to demarcate a ‘cycle’ of interest. The use of HR or CR to quantify the BF signal
is necessary because of the physiological fluctuations in the BF profile caused by the
systolic and diastolic phases of the cardiac cycle, as well as periodic BF occlusion caused
by the muscle contraction-relaxation cycle. To date, those studies that have examined the
effect of different analysis techniques on quantifying BF have used only steady-state
conditions (Osada & Radegran 2006a/b, Osada 2004, Shoemaker et al., 1996), without
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consideration given to the non-steady-state conditions associated with changes (transitions)
in exercise intensity in which a clean signal with good temporal resolution is fundamental.
Although the lack of a ‘gold standard’ for analyzing BF constrains the ability to define a
‘true’ BF for each exercise transition, comparisons of the various BF analysis techniques
used in the present study across several kinetic parameters (e.g., baseline, amplitude, time
constant, and confidence interval) yielded several noteworthy findings. The findings of
Chapter II corroborated the findings of previous studies showing that analysis technique
does not influence “steady-state” BF, but when focusing on “non-steady-state” conditions
associated with changes in exercise intensity, it was found that: i) estimating MRT from a
single CR cycle (CR1) within the MOD domain resulted in values that were smaller than
observed for most other analysis techniques; ii) analysis using CR1 yielded BF amplitude
(ΔBF) values that were higher than (or similar to) the other analysis techniques in HVY,
but not in MOD; iii) analyses using a single cardiac cycle (HR1) had the highest confidence
interval (CI95; i.e. largest variability), while those using CR1 had the lowest CI95 for both
MOD and HVY; and iv) when comparing the difference between ‘model determined’ and
‘data determined’ steady-state BF values for MOD and HVY, those analysis techniques
that incorporated a ‘rolling’ average (HR2r, HR5r, CR2r, CR5r) had a significantly larger
difference in these values for HVY than MOD. In considering the outcomes for the kinetic
parameters estimated using the various analysis techniques, the CR1 method was chosen
as the preferred method of BF analysis, and was used throughout the thesis, because of its
low variability, reliability in modeling end-exercise values, and shorter interval duration
which minimizes ‘overlap’ of the steady-state and non-steady-state data.
Several studies have reported that the kinetics for the primary component of the V̇O2p
response are similar for step-transitions in WR (ΔWRs) initiated from a common, lightintensity, baseline metabolic rate into the MOD or HVY domains (Nyberg et al., 2017,
Keir et al., 2016b, Spencer et al., 2013, Jones et al., 2012, Koga et al., 2005, MacPhee et
al., 2005, Ozyener et al., 2001, Scheuermann et al., 2001, Koga et al., 1997). Furthermore,
studies that have investigated the relationship amongst BF or O2 delivery and V̇O2p
kinetics, in general, report no differences in BF kinetics between transitions into the MOD
or HVY domain if initiated from a common, light-intensity, baseline metabolic rate
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(Nyberg et al., 2017, McNarry et al., 2014, Jones et al., 2012, Koga et al., 2005, MacPhee
et al., 2005, Hughson et al., 1996). However, previous studies only investigated and report
the response of BF kinetics to two different ΔWR transitions. Although recent studies from
our laboratory using leg-cycling ergometry (Keir et al., 2016b, Spencer et al., 2013)
reported no differences in V̇O2p kinetics with step-transitions using multiple, different
ΔWRs, BF dynamics and the relationships of BF and V̇O2p responses were not investigated.
Therefore, in Chapter III alternate-leg knee-extension exercise was used which allowed the
simultaneously measurement of V̇O2p, BF, deoxy[Hb + Mb], HR, and MAP (and the
calculation of Q̇cap, and VC) across multiple transitions of different absolute ΔWRs from a
common, low baseline metabolic rate. The purpose of this study was to investigate the
effect of these different ΔWRs (which spanned the MOD, HVY, and VH domains) on the
dynamic adjustment of V̇O2p, BF, deoxy[Hb + Mb], HR, MAP, Q̇cap, and VC, and the
interactions of these variables throughout these transitions. It was hypothesized that V̇O2p,
BF, deoxy[Hb + Mb], HR, and VC kinetics would be similar across the different ΔWR
transitions and that these variables would increase proportionally with the increasing
metabolic demand of larger ΔWRs.
The main findings of Chapter III were that: i) phase II V̇O2p kinetics became progressively
slower (i.e., V̇O2p larger) in a linear manner with increasing ΔWR; ii) phase II BF kinetics
(τBF) were not different amongst the different ΔWRs (although there was a trend for a
progressive slowing of BF kinetics with increasing ΔWR, with the largest ΔWRs being
significantly slower when fitting the entire transition (MRT BF)); iii) the increase in BF
per increase in V̇O2p (ΔBF/ΔV̇O2p) became smaller as ΔWR became larger; iv) muscle
deoxygenation kinetics became progressively faster (i.e., MRT deoxy[Hb + Mb] smaller)
in a linear manner with increasing ΔWR; v) HR kinetics were similar across all ΔWRs; and
vi) VC kinetics had a tendency to become slower with increasing ΔWR. Collectively, these
findings suggest that to compensate for a relative decrease in bulk BF (O2 delivery) with
increasing ΔWR, there is an increase in O2 extraction to help augment the O2 requirements
of the muscle. This decrease in the ΔBF/ΔV̇O2p ratio may be attributable to the increased
force production of the muscle – to meet the larger ΔWR – which increases vascular
occlusion causing an attenuated increase in BF. Alternatively, it is possible that an increase
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in sympathetic nerve activity at the higher WRs leads to an increase in vasoconstriction in
the large amount of non-active muscles of the leg, and therefore, a relative decrease in bulk
BF to the leg. In turn, this could cause a redistribution of BF to the relatively small amount
of active musculature (quadriceps) in the leg where the metabolic demand is highest.
Although these higher ΔWRs will lead to a greater recruitment of less efficient fibres (in
particular, type II fibres) to meet force production requirements, the BF may be higher to
type I fibres (McDonough et al., 2004, Behnke et al., 2003). This will lead to type II fibres
relying more on O2 extraction than type I fibres, which will create a smaller pressure head
for ‘driving’ O2 into the type II muscle fibres. Therefore, the slowed V̇O2p kinetics with
increasing ΔWR may be due to a smaller BF and O2 delivery to these newly recruited type
II fibres, or a metabolic sluggishness of the oxidative pathways in these less efficient type
II fibres.
Recent studies have investigated the effect of performing exercise transitions from an
elevated baseline metabolic rate (i.e., higher WRbl and V̇O2p) with the consistent findings
that V̇O2p kinetics become slower when transitions are initiated from elevated WRbls and
the gain (Gp; ΔV̇O2p/ΔWR) becomes larger (Nederveen et al., 2017, Keir et al., 2016a/b,
Bowen et al., 2011, MacPhee et al., 2005, Brittain et al., 2001). Although the mechanism
has not been identified, it was suggested that the slower V̇O2p kinetics and greater V̇O2p Gp
associated with transitions from the higher compared to the lower baseline metabolic rate,
perhaps, was related to recruitment of a less efficient muscle fibre pool to meet the
increased muscle force/power requirements of the imposed, higher WRs (Nederveen et al.,
2017, Keir et al., 2016a/b, Bowen et al., 2011, MacPhee et al., 2005, Brittain et al., 2001).
The delayed adjustment of muscle O2 utilization in response to an instantaneous increase
in WR or ATP requirement has been attributed to a sluggish activation of rate limiting
enzymes and metabolic pathways responsible for providing oxidizable substrate (other than
O2) to the mitochondria, to a slow increase in muscle BF and O2 delivery, or a combination
of these. To date, only one study has investigated the effect of a raised WRbl on the response
of BF, with the finding that, like V̇O2p, BF kinetics also are slowed with a transition from
an elevated WRbl (MacPhee et al., 2005). However, this study used only two WRbl’s and
the entire response profile was constrained within the MOD domain. Therefore, the
purpose of Chapter IV of this thesis was to extend these findings by expanding the range
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of baseline metabolic rates to include exercise across the MOD, HVY, and VH intensity
domains and examining the response and integration of V̇O2p, BF, deoxy[Hb + Mb], HR,
MAP, Q̇cap, and VC between these different transitions.
The main findings for Chapter IV were: i) V̇O2p kinetics were slower at the highest WRbls
compared to the lowest WRbls; ii) conduit artery BF kinetics were slower (i.e., BF & MRT
larger) when WRbl was increased, with the exception of the highest exercise transition
where BF kinetics were faster than what was seen in the previous, penultimate, transition;
iii) the increase in BF relative to the increase in metabolic demand (ΔBF/ΔV̇O2p) became
progressively smaller as WRbl increased; iv) the MAP gain (ΔMAP/ΔWR) was larger at
the higher WRbls; v) HR kinetics were fastest at the highest WRbl; and vi) deoxy[Hb + Mb]
MRT became progressively larger with increasing WRbl. While the slowing of BF kinetics
with increasing WRbl at the lower transitions is in line with initial hypotheses and previous
results (MacPhee et al., 2005), the significant speeding of BF kinetics at the highest WR bl
may be related to the intensity domain in which the subjects are exercising and the
vasodilation-inducing metabolites that have accumulated during the elevated baseline
metabolic rate. At the same time, there was a decrease in the absolute bulk BF relative to
the metabolic demand of the muscle as WRbl increased. This relative decrease in bulk O2
delivery appeared to be offset by a redistribution of microvascular BF to the active muscle
fibres as the observed slowing of deoxy[Hb + Mb] kinetics suggests an enhanced O2
delivery to the active muscle relative to O2 utilization within the microvasculature.
One of the most unanticipated observations of this thesis was a speeding of BF kinetics
when exercise was initiated from the highest compared to the second highest WR bl (see
Chapter IV). This speeding may be the result of vasodilation-inducing metabolites released
by the muscle as a result of the high intensity of exercise being performed as most subjects
were transitioning from the HVY (WRbl, 45 W) into the VH domain (WRbl, 66 W). Based
on the data from Chapter IV, it was not possible to discern whether this speeding of BF
kinetics in the highest transition was attributable to the metabolic conditions present at
baseline exercise prior to the transition (45 W; HVY domain for 7 of 10 subjects; see
APPENDIX III), or the metabolic instability that arose from the increased metabolic
demand of the transition (66 W; VH for 7 of 10 subjects). However, from the data collected
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in Chapter III, in which these same subjects performed an exercise transition to the same
absolute WR of 66 W, but from a baseline metabolic rate of light-intensity (3 W) exercise,
there was no speeding of BF kinetics compared to those transitions to a lower WR (in fact,
kinetics generally became slower with increasing ΔWR from a common light-intensity
baseline). With this comparison, it is tempting to speculate that since there was no
significant speeding of BF kinetics at the 66 W WR when the transition was initiated from
a low metabolic baseline (3 W), but there was a speeding when the transition was initiated
from a high metabolic baseline (45 W), that it was the pre-transition metabolic rate that
resulted in a speeding of BF kinetics, and not necessarily the metabolic rate of the
transition. However, it should also be noted that for both of these transitions to 66 W, the
time constant values were similar (MRT BF: 35 ± 16 s, 35 ± 24 s; τBF: 25 ± 12 s, 30 ± 22
s, for a low WRbl (3 W) and a high WRbl (45 W), respectively). Thus, the physiological
conditions of the 66 W transition may predispose BF towards a given rate of adjustment,
with this response possibly associated with the metabolic instability of a VH exercise
domain. However, with the study design of this thesis, any attempted explanation for the
speeding of BF kinetics at the highest WRbl is largely speculation, and therefore, there is a
need for further research to more accurately investigate this response.
Limitations
A large portion of this thesis was the investigation of BF kinetics in response to steptransitions in WR. Essential to this is a proper quantification of the mean blood velocity
(MBV) (and BF) response signal. However, at present, there is no ‘gold standard’ for
quantifying the BF signal. Therefore, in Chapter II the effect of different techniques for
quantifying BF was investigated. Based on the findings, none of the techniques
investigated stood out as being superior although the CR1 analysis was chosen as being
better and used throughout the thesis to estimate the BF response to exercise.
The same absolute WRs were used for all subjects in Chapters III and IV which resulted in
each absolute WR having a different number of subjects within each intensity domain
(MOD, HVY, and VH). While this setup was necessary for enhancing the signal-to-noise
ratio, creating a range of WRs to compare (i.e., 5 total), and ensuring that subjects could
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complete the 8 min transition for all WRs (i.e., 66 W max), it does restrict the ability to
definitively distinguish the physiological responses associated with the different,
individual, exercise-intensity domains. This is particularly important for interpreting the
V̇O2p and BF response profiles as profiles will differ depending on which (or into which)
intensity domain the exercise transitions are taking place (see Poole & Jones 2012 for
review). Additionally, due to the high knee-extension-specific WRs used in these studies,
participants were generally more fit, making it difficult to extrapolate responses to the
general population.
In Chapters III and IV, NIRS was used to measure muscle deoxygenation (i.e., deoxy[Hb
+ Mb]) and to infer the fractional O2 extraction. In humans, it is known that there is a
heterogeneity of fibre types within the muscle (e.g., ~50% type I fibres), dispersion of fibre
types within the muscle (with type II fibres being more superficial than the deeper type I
fibres), and heterogeneity of O2 utilization and BF amongst muscle fibre types and within
muscle regions. Due to the relatively shallow depth to which NIRS is able to penetrate, and
the very small area of interrogation, the deoxy[Hb + Mb] signal cannot be considered to be
representative of the whole muscle. Nevertheless, care was taken to ensure that the NIRS
probe was positioned on the same location over the muscle for each trial, which improves
the likelihood that differences in the NIRS signal can be attributed to changes in the
metabolic activity and O2 delivery within the same muscle region and muscle fibre pool.
Ideally measures of blood pressure (BP) and calculation of mean arterial pressure (MAP =
1/3 SBP + 2/3 DBP) should have been made on a more continuous basis that simply once
per minute. However, when data collection for the different studies began we did not have
access to a beat-by-beat blood pressure (BP) unit and so BP was measured by one of the
investigators experienced in sphygmomanometry. Because the min-by-min MAP profile
appeared to change with a monoexponential time course during the exercise transition it
was decided to model the MAP profile and estimate MAP kinetics. This also allowed
calculation of vascular conductance (VC = BF/MAP) and estimation of VC kinetics. In
doing so, it was recognized that the fidelity of the entire non-steady-state and steady-state
response profile was compromised because of such a low density of actual, measured data.
Also, although the increase in HR during exercise is accomplished by a decrease in the
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duration of both systole and diastole in the cardiac cycle, there is a larger reduction in the
diastolic phase, which offset the proportion of the cardiac cycle that was spent in systole
and diastole. In this study no attempt was made to compensate for this when calculating
MAP. However, even at the highest WR, HR was still relatively low (~130 bpm), which
quite possibly precludes a large influence of cardiac cycle phase durations on MAP
calculations.
While Q̇cap has been quantified previously as a measure of microvascular BF (Ferreira et
al., 2005, Harper et al., 2006, Schlup et al., 2015), its calculation does require the use of
two measures that are surrogate values within the Fick equation, namely the replacing of
V̇O2m with V̇O2p and a-vO2diff with deoxy[Hb + Mb]. In particular, Murias et al. (2012)
described a “proportionality issue” in which V̇O2p increases by a relatively small range
(e.g., 80-100%), whereas deoxy[Hb + Mb] can show a vastly larger range of increase (e.g.,
10-160%), with the authors finding that when Δdeoxy[Hb + Mb] values were greater than
~50% of deoxy[Hb + Mb]bl values the Q̇cap response showed a nonexponential or negative
adjustment during exercise, which is deemed unphysiological. However, in their study,
Murias et al. (2012) used a bout of ‘priming’ exercise (which would create an excess of
BF), which was not used in the present studies. Nevertheless, caution should be exercised
when using Q̇cap as a representation of microvascular BF.
Future Directions
One of the most intriguing (and unexpected) findings of this thesis was the speeding of
bulk BF kinetics when an exercise transition was initiated from the highest WRbl. While it
is postulated that this was a result of the intensity domain from which the transition was
initiated (HVY), or perhaps the intensity domain that the transition finished in (VH), this
cannot be stated decisively. This is largely limited by the decision to not individualize each
subject to their own relative intensity domains. Therefore, future studies should look to
adjust WRs to each subject’s relative intensity domain to help elucidate the source of this
speeding in bulk BF kinetics. Furthermore, a more direct comparison for determining
whether this speeding of BF kinetics is due to the WRbl or the WR that the subject is
transitioning to would provide better focus on the cause of this speeding.
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Additionally, in Chapter III there was a trend (p < 0.10) for BF kinetics to be slowed with
increasing ΔWR. Further study on bulk BF kinetics in response to increasing WRs may
want to include a larger sample size and use of actual “intensity domains,” rather than
simply “absolute WRs,” may also help to better define this potential relationship.
The decrease in the ΔBF/ΔV̇O2p ratio with transitions of both an increasing WRbl as well
as an increasing ΔWR was also an intriguing finding in these studies. A greater focus on
whether this relative decrease in bulk BF for the metabolic rate is compensated for by a
more efficient redistribution of microvascular BF within the active musculature could help
reveal the source of this response.
Lastly, future studies should consider incorporating a more direct measure of
microvascular BF, such as contrast enhanced ultrasound, instead of calculated Q̇cap. This
would allow for a more accurate quantification of the role of microvascular BF on the bulk
BF response, especially at higher WRs in which the microvascular network may be fully
perfused within the exercising muscle.
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Figure A. Normalized muscle deoxygenation (deoxy[Hb + Mb]) response profiles for: A,
transitions from a common baseline WR (3 W) to different ΔWRs; B, transitions of a
common ΔWR (21 W) from elevated baseline WRs.
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